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Abstract 
Research aiming to understand pathogens in infection is shifting rapidly towards 
considering not only the individual pathogen but the whole microbial 
community. Therefore, understanding microbial communities through exploring 
the key questions in community ecology, such as the relationship between 
diversity and stability, are relevant here also. Research has made considerable 
progress in characterising microbial communities of different body sites but the 
human oropharynx microbiome is still among the less well known despite its 
importance in hosting various commensal bacteria and being an important entry 
site for pathogenic intrusion. Determining the healthy oropharynx microbiome 
will allow comparison to various disease scenarios and the attributes that change 
a community from a healthy to diseased state. 
This thesis represents the most comprehensive survey of looking at the 
longitudinal bacterial community structure in the oropharynx. Here, analysis was 
done on the bacterial oropharynx microbiome composition, its natural 
fluctuations and stability, and relating these to the changes that occur to the 
microbiome before, during and after an infection. This involved initial swabbing 
of the oropharynx of eighteen baseline-healthy, non-smoking participants weekly 
for a total period of 9 months and sequencing the V1-V2 region of the 16S rRNA 
gene using Illumina MiSeq sequencing. This would determine the community 
make up that is representative of a healthy state. This was then directly 
compared to oropharyngeal samples taken weekly from 12 smokers within the 
same age range for a total period of 6 months to observe the community 
differences between smokers and non-smokers. 
Looking at the healthy participants (non-smokers) alone, the key taxa recovered 
were Firmicutes at phylum level and Streptococcus, Prevotella and Veillonella 
at genus level; these were the most abundant taxa in healthy samples. There 
was variation in taxa within and between participants, but this variability in 
microbial community structure occurred more at genus and OTU level. 
Variability was influenced by changes in health status, although environmental 
factors were also likely to play a role even though they were not investigated 
here. Disturbances to the oropharynx microbiome were shown in participants 
that had cold-related symptoms (negative for viruses) and antibiotic treatment. 
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These communities had decreased diversity (as opposed to high diversity healthy 
communities) and changes in abundances of certain taxa. However, participants 
recovered quickly from these disturbances (within one week after the 
disturbance) in that the microbiome returned to a state similar in community 
composition prior to the disturbance. This showed the oropharynx microbiome of 
baseline-healthy participants to be relatively resilient and stable as samples 
from the same participants were similar on a weekly basis.  
Looking at smokers, they had distinct changes in the bacterial community of the 
oropharynx in comparison to non-smoking healthy participants. This included 
changes in abundance of taxa with increased Bacteroidetes, Proteobacteria and 
Actinobacteria at phylum level and Streptococcus at genus level and increased 
abundances in pathogenic microorganisms such as S. pneumoniae which overall 
affected the functions associated with the bacterial community. These 
communities also appeared stable (regardless of having an altered state) in that 
samples from smoking participants were also similar on a weekly basis, but 
interestingly, were only disrupted during antibiotic treatment and not during an 
infection from samples with cold related symptoms. 
Therefore this thesis provides insight into the oropharynx microbiome of healthy 
participants (non-smokers) and smokers. It examines the stability and resilience 
of the oropharynx microbiome during specific scenarios and identifies the key 
and important taxa in a healthy and unhealthy community. By continuing to 
develop this research it may be possible to identify, treat and restore 
respiratory diseases by examining the oropharynx microbiome through 
identification of taxa and functions. 
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1    Introduction 
Microorganisms are microscopic living organisms including bacteria, viruses, 
protozoa and archaea. Many are abundant in the human body, but only recently 
have the composition, structure and function of the bacterial components of 
these communities at different body sites been investigated (Cho & Blaser, 
2012). Techniques used previously to study microbiology such as culturing were 
limited, with many bacteria (especially anaerobic bacteria) remaining 
uncultivable due to requiring different growth conditions or long incubation 
periods (Jones, 2009). However, advances in culturing due to formation of 
complex and nutrient rich media have now made it possible to culture various 
anaerobic bacteria from the gastrointestinal (GI) tract (Browne et al., 2016). 
There has also been an increase and expansion in non-traditional molecular 
methods such as DNA sequencing (Petrosino et al., 2009) resulting in fast and 
less laborious detailed investigations and analysis of microbial communities in 
the human body, where it has now been discovered that each different body site 
or niche is home to millions of microorganisms living as a community. In order to 
develop understanding of these complex ecosystems it is essential to explore and 
investigate the microbial diversity and variation in a healthy and diseased state 
which will create the basis for subsequent analyses such as identifying key taxa 
responsible for shaping the structure and function of these communities.  
 
1.1 Investigating the microbiome 
 
The term microbiome is a relatively new one, first coined by Joshua Lederberg 
to describe any ecological community of commensal, symbiotic and pathogenic 
microorganisms that share our body space (Hooper, 2001). Microbiota studies 
refer to the identification of bacteria whereas microbiome projects identify 
bacteria, genes and genomes as well as environmental conditions of the 
community. The collection of genes and genomes within a community is also 
known as the metagenome. However the term microbiome is increasingly being 
used in studies that also only refer to the microbial community and so for this 
reason the term microbiome was specifically used in this project to characterise 
the bacterial community and to identify the predicted functions associated with 
16S rRNA gene datasets. Most microbiological studies have historically focussed 
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on investigating the disease causing microorganisms found in the human body, 
with little recognition of the benefits of the residential bacteria. With the 
completion of the human genome sequencing project in 2001 (International 
Human Genome Sequencing Consortium, 2001) discussions regarding a second 
human genome project arose that would detail the microbial genes and genomes 
at particular body sites (Relman & Falkow, 2001) giving an insight into the role 
of endogenous microorganisms in healthy individuals. The benefits of such a 
project would be to understand the organisation of microbial communities all 
over the human body and their potential influence on health. These initial 
studies and findings were pivotal in determining the aims and procedures of the 
Human Microbiome Project (HMP).  
 
1.2 The Human Microbiome Project 
 
In 2008, the National Institute of Health (NIH) led a 5 year wide scale research 
project to determine the components of microbial communities at various body 
sites with the aim to understand the roles of the human microbiome. The NIH 
described the concept of the microbiome as the entire community of microbes 
that inhabit the human body, their genetic elements and their environment 
(Petrosino et al., 2009). The main aim was to characterise the human 
microbiome and its role in health. To achieve this aim, healthy individuals were 
recruited for sampling each individual microbiome (Figure 1.1) to determine if 
individuals shared a core microbiome at the lowest taxonomic level that was 
dependent on body site (species level), and to understand if changes in the 
human microbiome within and between individuals could be correlated with 
changes in human health.  
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Figure 1.1 - The workflow process involved in recruiting and determining the 
microbiome of various body sites in the Human Microbiome Project (HMP). The 
areas tested included 9 oral sites, 4 skin specimens, 1 nostril sample and 1 stool 
sample, with 3 additional samples collected from the vagina in women. 
Sequencing of the 16S rRNA gene was performed using 454 pyrosequencing 
whereas Illumina platforms for metagenomics analysis were selected to explore 
community function. 
 
The HMP also had various goals over the course of the project that would enable 
them to develop a reference set of microbial genome sequences, explore and 
develop new tools and technologies for computational analysis and examine the 
ethical, legal and social implications involved in studying the microbiome. To 
investigate the microbiome, millions of DNA sequences were analysed through 
taxonomic assignment and clustering to identify operational taxonomic units 
(OTU) at the lowest taxonomic assignment, usually genus or species level. An 
example is oligotyping, a process which allows investigation into the diversity of 
closely related bacteria through determining variations in the 16S sequences 
(Eren et al., 2013). It is a supervised computational method that investigates 
and reveals the microbial diversity concealed within OTUs by focussing on the 
variable sites in sequences that contain the most discriminating information. 
This uses Shannon entropy rather than pairwise sequence similarity to discard 
low-entropy nucleotide positions providing ecological information of microbial 
communities. 
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This investigation produced extensive datasets of which the main results are 
summarised: The microbiota consists of 10-100 trillion symbiotic microbial cells 
(Cho & Blaser, 2012) (Segata et al., 2012). Each body site contains a vast number 
of microbes living as a complex microbiota that vastly exceeds the number of 
human cells. Body sites showed differences in microbial richness (Huse et al., 
2012). At the lowest taxonomic classification level of identifying bacteria to 
genus and species level, the oral site had the most number of shared OTUs 
between healthy people whilst the vagina and skin had the least number of 
shared OTUs when looking at the numbers and percentages of OTUs; an OTU is 
classified as a specific type of bacterium based on sequence similarity, usually at 
a cut off level at 97% identity (Schloss & Westcott, 2011). The abundance of 
microbes and diversity of communities on each body site varied widely amongst 
healthy individuals (Huse et al., 2012). Even though key taxa were present at 
each body site (taxa that were always the most abundant) there was still a lot of 
variation in these abundances within and between healthy individuals. This 
individual variation of bacteria can be a result of natural variation, as well as 
external factors such as diet and lifestyle choices (The HMP Consortium, 2012). A 
core microbiome representing health was not found (Huse et al., 2012). A core 
microbiome was defined as OTUs being present in 100% of samples. However a 
healthy state could not be described by identifying the OTUs (at species level) as 
very few shared OTUs were found across all subjects. The functions of 
communities at different body sites were not influenced by microbial 
abundances (The HMP Consortium, 2012). Even though there was great variation 
in microbial abundances in body sites across individuals, the metabolic pathways 
remained the same suggesting that a community of microbes (rather than 
individual species) are responsible for function. This was shown by Arumugam et 
al., (2011) where healthy individuals were classified into three different 
enterotypes based on the taxa found in their GI tract. These enterotypes were 
each dominated by Bacteroides, Ruminococcus or Clostridiales and Prevotella at 
the genus level and all three enterotypes had the same metabolic pathways such 
as carbohydrate and amino acid metabolism (Turnbaugh & Gordon, 2009). This 
research showed that even though the healthy GI tract had variability in taxa in 
individuals, this did not interfere with the functions provided by that 
community. This study highlighted the importance of investigating the 
abundances of taxa present in addition to the function of communities, but to 
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also understand that variation between individuals is still representative of a 
healthy state.  
 
These initial findings led to a massive increase in microbiome related projects 
where studies explored taxa compositions in specific disease scenarios. The 
microbiome may be responsible for influencing various processes such as 
metabolism (Turnbaugh & Gordon, 2009), immunity (Lozupone et al., 2012) and 
resistance to pathogens (Gao et al., 2014), all of which are beneficial to the 
host. But there is now evidence to also link taxa abundances and microbiome 
changes in various disease states as shown in Table 1.1 which describes 
associations of bacteria with specific diseases. These studies collectively 
highlight the importance of studying the microbiome in health and disease as 
correlations between microbial abundances and disease have been established. 
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Table 1.1 – Microbial abundances associated with specific diseases. 
Disease types Microbial abundances in disease 
Childhood onset asthma H. pylori absent in stomach (Blaser et al., 
2008) 
Colorectal cancer Increases in Fusobacterium spp in colorectal 
tumour tissue (Warren et al., 2012) 
Crohn’s disease Increase in Enterobacteriaceae in biopsies 
taken from the terminal ileum and rectum 
(Gevers et al., 2014) 
Irritable Bowel Syndrome 
(IBS) 
Decrease in Bacteroidetes and increase in 
Enterobacteriaceae in faeces (Distrutti et al., 
2016) 
Periodontitis Higher diversity in communities and increase 
in Spirochaetes from oral cavities (Abusleme 
et al., 2013) 
Psoriasis Increased ratio of Firmicutes to Actinobacteria 
on skin (Zhan et al., 2008) 
Obesity Increased ratio of Firmicutes to Bacteroidetes 
in faeces (Turnbaugh et al., 2009) 
Schizophrenia Increase in lactic acid bacteria in 
oropharyngeal communities (Castro-Nallar et 
al., 2015) 
Vaginosis Higher diversity in communities and a 
reduction in Lactobacillus (Ravel et al., 2013) 
 
Therefore, identifying the taxa at different classification levels in the 
microbiome of a specific body site is only a starting point for understanding its 
influence on the host. Further challenges exist in considering the biotic 
interactions, community assemblage and evolution within these communities 
(Castro-Nallar et al., 2015) (Fierer & Lennon, 2011). In addition, the variation 
present between healthy individuals and its relevance must be investigated to 
fully determine the roles of the microbiome in health and then compare this in 
disease situations.  
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1.3 Understanding the ecology of microbial communities 
 
Microbial ecology investigates communities of microorganisms living together in 
a specific environment and the interactions between them and their 
environment (Konopka, 2009). One goal of ecology is to measure, understand 
and predict biodiversity and function of an ecosystem whereas microbiome 
projects aim to identify the microorganisms present and how their functions 
influence the host. With the increasing microbiome data available there is a 
growing interest to apply ecological theory to analysis and thereby gain an 
improved understanding of why these communities have the structure and 
functions observed. This section will explore the common and increasing 
ecological terms and theories applied to microbiome studies. 
 
The microbiome can affect the host organism in many ways by influencing 
attachment of secondary colonised microorganisms and interacting with 
pathogenic species, consequently affecting risk of disease. Such conclusions 
require an understanding of the ecological processes in microbial communities. 
Resilience is an important term that can be described as measuring the 
fluctuations in a community and its ability to withstand and recover from 
disturbances through looking at community composition; stable communities 
tend to have minimal fluctuations as well as quick recovery from drastic 
community changes. To illustrate the role of ecology in understanding the 
function of the human microbiome, the GI microbiome, a reasonably well-known 
part of the human microbiome, provides a good example. The healthy GI tract 
consists of two main phyla Bacteroidetes and Firmicutes (Turnbaugh et al., 
2009) forming usually a stable community with the former phylum in dominance. 
Bacteroidetes regulates various metabolic activities such as the breakdown of 
substrates and carbohydrate metabolism. A disturbance in this proportion such 
as a decrease in Bacteroidetes and increase in Firmicutes has been associated 
with a predisposition to obesity in humans (Turnbaugh et al., 2009) resulting in 
an unstable and disease prone state. Obese subjects were found to have higher 
levels of Firmicutes and a greater expression of obesity prone genes. Therefore 
the phylum Bacteroidetes may be regarded as a key phylum in shaping the 
community and maintaining the health of an individual whereas an increase in 
Firmicutes may contribute to decreased diversity and instability. Therefore, 
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community properties such as abundance, biodiversity and stability (Table 1.2) 
may be key features in linking the human microbiome to health and disease. It is 
crucial to understand how and to what extent these properties shape a 
community in health, disease and post disease, and many of these theories can 
now be tested in microbiome studies (Li & Ma, 2016). The details of important 
processes differ in different communities but the common theme in an 
ecological viewpoint is that it focuses on a wider context than on a single 
species; between-species interactions and/or interactions with the environment 
are considered even if the whole community is not always of interest.  
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Table 1.2 – Key terms in microbial community ecology. 
Ecological 
term 
Definition and importance to microbiome studies 
Colonisation 
resistance 
The process of when a bacterial community forms and maintains a 
barrier for protection from invading pathogens (Robinson et al., 2010) 
Community A group of different microorganisms living together in a particular 
environment (Konopka, 2009) 
Community 
assembly 
Processes that build and shape the community. These processes can 
include dispersal, diversification, environmental selection and 
ecological drift (Costello et al., 2012) 
Dispersal Movement of microorganisms across space (Costello et al., 2012) 
Diversification Evolution of divergent ecological traits (Costello et al., 2012) 
Diversity Species richness and evenness present in a community (Fierer et al., 
2012). This can be broken down into : 
Alpha diversity - diversity measured in a single habitat or community 
Beta diversity – diversity between habitats 
Gamma diversity – diversity of an area that is composed of many 
habitats 
Ecological 
drift 
The processes of birth, death, colonisation and extinction to 
determine the diversity and species of local communities that are 
independent of traits and niches (Rosindell et al,. 2012)  
Environmental 
selection 
Role of the environment in shaping the community (Costello et al., 
2012) 
Functional 
redundancy  
The concept of where the function of a community remains the same 
after a decline of one type of species resulting in other species to 
compensate to provide the same function (Lozupone et al., 2012) 
Relative 
abundance 
Proportion of a microorganism relative to the total number of 
microorganisms in a community 
Resilience Rate of recovery after a disturbance to a community, it can be a 
measure of stability (Robinson et al., 2010) 
Resistance Degree to which a community is unchanged when the environment 
changes, it can be a measure of stability (Robinson et al., 2010) 
Stability The ability of a community to withstand or recover from disturbances 
(Robinson et al., 2010) 
 
Diversity is an important measure in microbiome studies that can be calculated 
in many ways. Alpha diversity can be measured by various indicators that take 
into account species richness (the number of different species present) and 
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species evenness (the spread of the species present). Taking into account the 
species richness and evenness is known as the relative abundance. This includes 
the Shannon-Wiener Index (H) that ranges from values of 0 to 5, with the higher 
value representing higher diversity. Simpson’s Index (D) is a measure of 
dominance and gives the probability that individuals drawn at random from a 
large community belong to different species. Values range from 0 to 1, with the 
higher value representing dominance in the community. On the other hand, beta 
diversity measures the change in species diversity between communities by 
calculating the number of species that are not the same in 2 communities. 
Indices used to calculate beta diversity can measure the similarity and 
dissimilarity of communities by investigating abundances or presence and 
absence data. An example is the Bray-Curtis dissimilarity index which uses 
clustering to determine the dissimilarities between samples using abundance 
data. This gives values ranging from 0 to 1, with a value of 1 indicating 2 
samples not sharing any species and so being extremely dissimilar to each other.   
 
Determining the diversity of communities is important because high diversity 
communities may prevent extinction of bacteria as well as allowing bacteria to 
adapt to changes in the community (reduction or elimination of some species) 
therefore regulating the behaviour and function of communities. Stability on the 
other hand, refers to the ability to withstand and return from disturbances to a 
state similar to before the disturbance and stable communities tend to be highly 
resilient (Fierer et al., 2012). In community ecology, stability has been linked to 
diversity. Since the seminal work by ecologists MacArthur and Elton, low 
diversity has been linked to many diseases, whereas high diversity has been 
linked to a more stable and resilient environment that may be more immune to 
changes (Richardson & Pysek, 2007). Elton argued that the simplest communities 
are more vulnerable to invasion (McCann, 2000) suggesting that high diversity 
communities are more prepared for perturbations due to having more species 
that will respond differently to the perturbation. If this is the case then diversity 
may be responsible for providing functional redundancy as a means to protect 
key processes for community survival (Konopka, 2009). If individual species can 
contribute to a range of functions, the community as a whole may survive on less 
diversity when challenged to still maintain stability as long as they have those 
key species present; also known as the insurance hypothesis (McCann, 2000). 
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High levels of diversity in communities have been seen as beneficial and 
favourable to protect communities from disturbances by broadening the 
sustainable conditions in which the community can endure.  
 
The diversity/stability debate aims to understand whether diversity is associated 
with community stability. This can be tested by identifying perturbations that 
disturb the community to test the resilience and ability to resist invasion, whilst 
observing if any changes to diversity occur throughout the process. Various 
studies suggest a high diversity community is indicative of a healthy and stable 
state (McCann, 2000), whereas low diversity communities represent disease and 
unstable environments. This has been shown in obesity which is linked to a low 
diversity state (Turnbaugh & Gordon 2009). By having a high diversity 
community, the community will still be able to maintain the stability and 
functions of the community. The role of the gut microbiome has also been shown 
to be important in Inflammatory Bowel Disease (IBD) where a low diversity 
community has been observed from the intestinal microbiome of IBD patients in 
comparison to healthy controls. In IBD there are decreases in the abundance of 
anti-inflammatory species such as Faecalibacterium prausnitzii which are known 
to reduce inflammation by releasing anti-inflammatory cytokines and produce 
short chain fatty acids such as butyrate (Khan et al., 2012) which the host 
cannot produce itself. Therefore certain bacteria in the GI tract are needed for 
metabolism and to maintain a healthy state. By having a high diverse 
community, it provides insurance to the community that another species can 
help contribute to the overall functions of the community. However, there are 
exceptions to this theory as the vaginal tract consists of low diversity 
communities dominated by Lactobacillus which is representative of a healthy but 
stable state (Ravel et al., 2013). The onset of vaginosis results in a reduction in 
Lactobacillus and an increase in diversity resulting in decreased stability which 
allows colonisation by other microorganisms and the possibility of other 
infections. More studies investigating this in the microbiome are required to see 
if there is a general pattern of diversity and stability linked to health and 
disease. 
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1.4 Exploring the human oropharynx microbiome 
 
This thesis investigated the human oropharynx microbiome in two groups of 
populations, non-smokers and smokers. The oropharynx (the part of the throat 
immediately below the nasal cavity) was specifically chosen due to the presence 
of commensal bacteria in addition to being an important entry point for 
pathogenic bacteria. 
 
1.4.1 The healthy oropharynx microbiome 
 
The human pharynx consists of three main parts as shown in Figure 1.2. The 
oropharynx is constantly exposed to inhaled and ingested microbes, those 
cleared by mucociliary mechanisms from the respiratory tract and those 
contained in saliva, food and water. It is a niche for various microorganisms 
made up of bacteria, viruses and yeast, with the majority of the community 
dominated by bacteria. The oropharynx is home to various commensal species, 
many belonging to the Streptococcus and Prevotella species but is also a site for 
many pathogenic bacteria such as Streptococcus pneumoniae (Pelton, 2012) 
Haemophilus influenzae and Neisseria meningitides (Gazi et al., 2004). The 
oropharynx is dominated by the specific phyla Firmicutes and Bacteroidetes with 
other phyla (Proteobacteria, Actinobacteria and Fusobacteria) residing at less 
prevalent numbers (Lemon et al., 2010). 
 
 
Figure 1.2 – A representation of the different parts of the human pharynx as 
adapted from Matsuo et al., (2009). 
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1.4.1.1 Diversity and variation in the healthy oropharynx microbiome 
The oropharynx microbiome is a diverse habitat that has previously been shown 
to include a range of 400-800 different taxa from individuals (Lemon et al., 
2010). These individuals varied in the spread of abundance (evenness) in samples 
but samples from the same individual were shown to be more similar in 
comparison to samples from other individuals; there was also greater variation in 
the diversity between individuals. However, individuals did have large intra-
personal variation which was increased at further taxonomic levels showing that 
variation in microbial abundances and taxa within samples is common and 
representative of a healthy state. This highlights the extent of variation in 
microbes within and between individuals but also the importance of identifying 
variation to determine what is considered healthy for individuals. 
1.4.1.2  Microbial community functions in the oropharynx 
Microbiome studies are now focusing on identifying functions of microbial 
communities. This gives an indication of the processes the community 
contributes to in the host in both healthy and diseased states which in turn 
determines how exactly the microbiome changes during a specific disease 
situation and what consequences this has for the host. Literature investigating 
the functions of the oropharyngeal microbial community is limited. Evidence 
regarding the functional diversity of the respiratory tract has shown microbial 
communities from the healthy oropharynx to be associated with pathways 
involved in ATP synthesis and lipid and carbohydrate metabolism (Castro-Nallar 
et al., 2015). Detailed characterisation of the functions associated with 
oropharyngeal microbial communities in health is needed to fully understand 
how variation of microbial communities affects function. This can then be 
compared against disease scenarios to show how the oropharynx microbiome 
affects the host during a specific disease and if this impairs function.  
1.4.2 The diseased oropharynx microbiome 
 
In order to fully understand the potential role of the oropharynx microbiome in 
health, it is also required to investigate the oropharynx microbiome in a 
diseased state. The effects of infections such as the common cold, pharyngitis 
and tonsillitis on the oropharynx microbiome are currently being investigated 
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through exploring and examining the changes that occur in the microbiome 
during these infections. These infections tend to be viral; however, pharyngitis 
and tonsillitis could also be caused by bacterial pathogens. The relationship 
between viral infections and the oropharynx microbiome is gaining interest and 
there has been evidence showing Rhinovirus (one of the viruses responsible for 
the common cold) resulting in increases in Neisseria and Haemophilus in the 
nasopharynx (Hofstra et al., 2015) which possibly leads to secondary bacterial 
infections. In another study, Leung et al., (2012) showed that infection by a 
certain strain of influenza (pH1N1) resulted in a decrease of commensals 
Prevotella and Veillonella and an increase in pathogens such as Pseudomonas 
showing that viral infection does interfere with the host microbiome. However, 
additional studies are needed to explore this relationship in order to fully 
understand the role of viral infections on bacterial populations.  
 
1.4.2.1 Can the oropharynx microbiome be a marker for other illnesses? 
Understanding the oropharynx microbiome in healthy individuals and its response 
to a disturbance could potentially be used as a model for disease scenarios. 
Changes in the oropharynx microbiome (in comparison to a control group) have 
been discovered in patients with laryngeal cancer. Significant differences were 
found in abundances of the following organisms with increases in Fusobacterium 
nucleatum, Fusobacterium sp. oral taxon and Prevotella intermedia with 
reductions in Streptococcus sp. oral taxon and Streptococcus parasanguinis 
(Gong et al., 2014). At the phylum level there was also a significant increase in 
Fusobacteria which is not considered as a dominant phylum of a healthy 
community.  
Changes in the oropharynx microbiome at the phylum and genus level were also 
observed in individuals who suffered from schizophrenia (Castro-Nallar et al., 
2015). Schizophrenic subjects had higher abundances of the fungi Ascomycota 
and lactic acid bacteria such as Lactobacilli (especially Lactobacillus gasseri) 
and Bifidobacterium, as well as a reduction in Neisseria and Capnocytophaga. 
Functionally, schizophrenic patients had an increased number in pathways 
related to metabolite transport systems, whereas controls had more pathways 
involved in energy metabolism (Figure 1.3). This showed that the different 
microbial communities in controls and patients resulted in different functional 
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abilities. However, whether these functions play a role in exacerbating disease 
or symptoms still remains to be discovered especially as schizophrenic patients 
may have completely different behaviours and diets in comparison to control 
groups. This shows that studies investigating the microbiome in a disease and 
control group need to be carefully planned and executed to take into account 
external factors that may influence the results. 
 
Figure 1.3 – The most abundant functional pathways present in schizophrenic 
patients (blue) and the control group (red). The pathway for pyrimidine 
metabolism was an exception in that it was abundant in both groups. 
1.4.3 The effects of smoking on the oropharynx microbiome 
 
The role of the microbiome in disease and the effects of environmental stimuli 
such as smoking are now being investigated. With smoking increasing the risk of 
infectious diseases (Bagaitkar et al., 2008) it is only expected that smoking will 
also alter the microbiome; smoking may promote pathogenic microbial 
colonisation by disrupting mucocilliary processes and impairing host immune 
responses against pathogens (Tamashiro et al., 2009). Charlson et al., (2010) 
reported evidence for the presence of distinct communities in smokers and non-
smokers but this has not been done on a longitudinal basis. The effects of 
cigarette smoke have been explored in the oral cavity with increases in 
Parvimonas, Fusobacterium and Campylobacter species, whereas the oropharynx 
has shown increased abundances in Megasphaera and Veillonella with decreased 
proportions of Fusobacterium and Peptostreptococcus (Charlson et al., 2010). 
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Smokers have also shown increased diversity in their samples – there was an 
increase in pathogens associated with disease, but also microorganisms not 
previously recognised with disease (Charlson et al., 2010). However more 
investigation is required when studying the effects of smoking in all microbiomes 
– there needs to be more focus in how exactly smoking changes the microbiome 
and whether it is a cause or effect process; does the effects of cigarette smoke 
actually kill off some species whilst enabling others to survive, or does smoking 
result in defective host immune responses and increased inflammatory responses 
which in turn changes the microbial community structure enabling infection to 
occur. It is also unknown if the effects of smoking on the microbiome are 
reversible and whether these changes affect the overall function of the 
community. 
 
1.4.4 Significance of the oropharynx microbiome 
 
It is estimated that 6 million deaths occur globally as a result of smoking and 
smoking related causes, whereas acute respiratory infections result in an 
additional 4 million deaths (Ferkol & Schraufnagel, 2014). Smokers also have a 
higher death rate from respiratory diseases compared to non-smokers (Carter et 
al., 2015). Understanding how smoking affects the microbial communities over a 
period of time and the functions associated with the communities is important 
to investigate on any microbiome. However, in order to fully understand the 
effects of smoking, there must be an investigation in non-smoking and smoking 
individuals in both healthy and unhealthy scenarios. Investigating these two 
groups will be the foundation to determine what changes occur to the 
microbiome of a non-smoker during a respiratory infection and what changes 
occur to the microbiome of a smoker during a respiratory infection, as well as 
determining how long these changes last. Therefore, it is of interest to 
understand the structure and stability determinants of the oropharyngeal 
microbial community in non-smokers (both healthy and unhealthy states) and 
smokers. Therefore characterising the oropharynx microbiome of non-smokers 
will improve our understanding of why some individuals become colonised with 
pathogens while others do not.  It is still not known how these microbes interact 
together, the stability of these communities in regards to health and smoker 
status and what changes occur in these communities on a longitudinal basis 
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before, during and after a disturbance (cold symptoms) or infection. This 
research could be a starting point in making a clinical impact, where in the 
future it may be possible to diagnose oropharyngeal disease, restore diseased 
communities from the effects of smoking or even just give an indication of 
overall oropharyngeal health status from looking at the microbial populations 
alone.  
 
1.5 Molecular techniques used to explore microbial 
communities 
 
Modern microbial ecology requires using molecular techniques. The goal of using 
such molecular techniques is to study an entire microbial community sampled 
directly from its natural habitat. DNA-based microbiome studies usually fall into 
two approaches: either a marker gene (targeted amplicon studies) or the entire 
metagenome of the community is sequenced. Research presented in this thesis is 
based on amplicon sequencing of the 16S rRNA gene. 
 
1.5.1 DNA extractions 
Before investigating specific genes, genomic DNA must be isolated from 
bacteria. DNA can be isolated through various commercial kits which either 
involve bead beating to break down cells and expose the genetic material or a 
lysozyme step to hydrolyse the peptidoglycan present in the cell walls. The goal 
of DNA extraction is to have a final volume of DNA which can then be used for 
molecular processes. However there are various drawbacks and challenges in 
using DNA extraction kits. This includes obtaining low concentrations of DNA 
from difficult to lyse samples or low density communities. This can be overcome 
through optimising the DNA extraction protocol or using the bead beating 
protocol rather than lyzosyme based kits to ensure higher DNA concentrations. 
DNA contamination can also be introduced into the sample from any dead 
external bacteria remaining in the kit, which could be especially problematic for 
low density communities. This can be overcome through the use of DNA 
extraction controls where the protocol is run (not using any samples) to help 
determine the contaminating bacteria present in the kits. The controls are 
sequenced along with the samples and any reads present just in the controls are 
manually removed from the samples. 
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1.5.2 The 16S rRNA gene 
 
The gold standard of bacterial identification and community diversity 
characterisation is to sequence the highly conserved 16S rRNA gene which is 
ubiquitous in all prokaryotes (Pace, 1997). The 16S rRNA gene is conserved 
enough to enable the design of PCR (polymerase chain reaction) primers to 
target different taxonomic groups, but also has enough variability to provide 
phylogenetic comparisons of microbial communities (Woese, 1987). All 
prokaryotes contain the 1500 base pair long 16S rRNA gene for protein 
production, making it a useful tool in evolutionary studies. The gene consists of 
conserved regions and 9 hyper variable regions known as V1-V9 (Figure 1.4) 
varying from 50-100 bases; these sequences are used as targets for microbial 
identification and can be amplified through PCR. However there are drawbacks 
in using the 16S rRNA gene as some bacteria have multiple copies of this gene 
resulting in over amplification during PCR resulting in some bacteria being over 
or under represented. However, this can be overcome by statistical analyses to 
take into account over representation of taxa. PCR can also not determine the 
functions of the gene of interest, as PCR only indicates detection of the gene 
amplified. 
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1.5.3 PCR methods 
 
The PCR protocol was developed in 1983 by Kary Mullis (Bartlett & Stirling, 2003) 
in order to multiply genes to a significant concentration that is necessary for 
molecular and genomic analyses. The technique works by producing millions of 
copies of a desired gene within a few hours as shown in Figure 1.5.  
 
 
 
Figure 1.5 – The stages involved in a simple PCR reaction showing the crucial 
steps of denaturation, annealing and extension to produce copies of a target 
gene. 
 
Certain regions of the 16S rRNA gene can be amplified to investigate microbial 
community structure due its occurrence in all prokaryotes. However, as with all 
molecular methods, there are biases associated to it and its efficiency is reliant 
on the quality of the starting DNA, presence of inhibitory substances which can 
be extracted alongside the DNA, as well as other biases that need to be 
considered such as template concentration, number of cycles and chimera 
formation (Janda & Abbott, 2007). However, in spite of this, 16S rRNA gene PCR 
is a fast, effective and reliable technique used in microbiome studies (Petrosino 
et al., 2009).  
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1.5.4 Preparation of a DNA clone library for Sanger sequencing 
Clone libraries are a collection of DNA fragments that are stored in vectors each 
containing a different insert of DNA. Clone libraries are very useful for a 
preliminary observation into the community make up - the creation of a clone 
library for a particular gene such as the 16S rRNA gene is one of the most useful 
and widely used methods for initial community exploration (Leigh, 2010) which 
can then be used for the production of mock communities as the community 
make up is already known. Universal primers targeting the 16S rRNA gene are 
used to amplify the gene of interest. The amplified products are then cloned and 
inserted into E. coli vectors through transformation, with fragments digested 
with restriction enzymes and separated by gel electrophoresis (Figure 1.6).  
 
 
 
Figure 1.6 – The stages involved in preparing a clone library for initial 
community exploration. The 16S rRNA gene is PCR amplified and cloned into an 
E. coli vector in preparation for Sanger sequencing. 
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Due to the differences in DNA content, unique banding patterns are generated 
for each microorganism. Representatives of each different band are identified as 
a single operational taxonomic unit (OTU) - an OTU is classified as a specific 
type of bacterium based on sequence similarity, usually at a cut off level at 97% 
identity (Schloss & Westcott, 2011). Different OTUs are then selected and sent 
away for Sanger sequencing (Sanger & Nicklen, 1977), a technique that involves 
replicating single stranded DNA through the use of DNA polymerases to add 
nucleotides to a growing chain. This is stopped when it randomly incorporates a 
fluorescently labelled dideoxynucleotide (ddNTP) which results in DNA strands of 
different lengths. This process is repeated various times which in turn generates 
a large number of fragments that end in fluorescently labelled bases. The 
fragments run through a thin glass capillary where an electrical charge separates 
the fragments by size; the shorter fragments move faster than the longer 
fragments. The final fluorescent base of each fragment is recorded as it passes 
through the glass capillary allowing the original DNA sequence to be read.  
 
Sanger sequencing remains a useful method; however there are faster, cheaper 
and more efficient sequencing methods in use today. Thousands of clones may 
be required to document the actual richness of the community, hence the 
preferred choice of next generation sequencing (NGS) techniques. Nevertheless, 
clone libraries and Sanger sequencing are still beneficial for preparation of mock 
communities for use as positive controls and quality control for a sequencing 
run. 
 
1.5.5 Next generation sequencing 
DNA sequencing is now routinely used in various fields of study due to the 
introduction of NGS platforms allowing scientists to sequence a large number of 
DNA fragments in a single run. NGS platforms have made it possible to recover 
and characterise genomic material from a wide range of samples, allowing 
microbial community structure to be explored at a cost effective rate. An 
example is shotgun sequencing which allows the sequencing of the whole 
genome by separating the DNA into smaller fragments which can be individually 
sequenced and then reassembled. The advantages of shotgun sequencing are 
that it is a fast process that can produce large amounts of data. The 
disadvantages are that it requires a lot of computing power and errors can occur 
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during reassembly. The reassembly of genomes may also be difficult if there is 
not a reference genome already available. Different sequencing platforms are in 
use for amplicon studies, but they all require extraction of nucleic acids, library 
preparation for sequencing and bioinformatics processing (Vincent et al., 2016). 
However each platform comes with advantages and disadvantages in terms of 
their read length, quantity of data, run time and cost (Table 1.3) all of which 
must be considered when choosing a platform. 
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1.5.5.1 Illumina technology  
Illumina platforms are the most popular and economical NGS platform, 
accounting for 60% of all platforms used (Eisenstein, 2012). Today, five versions 
of Illumina sequencer are commercially available: HiSeq 2500, HiSeq 1000, 
Genome Analyser, Genome Analyser IIx and MiSeq. The Illumina MiSeq 
technology uses a unique paired end strategy where the DNA strand is sequenced 
from both ends with the forward and reverse reads aligned as a read pair to 
increase the length of the sequence reads.  
 
The process of MiSeq amplicon sequencing (Hodkinson & Grice, 2015) involves 
attaching library adapters to DNA fragments (Figure 1.7). The library is loaded 
onto a flow cell where the adapters from the DNA fragments attach to 
oligonucleotide adapters on the flow cell. These fragments are amplified locally 
within clusters to create high densities ready for sequencing, a process known as 
bridge amplification where the single stranded molecule flips over and forms a 
bridge by hybridising to an adjacent complementary primer. This in turn forms a 
double stranded bridge through extension by polymerases, but the double 
stranded DNA is then denatured resulting in single stranded templates. This 
process is repeated many times until a high density cluster is formed ready for 
sequencing. The actual sequencing process uses a reversible terminator based 
method incorporating one base at a time. Flows of 4 different fluorescently dyed 
deoxynucleotides (dNTP) are run over the plate and block incorporation once a 
dNTP attaches to the growing chain which in turn releases a fluorescent signal. 
After signal detection the dyes are cleared and another cycle of reagents is 
added as before allowing identification of the DNA sequence. Illumina 
sequencers are considered the best choice for use in microbiome studies due to 
the fast improving technology, longer read lengths and reasonable cost. 
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Figure 1.7 – The process of MiSeq sequencing as taken from Biggar & Storey, 
2014. 
 
1.5.5.2  Bioinformatics 
Next generation sequencing platforms are now capable of generating a high 
number of reads in a single run with an increased need for improved software to 
be able to handle large datasets. A read refers to a data string of nucleotides A, 
T, C and G that correspond to a DNA sequence. In order to remove low quality 
reads from true reads, a series of bioinformatics processes are necessary to 
produce high quality DNA sequences that can be used for statistical analysis. The 
workflow involves quality filtering of raw sequences which discards reads that do 
not meet the required quality or length thresholds. Reads are also checked 
against chimeric sequences. These are artificial sequences that are produced 
during PCR that do not represent amplicon products. The remaining sequences 
are then clustered into OTUs against a reference database which assigns DNA 
sequences to microbial species. There are various programs available that 
consist of multiple steps to prepare sequencing reads with the most common 
programs described in Table 1.4. AmpliconNoise was chosen due to decreased 
error rates, a greater number of reads and longer read lengths in comparison to 
Mothur (Gaspar & Thomas, 2013).  
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Table 1.4 – Various bioinformatics programs used in amplicon sequencing 
projects. 
Program Description of use 
AmpliconNoise Used mainly for 454 and Illumina generated sequences 
(Quince et al., 2011) and consists of 3 main processes:  
Pyronoise – detects any misreads in sequences 
SeqNoise – removes PCR mutations 
Perseus – removes PCR chimeras 
Mothur Open source software package for bioinformatics data 
processing (Schloss & Westcott, 2011) of raw sequences to 
OTU construction and phylogenetic construction  that can be 
adapted for processing data from various sequencing 
platforms including Sanger, PacBio, IonTorrent, 454 and 
Illumina 
QIIME 
(Quantitative 
insights into 
microbial 
ecology) 
Open source pipeline for analysis from raw DNA sequencing 
data (Caporaso et al., 2011). It can be used on sequences 
from 454 and Illumina platforms.  The processes involve 
demultiplexing and quality filtering, OTU picking, taxonomic 
assignment and phylogenetic reconstruction 
 
Quality control steps can also be added through using mock communities to 
check error rates and ensure the correct sequences are being sequenced. This 
can also be a way to check for any external contamination introduced into 
samples through preparing DNA extraction kit controls. Once reads have been 
filtered and quality checked, rarefaction is then used to assess the species 
richness from sampling depth and reads coverage to determine if all species 
within the community have been sampled. The reads can then be used for data 
analysis. This can include analysis investigating the genetic distance between 
the DNA sequences and testing variables in a statisitical model to investigate 
whether there are any correlations in taxa abundance and specific metadata. 
However there are many issues to take into account when analysing sequence 
data. This includes ensuring there are enough reads present in each sample for 
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sufficient sampling depth which could especially be a concern in samples with 
low reads. It is also important to determine what statistical tests to use and this 
will depend on whether data follows a normal distribution or not; data that has 
unequal samples sizes, a very small size or does not follow a normal distribution 
would require non-parametric tests. However there are disadvantages of using 
non-parametric tests some of which include losing some data and these tests not 
being as powerful in comparison to using parametric tests. Microbiome data can 
be visually analysed through various clustering and ordination methods with the 
statistical testing performed from using univariate and multivariate analysis. 
However, testing for more than one variable in microbiome studies is now 
extremely common especially in hypotheses that concern the effects of 
treatments as well as various factors on bacterial communites. Therefore 
multivariate analysis is useful for studies assessing the association of many 
variables with the microbiome in human health. 
1.5.5.3 Metagenomic techniques: assigning function to communities 
The majority of microbiome studies focus solely on the 16S rRNA gene, even 
though it is now possible to sequence all genes from a community. The benefit 
of this is to gain an insight into the overall function of a community as well as 
the potential functional properties of individual members. This technique is 
known as metagenomics and provides greater and richer data in the description 
and quantification of genes in a microbial community. The increase in 
metagenomic studies has also made it possible to assign predicted functions to 
communities from using only sequences from the 16S rRNA gene that have been 
previously assigned to a functional pathway from earlier metagenomic studies. 
As the 16S rRNA gene is a powerful marker gene as well as more cost effective 
than performing whole metagenome sequencing, this gene can be used to 
predict the functional capabilities of microbial communities based entirely on 
16S rRNA gene datasets. This is the basis of the Tax4Fun package available in R 
(Aßhauer et al., 2015) that is used to estimate the metabolic profile of a 
metagenome based on taxonomic abundance estimates and references using the 
Kyoto Encyclopedia of Genes and Genomes (KEGG) database (a collection of 
databases dealing with identification of genomes and biological pathways). This 
package is useful for initial exploration of the functions which could then be 
further investigated by metagenomic sequencing. This package has also been 
  48 
 
shown to have greater accuracy in predicting functions of 16S genes in 
comparison to PICRUSt (Aßhauer et al., 2015). However the disadvantages of 
using these packages is that it only predicts function from DNA sequences and 
not from RNA or proteins which are actually used to measure gene expression. 
1.5.6 Implications of using next generation sequencing in 
microbial ecology 
 
The use of NGS in microbial ecology is constantly advancing and expanding at a 
fast rate. However, various issues have occurred. The main issues with NGS 
technology include DNA extraction quality, PCR amplification, computational 
power, storage space, cost and analysis. In order to taxonomically assign DNA 
sequences, it is assumed that the reference database must contain DNA 
sequences that are correctly identified and annotated. However, current 
sequence databases may also be limited and not up to date. Although there are 
various databases such as BLAST, NAST and GenBank to identify and group 
sequences, the quality of these sequences are questionable. A study conducted 
by Clayton et al., (1995) showed that 26% of identical 16S rRNA gene sequences 
in GenBank had random sequencing errors questioning the true accuracy of that 
sequence representing the labelled species. In order to overcome this problem it 
is now reasonable to search a query sequence in at least 2 databases or 
alignment tools to show that the sequence does represent the query sequence. 
In spite of all this, NGS has and will continue to revolutionise and accelerate 
biological and biomedical research, allowing scientists to explore complex and 
new areas of microbiome study.  
 
1.6 Aims and hypothesis 
 
The main aim of this PhD project is to characterise the microbiome of the 
oropharynx in terms of microbial community structure and temporal stability in 
non-smoking individuals and smokers, and to identify the key factors associated 
with infection and recovery from these.  
 
The project will first characterise the oropharynx microbiome in non-smokers. 
This will determine the baseline oropharynx microbiome from healthy samples in 
non-smokers in terms of occurrence and relative abundance of different phyla, 
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genera and OTUs. This will then be compared to unhealthy samples from non-
smokers to determine what happens to the healthy community during a 
disturbance, infection and antibiotic treatment. The stability of the oropharynx 
microbiome in non-smokers will also be addressed. This will determine how 
much temporal variation is there in the oropharynx microbiome, how stable the 
oropharynx microbiome is, how long recovery takes from a disturbance and 
whether diversity is linked to stability.  
 
The next section will then compare the non-smoking microbiome to a smoker’s 
microbiome in terms of phyla, genera and OTU abundance. This will also 
compare the stability of non-smokers and smokers microbiomes to determine if 
smokers have a longer recovery time from a disturbance compared to non-
smokers. Finally the predicted functions of bacterial communities will be 
characterised in non-smokers and smokers to determine whether smokers have 
changed functions in comparison to non-smoking participants. 
 
The significance of investigating this work is that the oropharynx microbiome is 
less defined compared to other body sites but still a very important one to 
consider. Longitudinal studies are needed to determine the fluctuations that 
occur naturally and during disturbances in many participants, but to also 
investigate how the community is constructed first and how it changes. The 
healthy microbiome can then be established and compared to various disease 
scenarios and disrupted communities. For this reason, the main hypothesis for 
this project is as follows – healthy non-smoking participants will have a distinct 
and stable oropharynx microbiome over time, in comparison to a smoker’s 
microbiome which is expected to be unstable with a different microbial 
structure. 
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2 Materials & methods 
2.1 Recruitment and consent of participants 
 
The study was approved by the University of Glasgow Ethics Committee (Ethics 
Application 2012107 & 200140023) and recruitment of participants occurred 
through mass email targeting mostly students.  
 
2.1.1 Non-smoking participants 
 
Eighteen participants between the ages of 18 - 37 (39% male, 61% female) were 
recruited on the basis that they were healthy, non-smokers, had no respiratory 
disease or infection and were not on any long-term medication.  
 
2.1.2 Smoking participants 
 
Twelve smoking participants were recruited (using the same requirements for 
the non-smokers) between the ages of 19 – 40 (17% male, 83% female) on the 
basis that they had no underlying health issues and were not on any long term 
medication. 
 
2.2 Sampling periods and collection 
 
Swabs were collected for non-smoking participants and smokers over two 
separate time periods. The swabbing period for non-smoking participants started 
on 20 January 2013 until end of May 2013, recommencing in September 2013 
until December 2013 to represent semester times, although some participants 
continued to hand in swabs over the summer period. The swabbing period for 
smokers took place from 17 November 2014 to 14 June 2015 giving a sampling 
period of 30 weeks (excluding Christmas holidays). The smokers sampling period 
was shorter than the swabbing period for the non-smoking participants due to 
time and funding restrictions. As non-smokers and smokers were sampled in 
different years, this could also potentially introduce bias into the project, 
especially as non-smokers were also sampled in autumn whereas smokers were 
not. Other factors that could have been different during the two years include 
weather, pollen levels and levels of circulating microorganisms. Prior to 
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sampling, all participants were given a briefing of the project, a swabbing 
demonstration and a consent form to sign. 
 
2.2.1 Non-smoking participants 
 
Participants were provided with 2 swabs – Sigma Transwabs in liquid amies 
(Medical Wire Ltd, UK) for bacterial detection and flocked dry swabs (Copan 
Diagnostics Ltd, UK) for viral detection. Participants were shown how to take a 
swab of the oropharynx and were provided with swabs for practice before the 
official swabbing start date. The swabbing procedure involved washing hands 
before taking the swab, opening the mouth as wide as possible and touching the 
swab over the following areas – tonsil, posterior wall to tonsil as shown in Figure 
2.1. 
 
 
Figure 2.1 – The bacterial swab used for weekly swabbing (Fig. 2.1A) and a 
diagram showing how to take an oropharynx swab (Fig. 2.1B). 
 
This motion was repeated at least 5 times to ensure all the areas of the swab 
were used, with the swab then inserted into transport medium ready for 
storage. Participants were asked to take a swab every Monday morning as soon 
as they got up and before they had breakfast or brushed their teeth, in order not 
to disrupt their microbial community. Participants kept a diary stating the time 
when they took the swab and to record their overall health status. This involved 
noting if they were healthy or had any illnesses or symptoms, whether there had 
been any change in their normal routine (on holiday, change in diet or 
commencing any medication) and if they had touched any other surface in the 
mouth such as teeth, tongue or cheek. It was likely that participants would 
A B 
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become ill during the swabbing period, therefore participants were asked to 
record this and continue taking swabs throughout. During routine weekly 
swabbing, participants used the Sigma Transwabs for bacterial detection only.  
By contrast, if they had a fever, cold symptoms including runny nose, sore throat 
or a cough, illness, flu or were prescribed any antibiotic treatment participants 
were also asked to take a dry swab for viral detection (tested for a respiratory 
screen at Gartnavel hospital). This respiratory screen tested for the following 
viruses – Influenza A, Influenza B, Respiratory Syncytial Virus A, Respiratory 
Syncytial Virus B, Parainfluenza, Adenovirus, Rhinovirus, Human 
metapneumovirus and Coronaviruses NL63, 229E and CC43. 
 
Samples were collected on a weekly basis through a collection box so 
participants could drop off used swabs and collect new ones. Participants 
typically took a swab as soon as they got out of bed and all swabs were received 
before midday. During this period swabs were stored at room temperature in 
Amies transport medium but were frozen at ־20°C if they were not received on 
the same day of swabbing. Bacterial swabs were processed as soon as possible 
(typically within 2 hours after collection) for DNA extractions whereas viral 
swabs were taken immediately to West of Scotland Virology Centre (Gartnavel 
hospital) for a respiratory screen. Participant metadata including the number of 
samples received from each participant throughout the sampling period is shown 
in Table 2.1. 
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Table 2.1 – Summary metadata for non-smoking participants. 
Participant  Age at time of 
sampling 
(years) 
Sex Total 
number of 
samples 
received 
Number of unhealthy and 
antibiotic treated 
samples 
Cold Antibiotics Viral 
HA  26 F 34 2 0 0 
HB  21 M 2 0 0 0 
HC  18 F 16 2 0 0 
HD  23 F 24 0 0 1 
HE  23 F 7 1 0 0 
HF  21 M 22 0 4 1 
HG  20 F 8 1 0 0 
HI  37 F 31 4 0 2 
HJ  21 F 12 1 3 0 
HL  18 F 6 0 1 0 
HM  18 M 14 3 0 0 
HN  19 F 12 1 0 0 
HO  30 F 26 1 0 0 
HQ  21 M 9 1 0 0 
HR  19 M 14 0 0 0 
HS  31 M 30 1 0 0 
HT  23 M 30 0 0 0 
HV  18 F 16 1 0 3 
 
At the end of the sampling period, 313 samples were received in total and 
samples were broken down into the following groups – healthy (n=279 from 18 
participants), cold (n=19 from 12 participants - this includes samples that had 
the symptoms of a cold but were detected as negative for the standard viruses 
tested from the respiratory screen at Gartnavel hospital), antibiotics (n=8 from 3 
participants – this includes samples positive for antibiotic treatment) and viral 
(n=7 from 4 participants – this includes samples with confirmed viruses from the 
respiratory screen). The cold, antibiotics and viral samples were grouped as 
unhealthy samples. Even though the participants on antibiotics were on 
treatment for acne and not because of an infection, they were still categorised 
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with the unhealthy group due to disturbing the community structure. The 
metadata of atypical and unhealthy samples are shown in Table 2.2.  
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Table 2.2 - Metadata for atypical healthy samples and all unhealthy samples 
from non-smoking participants (all samples were included in analysis). 
Oropharyngeal samples are colour coded: green = healthy but with swabbing 
deviations, black = antibiotics, red = cold related symptoms and blue = viral.  
Samples Health status Samples Health status 
HA14 Cold symptoms, dry 
throat 
HI39 Cold, sore throat 
HA26 Runny nose HJ2 250mg erythromycin 
antibiotics twice daily (acne) 
HC9 Hit tooth after swabbing HJ5 250mg erythromycin 
antibiotics twice daily (acne) 
HC11 Touched back of tongue 
slightly before swabbing 
HJ7 250mg erythromycin 
antibiotics twice daily (acne) 
HC18 Cold, sore throat HJ37 Cold, sore throat 
HC44 Cold, sore throat HL3 Antibiotics 
HD9 Rhinovirus – sore throat HM5 Cold, sore throat 
HD27 Swab taken after holiday HM28 Cold, runny nose 
HE12 Cough, sore throat HM31 Cold, runny nose 
HF5 Respiratory synctial virus 
– fever, sore throat 
HN10 Hit tooth during swabbing 
HF10 Swab taken on holiday HN36 Cold 
HF13 Swab taken after holiday HO8 Runny nose 
HF20 Tetracyclines for acne HQ38 Cold 
HF23 Tetracyclines for acne HR14 Dropped swab on desk before 
swabbing1 
HF24 Tetracyclines for acne HS3 Swab taken after breakfast 
HF25 Tetracyclines for acne HS43 Cold, sore throat 
HG6 Cough, sore throat HT12 Swab taken after holiday 
HI2 Cold HV36 Rhinovirus – runny nose 
HI14 Sore throat HV37 Rhinovirus – fever, dry throat 
HI18 Cold, sore throat HV38 Rhinovirus – dry cough 
HI27 Rhinovirus – sore throat HV43 Sore throat 
HI28 Rhinovirus – sore throat 
                                         
1
  Sample included in analysis 
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2.2.2 Smoking participants 
 
Participants were given the same sampling instructions as described in section 
2.2.1, but were also asked to record the rough number of cigarettes smoked per 
week, with Monday as the start of the week. Participant metadata from each 
smoking participant throughout the sampling period is shown in Table 2.3. 
 
Table 2.3 – Summary metadata of smoking participants. 
Smoking 
participant  
Age at time 
of sampling 
(years) 
Sex Number 
of years 
smoking 
Total 
number of 
samples 
received 
Number of 
unhealthy and 
antibiotic treated 
samples 
Cold Antibiotics 
SA  40 M 20 23 0 0 
SB  19 F 5 3 0 3 
SC  19 F 2 23 2 0 
SD  19 F 1 8 1 0 
SE  19 F 5 1 1 0 
SF  19 F 4 19 0 15 
SG  33 M 15 25 0 0 
SH  30 F 13 25 5 0 
SI  30 F 10 24 3 0 
SK  19 F 5 10 2 0 
SL  19 F 3 10 0 0 
SM  19 F 3 6 0 0 
 
At the end of the smokers sampling period, 177 samples were received in total; 
samples were broken down into the following groups – healthy smokers (n=147 
from 12 participants - classified as healthy samples in that there were no 
symptoms of disease or infection), cold (n=14 from 6 participants - this includes 
samples that had the symptoms of a cold but were detected as negative for the 
viruses tested from the respiratory screen at Gartnavel hospital) and antibiotics 
(n=18 from 2 participants – this includes samples positive for antibiotic 
treatment). No viruses were detected from the viral swabs. Cold and antibiotics 
samples were grouped as unhealthy samples as described before with the 
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metadata of atypical and unhealthy samples from smoking participants shown in 
Table 2.4.  
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Table 2.4 - Metadata for atypical and unhealthy smoker samples (green = 
healthy with swabbing deviations, black = antibiotics and red = cold related 
symptoms). 
Samples Health status Samples Health status 
SB2 Lymecycline (408mg) one per 
day (acne) 
SF19 Tetralysal (300mg) once a day 
(acne) 
SB3 Lymecycline (408mg) one per 
day (acne) 
SF22 Tetralysal (300mg) once a day 
(acne) 
SB4 Lymecycline (408mg) one per 
day (acne) 
SF23 Tetralysal (300mg) once a day 
(acne) 
SC3 Cough, sore throat SF24 Tetralysal (300mg) once a day 
(acne) 
SC4 Cough SF25 Tetralysal (300mg) once a day 
(acne) 
SD2 Cold symptoms SH2 Touched tongue 
SE3 Cold symptoms, sore throat SH4  Sore throat 
SF9 Tetralysal (300mg) twice 
daily (acne) 
SH5 Sore throat, cold symptoms 
SF10 Tetralysal (300mg) twice 
daily (acne) 
SH8 Cough 
SF11 Tetralysal (300mg) twice 
daily (acne) 
SH9 Cough 
SF12 Tetralysal (300mg) twice 
daily (acne) 
SH18 Cold, sore throat symptoms 
SF13 Tetralysal (300mg) once a 
day (acne) 
SI4 Flu-jab received 
SF14 Tetralysal (300mg) once a 
day (acne) 
SI13 Cold, sore throat 
SF15 Tetralysal (300mg) once a 
day (acne) 
SI14 Cold, sore throat 
SF16 Tetralysal (300mg) once a 
day (acne) 
SI16 Cough 
SF17 Tetralysal (300mg) once a 
day (acne) 
SK3 Cold symptoms, sore throat 
SF18 Tetralysal (300mg) once a 
day (acne) 
SK14 Chesty cough 
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2.3 DNA extractions 
 
DNA was extracted using the QIAamp DNA Mini kit (Qiagen Ltd, UK) following the 
bacteria, swab and tissue protocol (Biesbroek et al., 2012) (Salter et al., 2014) – 
Appendix 1. A negative extraction (containing no sample) was performed each 
time the kit was used. These negative extractions were then sequenced to 
ensure minimal contamination from the reagents in the kit into samples. 
Extracted DNA was quantified using the Qubit and picogreen HS DNA assay 
(Invitogen Ltd, UK). A volume of DNA (5µl) was mixed with 2µl of loading dye on 
a 1% agarose gel (1g agarose to 100ml TBE) along with a 1Kb Invitrogen DNA 
ladder and ran at 100v for 60 minutes to check presence. The DNA was then 
stored at -20°C until required. 
 
2.4 16S rRNA gene PCR 
 
Due to the variability in DNA concentration extracted swabs (a range from 0.2-
50ng/µl), 16S rRNA gene PCR reactions were set up to ensure bacterial DNA was 
present. A 25µl reaction was set up with the following reagents – 12.5µl Bioline 
PCR Mix (Bioline Ltd, UK), 1µl of forward primer (12.5pmol), 1µl of reverse 
primer (12.5pmol), 2µl of DNA template (ensuring a DNA concentration of 10-
15ng depending on initial DNA template concentration) and 8.5µl of DNAse free 
water. The universal prokaryotic 16S primers used were 27F (5’-
GAGTTTGATCCTGGCTCAG-3’) and 1392R (5’-ACGGGCGGTGTGTRC-3’). 
 
The PCR amplification cycle was carried out at the following conditions: 
initial denaturation – at 95°C for 5 minutes, 30 cycles of denaturation at 94°C 
for 1 minute, annealing at 62°C for 1 minute and extension at 72°C for 1 minute. 
A final extension was carried out at 72°C for 10 minutes with a holding stage at 
4°C. A 1% agarose gel was prepared to run 10µl of amplicon product along with a 
1Kb Invitrogen DNA ladder at 100v for 60 minutes to ensure correct length of the 
amplicon product which represents the targeted 16S region (Figure 2.2). A 
positive control was set up using DNA from the mock community. A negative 
control was also set up to show no DNA was present in the PCR reagents and 
resulting in no amplification of the 16S rRNA gene.  
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Figure 2.2 – Diagram of a 16S rRNA gene gel showing the 1365bp amplicon 
product (labelled as samples 1-8) against a 1Kb Invitrogen DNA ladder. 
 
2.5 Preparation of a clone library for Sanger sequencing 
 
A clone library was prepared using the Invitrogen Topo-Seq Kit (Invitrogen Ltd, 
UK) as a quality control step to produce a mock community for future Illumina 
MiSeq runs. The purpose of the mock community was to act as a positive control 
for each MiSeq run to ensure that the correct sequences were being sequenced. 
DNA from 10 participants was mixed together in equal concentrations (3µl of 
5ng) for preparation of a clone library. The DNA was amplified for the 16S rRNA 
gene using specific bacterial primers and the amplicon product was loaded onto 
a 1% agarose gel along with a 1Kb Invitrogen DNA ladder and run for 60 minutes 
at 100V. The full protocol of performing a clone library is shown in Appendix 2. 
 
Each type of OTU (operational taxonomic unit) that had a unique banding 
pattern after restriction enzyme digest (as observed on the gel) was assumed to 
be a different species and was sent for Sanger sequencing to Source Biosciences 
Ltd (Cambridge, UK). In total 96 clones were analysed of which 38 different 
banding patterns were identified and were labelled as different OTUs; these 
OTUs were sent for sequencing. The forward and reverse strands were trimmed 
at each end using a program called DNA Dynamo Sequence Analysis Software 
(BlueTractorSoftware Ltd, UK) to produce a contig sequence which were then 
checked against BLAST (Altschul et al., 1990) to identify each OTU to species or 
genus level; sequences were identified to species level at a >97% identity cut 
off. The mock DNA community was prepared by diluting each OTU to 13ng/µl 
and using 3µl of DNA from 26 chosen OTUs; these were high quality sequences 
that had an overlap of at least 20 base pairs when joining the forward and 
reverse sequences to produce a contig sequence.  
1300bp 
Positive 
control  
 
Negative 
control  
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2.6 Optimisation of 16S rRNA PCR 
 
The V1-V2 region of the 16S rRNA gene was chosen for amplification and 
sequencing. The significance of this region was to try to identify bacterial 
sequences to genus and OTU level and to differentiate the different types of 
Streptococcus species in the oropharynx as research showed the genus 
Streptococcus as a dominant member of the healthy oropharyngeal community 
(Charlson et al., 2010) (Charlson et al., 2011). 
 
Primers were provided by the Sanger Centre (Cambridge, UK) and were specific 
golay barcoded primers covering regions 27F (AGMGTTYGATYMTGGCTCAG) and 
338R (GCTGCCTCCCGTAGGAGT). The total amplicon product expected after PCR 
amplification was 398bp including lengths of adapter and linker sequences. 
Primers were tested in a 25µl PCR assay using the HotStart High Fidelity Taq 
KAPA kit (Anachem Ltd, UK) with the following components: 12.5µl of readymix, 
0.75µl of dNTPs, 1µl of forward primer, 1µl of reverse primer, 1.25µl of dimethyl 
sulfoxide (DMSO), 6.25µl of nuclease free water and 2µl of DNA (DNA from the 
mock community at a concentration of 3ng/µl). Optimisation of the protocol 
included setting up a temperature gradient to determine annealing 
temperatures of primers, increasing primer concentration from 0.3mM to 0.4mM, 
decreasing extension time and increasing the number of cycles from 23 to 26 
cycles to accommodate for low DNA templates as shown in Figure 2.3. 
 
 
 
 
Figure 2.3 – Optimisation gels of the V1-V2 region showing amplicon products 
between 300bp – 400bp at different temperature gradients (from 54°C - 60°C) at 
23 cycles (Fig. 2.3A) and 26 cycles (Fig. 2.3B). 
400bp 
B A 
   54       55       56       57      58          
    54    55    56    57    58     59    60  
400bp 
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2.7 Amplification of V1-V2 region of 16S rRNA gene  
 
All samples were amplified in triplicate and each sample was assigned a 
different barcode to ensure identification during the sequencing process. The 
final optimised PCR reaction (25µl) was carried out at the following conditions: 
initial denaturation – at 98°C for 5 minutes, 26 cycles of denaturation at 98°C 
for 20 seconds, annealing at 54°C for 15 seconds and extension at 72°C for 30 
seconds. A final extension was carried out at 72°C for 1 minute with a holding 
stage at 4°C. A 1% agarose gel was prepared to run amplicon product at 100V for 
60 minutes with a 1Kb Invitrogen DNA ladder (Figure 2.4) to check length of 
amplicon product.  
 
 
Figure 2.4 – Example of a V1-V2 region amplified gel (samples 1-3 done in 
triplicate) at an annealing temperature of 54°C at 26 cycles with necessary 
controls. 
 
2.8 Quality assurance 
 
To reduce PCR biases, all template DNA was diluted to the same concentration 
and 26 cycles were used in each PCR run to reduce non-specific binding with 
appropriate controls in place. A positive (DNA from mock community) and a 
negative control (for each different reverse barcode using nuclease free water) 
was set up for each PCR run. To ensure that the source of bacterial sequences 
was not the swab itself or the DNA isolation reagents, PCR was performed on 
DNA isolated from an unused swab. To confirm that the PCR reagents were not 
the source of bacterial sequences, PCR of the no-template extraction control 
was also performed. Neither of these control PCRs yielded products visible on a 
gel, indicating that there was no or minimal contamination from the swab or 
reagents. Sequencing of the mock community resulted in 93% matched reads for 
400bp 
    1                   2                  3  Negative 
control  
 
Positive 
control  
 
400bp 
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the forward sequences (error rate of 0.9) and 90% matched reads for the reverse 
sequences (error rate of 0.9) using the Bioinformatics tool AMPLImock  
(https://bitbucket.org/umerijaz/amplimock/src) (D’Amore et al., 2016). This is 
a pipeline used to quantify error and matched rates of a mock community 
against known reference sequences. Quality assurance was done through 
presence and absence by identifying species that were present in the mock 
community but this did not account for species abundances.  
 
2.9 Normalisation and pooling of PCR amplicons for 
sequencing 
 
After amplification, each sample had a total volume of 75µl that was run on a 1% 
gel for extraction to clean up the DNA. Gel extractions were performed using the 
Qiagen Gel Extraction kit (Qiagen Ltd, UK) – protocol shown in Appendix 3. After 
the DNA clean up, the concentration of DNA was measured using the Qubit (HS 
DNA assay). Samples with low DNA concentration (less than 2ng/µl) were 
precipitated using ethanol to increase the final DNA concentration. 
 
Each sample was normalised to a concentration of 2.5ng/µl using nuclease free 
water. A mixed pool consisting of 130-150 samples was produced using 2µl of 
each sample. Each pool also consisted of a positive mock community control and 
a negative extraction kit control (Salter et al., 2014). The pool was checked for 
the correct length on a 2% agarose gel using 5µl of amplicon product at 90V for 
40 minutes with a 1Kb Invitrogen DNA ladder as shown in Figure 2.5. Each pool 
was then sent for 2 x 250bp MiSeq sequencing at the Centre for Genomic 
Research at the University of Liverpool to conduct the sequencing. 
 
  64 
 
 
Figure 2.5 – Example of a final gel showing a mixed pool of 130-150 samples 
(amplicon product roughly at 400bp) against a 1Kb Invitrogen DNA ladder. 
 
2.10 Bioinformatics 
 
Trimming and filtering of paired-end sequencing reads was done using Sickle 
(version 1.2) by applying a sliding window approach and trimming regions where 
the average base quality drops below 20 (Joshi et al., 2011). This applied a 10bp 
length threshold to discard reads that fall below this length. BayesHammer 
(Nikolenko et al., 2013) was used from the SPAdes assembler (version 2.5) to 
error correct the paired-end reads followed by PANDAseq (version 2.4) with a 
minimum overlap of 50bp to assemble the forward and reverse reads into a 
single sequence spanning the entire V1-V2 region (Masella et al., 2012). The 
above choice of software showed a reduction in substitution errors by 77-98% 
with an average of 93.2% for MiSeq datasets (Schirmer et al., 2015). After having 
obtained the consensus sequences from each sample, UPARSE (version 7.0.1001) 
was used (https://bitbucket.org/umerijaz/amplimock/src) for OTU construction 
as described in Edgar, 2013. The approach pools together the reads from 
different samples and adds barcodes to keep an account of the samples these 
reads originate from. The reads are then dereplicated and sorted by decreasing 
abundance and discarding singletons. In the next step, the reads are clustered 
based on 97% similarity. Even though the cluster_otu() command in usearch 
removes reads that have chimeric models built from more abundant reads, a few 
chimeras may be missed, especially if they are present in very low abundance. 
Mixed 
pool 
400bp 
Positive 
control  
 
Positive 
control  
 
Positive 
control  
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Therefore, in the next step, a reference-based chimera filtering step using a 
gold database was used (http://drive5.com/uchime/uchime_download.html) 
that is derived from the ChimeraSlayer reference database in the Broad 
Microbiome Utilities (http://microbiomeutil.sourceforge.net/).  
 
The original barcoded reads were then matched against OTUs with 97% similarity 
(a proxy for species level separation) to generate OTU tables for different 
samples. The representative OTUs were then taxonomically classified against the 
RDP database using the standalone RDP classifier (version 2.6) (Wang et al., 
2007). Phylogenetic distances between OTUs were produced by first using MAFFT 
(version 7.040) (Katoh & Standley, 2013) to align the OTUs against each other 
and then by using FastTree (version 2.1.7) on these alignments to generate an 
approximately-maximum-likelihood phylogenetic tree (Price et al., 2010). The 
OTU table, phylogenetic tree, taxonomic information and metadata were then 
used in multivariate statistical analysis. A summary diagram showing the stages 
involved in the bioinformatics process is shown in Figure 2.6. 
 
 
Figure 2.6 – Stages involved in the bioinformatics workflow from raw data to 
taxonomic classified operational taxonomic units (OTUs). 
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2.11 Statistical analysis 
 
2.11.1 Initial analysis 
 
Results from samples that contained less than 5000 reads were discarded in the 
analysis (for non-smokers and smokers) to allow comparison of all samples with 
enough statistical power. This resulted in 490 samples altogether (313 from 
non-smoking participants and 177 from smoking participants). The relative 
abundance of taxa for each sample was calculated by dividing the read counts 
of that taxon by sample size whereas prevalence was calculated as the 
percentage of samples containing a given taxa. Abundance was shown as the 
count of reads (or percentage of reads) belonging to a particular taxon. 
Statistical analysis was performed in R software (version 3.1.2). Where 
appropriate before specific analyses, the abundance data was normalised 
(McMurdie & Holmes, 2014). 
2.11.2 Community analysis 
Microbial compositional structure was assessed using a non-metric 
multidimensional scaling plot (NMDS) at genus and OTU level (at 3% divergence) 
to determine the differences in communities of all samples of non-smokers and 
smokers. This determined the effects of various variables such as smoker or 
health status on community composition. Here, Bray-Curtis dissimilarity index 
was used which considers bacterial taxon abundance.  Additionally, the 
unweighted UniFrac distance analysis from the Phyloseq package (version 
1.17.2) (McMurdie & Holmes, 2013) was used which takes into account the 
phylogenetic distances (relatedness) of the bacterial taxa through presence or 
absence, without accounting for their proportional representation. A 
covariance ellipse using ordiellipse() and veganCovEllipse() in Vegan (version 
2.4.0) (Oksanen, 2013) was added (95% confidence interval calculated from the 
standard error of the mean of each group) with the centroid of the ellipse 
representing the group mean. Covariance for each group was calculated using 
cov.wt() and the shape of the ellipse was defined by the covariance within 
each group; the bigger the ellipse, the more variability in community structure 
in samples within the group. 
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To find OTUs that were significantly different in abundance between the 
conditions, the DESeq2 package (version 1.12.3) was used (Love et al., 2014). 
This uses a negative binomial GLM to model the abundance data (OTU 
frequencies) and empirical Bayes to shrink OTU-wise dispersions to identify 
OTUs that have log-fold changes between different conditions (at a cut off 
value of P < 0.01). This is then tested by performing a Wald test on shrunken 
log-fold changes and adjusting for multiple comparisons showing P adjusted 
values. 
 
Samples were rarefied to the minimum number of reads (5118) to test for alpha 
diversity. Rarefaction curves were done for each participant showing a 
sampling depth of 5118 reads could be used for adequate coverage. Even 
though some samples saturated at a higher cut off (10,000 reads), a sampling 
depth of 5118 reads was chosen as choosing a higher cut off would result in the 
removal of too many samples. Rarefaction curves were obtained for each 
participant to approximate OTUs detected as a function of sequencing depth.  
The rarefaction curves of selected participants (Figure 2.7) suggest that the 
total number of observed OTUs in samples from participants vary between 100 
and 300 OTUs.  
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Figure 2.7 – Rarefaction curves displayed for selected participants (non-
smokers) choosing a minimum cut off value at 5118 reads. 
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Alpha diversity at OTU level was investigated to determine the possible 
associations in oropharyngeal community structure from non-smokers and 
smokers. The diversity indices calculated for healthy and unhealthy samples 
(from non-smokers and smokers) were species richness, Shannon H index and 
Simpson index. Statistical testing used aov() from Vegan (version 2.4.0) to 
calculate pair-wise ANOVA (analysis of variation) P values (taking into account 
repeated sampling from participants) which were displayed on top of alpha 
diversity figures.   
 
Co-occurrence networks and sub-community analysis (Williams et al., 2014) 
were produced in healthy samples from non-smokers at genus level to explore 
the interactions between specific genera and identify keystone species.  
2.11.3 Stability analysis 
The Vegan package (version 2.4.0) was used, in particular the two functions 
adonis() for PERMANOVA and betadisper() for the analysis of multivariate 
homogeneity of group dispersions, using Benjamini-Hochberg correction for 
multiple testing to report P values. The variability of microbial community 
structure between participants and health status (for both non-smokers and 
smokers) was also investigated at OTU level using betadisper() to measure the 
distance of each individual sample to that group’s centroid (mean) allowing for 
comparison between participants and the different health groups. To 
understand multivariate homogeneity of groups dispersions (variances) between 
multiple conditions, betadisper() was used. Non-euclidean distances between 
objects and group centroids are handled by reducing the original distances 
(Bray-Curtis or unweighted UniFrac) to principal coordinates and then 
performing ANOVA on them. Adonis() was also used for analysis of variance 
using distance matrices (Bray-Curtis/unweighted UniFrac). This function, 
referred to as PERMANOVA, fits linear models to distance matrices and uses a 
permutation test with pseudo-F ratios, while using the strata command to take 
into account repeated sampling from participants. 
 
The community stability of the microbiome for each participant (non-smokers 
and smokers) was quantified by producing stability plots at OTU level using the 
distances produced from betadisper to display the timeline of sampling and 
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deviations. To address the question about a possible connection between 
community structure (diversity) and stability, community stability was 
quantified by calculating the coefficient of variation (ratio of standard 
deviation to the mean) (Donohue et al., 2016) for each individual participant 
using the distances from betadisper and testing them against diversity variables 
(number of phyla, genera and OTUs) and number of cold disturbances and viral 
infections using Spearman rank correlation analysis. The distances from 
betadisper were also tested in a linear mixed model (LMM) to determine if 
changes in distances could indicate a change in microbial community structure 
before, during and after a disturbance such as a cold. Sampling week (to 
accommodate for potential temporal trends) was fitted as a fixed effect and 
participant ID as a random effect using lme4 (version 1.1-9) and MASS (version 
7.3-44) packages.  AIC values and likelihood ratio testing were used to compare 
models.                                                                                                                                                                                                                                                                                                                                                                                                                              
 
2.11.4 Assigning functions to communities 
Predicted functional profiles of bacterial taxa using 16S rRNA gene sequences 
were identified using the Tax4Fun package (Aßhauer et al., 2015) which links 
sequences with the functional annotation of sequenced prokaryotic genomes 
using a nearest neighbour identification based on a minimum of 16S RNA 
sequence similarity. It works by blasting the OTUs against silva database (all 
prokaryotic KEGG organisms are available in Tax4Fun for SILVA SSU Ref NR 
database release 115 and KEGG database release 64.0) and then utilizing 
ultrafast protein classification (UProC) tool (Meinicke, 2015) to generate 
metabolic functional profiles after normalising the data for 16S rRNA gene copy 
numbers. This shows the pathways as KEGG K numbers which are significantly 
up/down regulated between multiple conditions, as determined through using 
Kruskal-Wallis test showing P values and multiple testing correction (Benjamini-
Hochberg) P adjusted values.  
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3 Characterising the healthy oropharynx 
microbiome of non-smokers 
3.1 Introduction 
High throughput sequencing has revealed each body site harbors a vast number 
of microbes living as a complex microbiome which may contribute to, or even be 
solely responsible for specific roles in the host (Jones, 2009) (Cho & Blaser, 2012) 
functioning like any macrobiotic ecological community. Research is now moving 
on from simple characterisation of the composition in microbiome communities, 
to improving knowledge about functioning of these communities (Robinson et 
al., 2010) and the possible links between the microbiome and health (Cho & 
Blaser, 2012). However, a necessary starting point of understanding any 
microbiome is the identification of the microbes present; investigations into the 
species interactions and putative health implications become possible only then 
(Costello et al., 2012) (Lemon et al., 2010).  
One body site that remains relatively unexplored is the oropharynx. The 
oropharynx is the middle part of the throat and is a component of the upper 
respiratory tract. The oropharynx is a niche for commensal bacteria that is 
constantly exposed to various environmental sources and consequently an 
important entry point for pathogenic bacteria. For instance, upper respiratory 
infections (which affect the nose and throat) are very common in all ages of 
people (Ferkol & Schraufnagel, 2014). It is therefore of interest to know the 
normal oropharynx microbiome which interacts with invading pathogens and 
either prevents or facilitates the growth of them, as well as that of opportunistic 
pathogens normally present. Previous studies (Segata et al., 2012) (Botero et al., 
2014) have shown the oropharynx microbiome to consist of an array of 
microorganisms lining the epithelium and existing as a complex community. Five 
major bacterial phyla have been identified in the oropharynx: Firmicutes, 
Bacteroidetes, Proteobacteria, Fusobacteria and Actinobacteria (Lemon et al., 
2010). Whilst the majority of microbes are commensal in the oropharynx, many 
opportunistic bacteria may be present such as Streptococcus mitis (Mitchell, 
2011) as well as pathogenic bacteria such as Streptococcus pneumoniae and 
Neisseria meningitides (Gazi et al., 2004). Investigating the bacterial 
composition in healthy communities will aid in determining the co-occurrence 
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patterns and whether there are correlations between types of bacteria (Williams 
et al., 2014). This is something that has previously had little recognition in the 
oropharynx although determining these relationships is important for 
characterisation of communities, as well as identifying keystone taxa which 
could be beneficial for therapeutic purposes.  
 
The impact of environmental factors on any microbiome is still poorly 
understood and there is now growing recognition of the importance of these 
factors to try and understand the relationship between the environment and the 
microbiome (Conlon & Bird, 2015). Although not investigated in this study, diet 
has shown to impact the GI tract microbiome (Turnbaugh et al., 2009). Host 
characteristics such as sex and age also affect the microbiome; there is now 
increasing evidence that the microbiome changes as age progresses (Whelan et 
al., 2014) and could also differ in regards to sex (Bolnick et al., 2014). All these 
factors may contribute to differences in microbial communities in healthy people 
and aid in understanding of community structure. 
 
Characterisation studies should also involve longitudinal sampling as this will 
determine what bacteria are present overall in healthy communities in the 
oropharynx and how participants naturally vary in community composition 
(measured by alpha diversity) over a defined time period. There are still minimal 
studies involving longitudinal sampling, but taking samples over various weeks 
also gives an indication of how many samples are needed to sample a naturally 
fluctuating oropharyngeal community in order to recover as many of the taxa 
present, but also determine the natural variation present and investigate the 
cause and effect relationship of certain diseases and disorders. Therefore this 
chapter will explore the community composition of the bacterial oropharynx 
microbiome in healthy samples from non-smoking participants through 
longitudinal sampling. The objectives are listed as follows: to characterise the 
oropharynx microbiome in healthy samples from non-smoking participants, to 
determine how sex and age affects the healthy microbiome and to produce co-
occurrence networks present in healthy samples.  
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3.2 Methods 
3.2.1 Initial exploration of the oropharynx microbiome 
All analyses were carried out using R (version 3.1.2). After sequencing (Chapters 
2.2.1, 2.7, 2.8 & 2.9) all samples below 5000 reads were removed from 
subsequent analyses because of lack of statistical support. This resulted in 313 
samples from healthy participants (n=18).  
Taxonomic classification at phylum, genus and OTU level was done through the 
RDP database classifier using the standalone RDP classifier version 2.6 (Chapter 
2.10). For alpha diversity analysis (such as species richness) samples were 
rarefied using rarefaction to the minimum number of reads (5118). To address 
the question of how many samples from a naturally-fluctuating, healthy 
oropharynx would be needed to capture 100% of taxa recovered per participant 
(at the phylum, genus and OTU level) cumulative box plots were produced. 
Participants that had a minimum of 5 healthy samples were included – this 
involved all participants apart from participant HB. The number of samples per 
participant instead of weeks was used as participants did not hand in a swab 
every week. 
3.2.2 Community composition  
The effects of age and sex were explored in healthy communities through NMDS 
plots using Bray-Curtis distance and unweighted UniFrac distance at OTU level. 
Variance ellipses were added as an indication of the variability of each group; 
the covariance was calculated using cov.wt() in Vegan (version 2.4.0) (Oksanen 
2013) and the shape of the ellipse was defined by the covariance within each 
group (Chapter 2.11.2). Significant difference testing between the different 
groups in the sex and age categories at OTU level was done using PERMANOVA 
(permutational ANOVA) through adonis() in Vegan using the command strata to 
take into account repeated sampling from participants. Due to the small 
sampling size, a cut of P value of < 0.1 was used to determine significance 
between the sex and age categories. The most significant OTUs present in terms 
of differing abundance between the different groups in sex and age were 
determined from a negative binomial GLM and was displayed showing the log 
relative transformation of samples using DESeq() from the DESeq2 package 
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(version 1.12.3) (Love et al., 2014). This uses a negative binomial GLM to model 
the abundance data (OTU frequencies) and empirical Bayes to shrink OTU-wise 
dispersions to identify OTUs that have log-fold changes between different 
conditions (at a cut off value of P < 0.01) (Chapter 2.11.2).  
 
3.2.3 Co-occurrence networks 
Co-occurrence network analyses (Williams et al., 2014) were performed on data 
from healthy samples (non-smokers) to explore the interactions between 
bacteria and to identify important members of the community. Analysis was 
done at the genus level to determine if there were any interactions between 
specific genera. Samples were rarefied to 5118 reads representing the minimum 
number of counts per sample. Co-occurrence patterns were investigated through 
generating a dissimilarity matrix consisting of Spearman correlation coefficients 
to represent co-occurrence between all pairs of genera from samples. Networks 
were produced using the igraph package (version 1.0.1) (Csardi & Nepusz, 2006) 
where microbial taxa were represented as nodes and the presence of a co-
occurrence relationship based on a 0.5 correlation level was represented by 
edges. Keystone taxa were identified as having the largest node size and the 
greatest number of connections to other taxa as used in Williams et al., (2014). 
3.3 Results 
3.3.1 Initial exploration of the healthy oropharynx microbiome 
At the end of the sampling period, 313 samples were received in total, with 279 
designated as healthy due to not having any symptoms of illness (Table 3.1). The 
taxonomic profiling of samples from the oropharynx of individual participants 
identified with RDP classifier revealed 5 to 10 phyla, 20 to 70 genera and 140 to 
340 assignments at OTU level.  
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Table 3.1 – The total number of healthy samples from non-smokers and the 
range in taxa numbers received from each participant.  
 
Cumulative plots showed the total number of taxa detected from each 
participant as a percentage of the participant total thereby indicating the 
minimum number of samples needed from each participant to recover the total 
numbers of different taxa present. There was relatively little variation in this 
between the participants, and a minimum of 2, 3 and 4 samples was needed at 
phylum, genus and OTU level to recover all the taxa present (Figure 3.1). 
 
 
 
 
Participant Healthy 
samples 
Phylum Genus OTU 
Min - 
Max 
Median Min –  
Max 
Median Min - 
Max 
Median 
HA 34 8-10 8 24-61 51 156-299 247 
HB 2 8-8 N/A 36-42 N/A 174-184 N/A 
HC 14 7-9 8 33-58 45 145-294 207 
HD 23 6-9 9 36-66 53 158-299 266 
HE 6 8-9 9 39-55 45 191-279 218 
HF 17 6-9 8 28-51 40 148-261 180 
HG 7 7-8 8 30-48 40 170-245 202 
HI 26 7-9 8 36-58 45 175-335 221 
HJ 8 5-9 8 34-51 44 162-209 192 
HL 5 7-9 8 41-67 46 180-268 210 
HM 11 5-9 7 33-53 36 150-289 177 
HN 11 8-9 8 33-59 42 174-297 211 
HO 25 7-10 8 35-57 44 165-291 204 
HQ 8 7-9 8 38-55 49 201-268 240 
HR 14 7-9 9 38-63 51 189-318 222 
HS 29 8-9 9 35-54 46 175-306 216 
HT 30 7-9 9 36-65 47 167-298 241 
HV 12 6-9 9 33-64 43 147-291 202 
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Figure 3.1 – Box plots showing cumulative percentage of phyla (Fig. 3.1A), 
genera (Fig. 3.1B) and operational taxonomic units (OTUs) (Fig. 3.1C) recovered 
from each participant over subsequent samples (100% = number of taxa 
recovered per participant). Box plots show the minimum, 25th percentile, 
median, 75th percentile and maximum values for the cumulative percentage of 
taxa recovered from consecutive samples within a single participant.  
 
A 
B 
C 
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3.3.2 Community composition of the healthy oropharynx 
microbiome 
At phylum level 99.7% of reads were taxonomically classified with the remaining 
0.3% belonging to unknown or unclassified bacteria. There were 5 main phyla 
that were always present in healthy samples: Actinobacteria, Bacteroidetes, 
Firmicutes, Fusobacteria and Proteobacteria. The occurrence of Spirochaetes, 
TM7, SR1 and Synergistetes was more variable. Considering the abundance of a 
given taxonomic level in a microbiome sample, the most abundant phylum 
overall was Firmicutes (mean ± SEM = 61% ± 1%) followed by Bacteroidetes (16% 
± 1%), Proteobacteria (11% ± 1%), Actinobacteria (7% ± 0.2%) and Fusobacteria 
(5% ± 0.2% (Figure 3.2 & Appendix 4). 
 
Figure 3.2 – Box plot showing the most abundant phyla (n=9) (the rest pooled 
in the category ‘Others’) and the median abundance in each participant in 
healthy samples. 
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At genus level 95% of reads were taxonomically classified with the remaining 5% 
belonging to unknown or unclassified bacteria. At the genus level, the patterns 
of presence and occurrence were similar to the phylum level with the most 
common genera present in all participants. However, some genera have 
conspicuously more variable occurrence (Porphyromonas). Streptococcus (mean 
± SEM = 47% ± 1%) was the most dominant genus in the majority of healthy 
samples followed by Prevotella (9% ± 0.4%) and Veillonella (5% ± 0.2%) (Figure 
3.3 & Appendix 5). 
 
Figure 3.3 – Box plot showing the most abundant genera (n=10) (the rest 
pooled in the category ‘Others’) and the median abundance in each 
participant in healthy samples. 
 
The most abundant OTUs belonged to Streptococcus species reflecting the 
general abundance of their phylum, Firmicutes (Figure 3.4). Some Streptococcus 
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OTUs could be identified to species level, however not all Streptococcus OTUs 
could be identified due to the V1-V2 region not being variable enough for 
adequate species identification. Streptococcus OTUs identified included 
Streptococcus mitis, Streptococcus salivarius and Streptococcus parasanguinis 
which are all commensal but can be opportunistic (Mitchell, 2011). Even though 
some Streptococcus OTUs could be named, there were Streptococcus OTUs from 
the oropharynx that remain unidentified and so could not be determined 
whether they are commensal or pathogenic. 
 
Figure 3.4 – Box plot showing the most abundant operational taxonomic units 
(OTUs) (n=10) with the rest pooled in the category ‘Others’ and the median 
abundance in each participant in healthy samples. 
 
3.3.3  Host characteristics affecting the microbiome 
NMDS plots at OTU level gave an indication of the similarity of community 
composition in males and females (Figure 3.5A) and between the different age 
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groups (Figure 3.5B). There was a visual divide in the communities between 
males and females; however these communities were not significantly different 
using Bray-Curtis distance (P = 0.8) but were significantly different using 
unweighted UniFrac distance (P = 0.07) at a cut off value at P < 0.1. This states 
that overall there was not a difference between the abundance and but there 
was a difference in the presence and absence of OTUs - the oropharynx 
microbiome between males and females differs in that males have different 
OTUs than females. However, further investigation did show specific OTUs being 
significantly different in abundance; females had higher abundances of Sneathia 
and Catonella, whereas males had increased Porphyromonas (Appendix 6).  
 
The NMDS plot for age showed the teens and the thirties group to be the most 
distinct of the groups. Again there was no significant difference in communities 
between the different age groups using Bray-Curtis distance (P = 0.6) but 
significant differences were present using unweighted UniFrac distance (P = 
0.05) which showed communities to be distinct by having different OTUs rather 
than differences in abundance. However, there were specific OTUs that were 
significantly different in terms of abundance between the different age 
categories; the most significant differences in increasing age (from the teenage 
years to twenties and thirties) included a significant increase in the abundance 
of Neisseria, Sneathia and Prevotella with a decrease in the abundance of 
Streptococcus (Appendix 7). This showed that overall the different groups within 
the sex and age categories had similar community composition; Streptococcus, 
Prevotella and Veillonella were the most abundant genera in all healthy 
communities regardless of age or sex. However, communities were significantly 
different in that males and females had different OTUs present, as did the 
separate age groups.  
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Figure 3.5 – Non-metric multidimensional scaling (NMDS) plots using Bray-Curtis 
distance at operational taxonomic unit (OTU) level showing the effects of sex 
(Fig. 3.5A) and age (Fig. 3.5B) on healthy samples (n=279).  
 
3.3.4 Co-occurrence of bacteria in the healthy oropharynx 
Co-occurrence relationships showed co-existence patterns of bacteria in healthy 
samples (Figure 3.6), with only the most significant co-occurrence patterns of 
A 
B 
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taxa shown at a correlation value of 0.5. Most correlations between the taxa 
were positive in that as one taxon increased in abundance, the other taxon 
would also increase in abundance. However a negative co-occurrence pattern 
was observed between unclassified Veillonellaceae and Streptococcus. There 
was a dominant sub-community where Megasphaera, Prevotella, Veillonella and 
unclassified Veillonellaceae had the biggest nodes due to having the most 
connections. These genera were also seen as having the greatest betweenness 
values (as displayed by the betweenness and eigenvalue plots) as they were 
shown to be located on the edge of the betweenness plot showing various 
connections to other nodes. Therefore these genera were seen as important 
members of the healthy oropharynx microbiome. By having the greatest number 
of connections in the co-occurrence network (being connected to the most 
number of nodes) they were shown to be the genera that interacted with other 
taxa the most.  
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Figure 3.6 – A co-occurrence network generated from all healthy samples 
(n=279) at genus level using a correlation value of 0.5. Sub-communities consist 
of various nodes and different genera are defined by colour coded nodes. 
Larger nodes show genera that have the greatest number of connections to 
other genera (through having a lower P value). 
 
3.4 Discussion 
The healthy oropharynx microbiome was investigated to determine community 
composition, the changes that occur to communities in regards to host 
characteristics such as age and sex, and the interactions of specific taxa within 
these communities. The results showed that Firmicutes and Streptococcus are 
the most dominant phylum and genus in healthy samples which was also seen in 
  84 
 
previous studies (Segata et al., 2012) (Lemon et al., 2010) (Lazarevic et al., 
2009) and so, these could be considered as important taxa as an indicator of 
health status. In order to fully identify the key Streptococcus species, all 
Streptococcus OTUs must be identified and categorised to commensal and 
pathogenic OTUs (Mitchell, 2011), something that was not possible for these 
samples. However, it was possible to identify the most abundant Streptococcus 
OTUs present in healthy samples which included Streptococcus mitis and 
Streptococcus salavarius.  
 
In this study, sex and age did not dramatically alter the microbiome, even 
though there were significant differences in the presence/absence and 
abundance of specific OTUs in regards to age. The effects of aging on the 
microbiome have been investigated previously showing that the microbiome 
changes as we age and elderly people have distinct communities compared to 
younger adults (Saraswati & Sitaraman, 2014). However, as this study only 
involved adults within specific age ranges (18-37) and did not investigate 
between the different extremes of age (young adults to elderly), only a subset of 
the wider age range was observed and smaller differences between age groups 
could therefore be expected. The communities of males and females also had 
similar microbiomes. Other factors may be responsible for changes in the 
microbiome such as diet. Diet has shown to affect the GI microbiome (David et 
al., 2014) which could also potentially affect the oropharynx microbiome. Males 
and females may have different diets also – males may have more meat 
consumption in their diet compared to females or females may be more aware of 
their diet compared to males. However a study has shown that the same diet in 
males and females has different effects on the GI microbiome showing that the 
host must also influence the microbiome in the different sexes (Bolnick et al., 
2014). Diet could be partly responsible for changes in the microbiome (and 
between the different sex and age groups) but diet was not investigated in this 
study. Therefore the role of sex and age (coupled with diet) requires further 
investigation in how it affects the oropharynx microbiome in healthy 
participants.  
 
Investigating the OTUs in healthy communities improved understanding of the 
bacterial community structure in the oropharynx and the interactions between 
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specific bacteria. This was partly investigated through co-occurrence network 
plots which showed the co-existence patterns of bacteria in healthy samples. In 
healthy communities Prevotella and Veillonella were important gatekeepers in 
that they had the biggest nodes and many edges showing they interacted with 
various bacteria in the oropharynx - these bacteria were also considered 
dominant bacteria as they were usually the most abundant following 
Streptococcus. This may influence the structure of the oropharyngeal community 
as a whole by controlling abundances of other taxa and overall functioning of the 
community. Most of these interactions were also positive, showing that a healthy 
state is created by the presence of these bacteria which in turn increases the 
abundance of other bacteria. Interestingly, in the healthy samples Streptococcus 
was not seen to have any positive significant co-occurrence networks with any 
other taxa at this correlation level even though it has been recognised as the 
most dominant genus in healthy oropharyngeal communities. This could be due 
to only creating co-occurrence networks at genus level indicating that 
Streptococcus species may prefer to interact with other species of 
Streptococcus. There is evidence that Streptococcus species interact in the oral 
tract (Kreth et al., 2009); the commensal S. sanguinis is able to produce 
hydrogen peroxide to inhibit the growth of the pathogenic S. mutans suggesting 
that the oropharyngeal community has a massive sub-community of 
Streptococcus species that are in constant existence and interaction with each 
other. This can be explored further by naming all the Streptococcus OTUs 
present, identifying which OTUs are commensal, opportunistic and pathogenic 
and then creating these co-occurrence networks at both the genus and OTU level 
in healthy samples making it possible to understand the interactions in key 
Streptococcus OTUs present in healthy and eventually unhealthy states. 
 
3.5 Conclusions 
Overall the healthy oropharynx microbiome in non-smoking participants was 
found to be similar at the phylum level with increasing differences at genus and 
OTU level. The most dominant taxa in healthy communities were identified as 
Firmicutes at phylum level and Streptococcus at genus level, but the oropharynx 
microbiome was not majorly impacted by sex and age in this study. Co-
occurrence networks did show interactions of specific bacteria in healthy 
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samples, but this needs to be further explored to show how Streptococcus OTUs 
co-exist in the different health states. 
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4 Characterisation of the unhealthy oropharynx 
microbiome in non-smokers 
4.1 Introduction 
A necessary starting point in understanding any microbiome is the identification 
of the microbes present in a healthy setting. This was explored in Chapter 3 
where the oropharyngeal community composition in healthy samples from non-
smokers was characterised. This provided the foundation of identifying universal 
features of the healthy microbiome such as community composition and the 
most abundant taxa present which can then be directly compared to 
microbiomes in specific disease scenarios. Links between disease and 
microbiome compositions have been reported in a variety of conditions such as 
IBS (Willing et al., 2010) and periodontitis (Abusleme et al., 2013) where 
deviations from the healthy state, dysbiosis, are associated with disease in the 
host.  
There are few studies comparing the healthy oropharynx microbiome to specific 
disease scenarios. The majority of these studies compare the healthy oropharynx 
microbiome to lower respiratory tract diseases that affect the lungs such as 
asthma (Park et al., 2014), chronic obstructive pulmonary disorder (Cabrera-
Rubio et al., 2012) or tuberculosis (Botero et al., 2014). Few studies have 
investigated upper respiratory tract infections such as the impact of viral 
infections like the common cold (Yi et al., 2014) or bacterial infections such as 
tonsillitis (Stenfors et al., 2003) and their impact on the oropharynx microbiome. 
However these studies do not take into account longitudinal sampling and only 
compare a healthy control group to diseased samples. It is important to consider 
the possible effects of upper respiratory tract infections, how they affect the 
whole population and the differing outcomes of disease depending on health 
status or age of the population affected. To improve our understanding of the 
possible role of the oropharynx microbiome in upper respiratory tract infections, 
the issue of causality needs to be addressed, i.e. whether infections follow from 
disturbances or if these are merely associated with them. This requires 
characterising the microbiome through longitudinal sampling and determining its 
overall stability (Chapter 5). 
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This chapter, in contrast, explores the differences in community composition of 
the bacterial oropharynx microbiome in unhealthy samples compared to those 
from the same non-smoking participants when they are healthy. Specifically, 
these differences were characterised during colds, viral infections and antibiotic 
treatment, and compare the alpha diversity (species richness and 
Shannon/Simpson Index) as well as specific beta diversity measures of healthy 
and unhealthy samples. As previous literature has demonstrated diseased states 
resulting in altered, low diversity communities, it is a possibility that this 
pattern will also be seen in the oropharynx. Therefore the objective of this 
chapter is to determine the changes in community composition between healthy 
and unhealthy samples from non-smokers. The hypothesis is that the healthy 
oropharynx microbiome from a non-smoker is a high diversity community 
consisting of keystone species which will become unbalanced during a 
respiratory disturbance (due to loss of keystone species and diversity). 
4.2 Methods 
4.2.1 Initial analysis  
All samples below 5000 reads were removed from analyses resulting in 313 
samples from non-smokers (n=18), of which 34 samples were identified as 
unhealthy samples. The definition of an unhealthy sample is a sample that was 
collected at the time a participant reported symptoms of a disease or illness or 
they were on antibiotic treatment. Even though participants on antibiotics were 
on treatment for acne and not because of an infection, they were still 
categorised with the unhealthy group due to disturbing the community structure. 
These samples were categorised into the following groups: cold (n=19 from 12 
participants), antibiotics (n=8 from 3 participants) and viral (n=7 from 4 
participants). The cold group includes samples from participants self reporting 
symptoms of a cold but were detected as negative for the standard viruses 
tested during the respiratory screen at Gartnavel hospital as described in 
Chapter 2.2.1. The antibiotics group included any participants undergoing 
antibiotic treatment and the viral group included only symptomatic samples with 
confirmed viruses from the respiratory screen.  
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4.2.2 Comparison of community composition between healthy 
and unhealthy samples 
Taxonomic classification at phylum, genus and OTU level was done through the 
RDP database classifier using the standalone RDP classifier version 2.6 (Chapter 
2.10). 
The abundances of specific taxa at phylum and genus level were log transformed 
and tested in a linear mixed model (LMM) to determine if changes in abundance 
could indicate a change in health status. Sampling week (to accommodate for 
potential temporal trends) was fitted as a fixed effect and participant ID as a 
random effect using lme4 package (version 1.1.9) from R (version 3.1.2). 
Species richness at OTU level was also tested in a LMM against sample status 
(healthy and unhealthy) to determine if unhealthy samples had reduced species 
richness overall. 
Local contributions to beta diversity (Vegan, version 2.4.0) in R (version 3.1.2) 
was performed to show dysbiosis of unhealthy communities as described in 
Legendre & De Cáceres, 2013. This method involves measuring beta diversity to 
show the variation in species composition by generating a single number 
estimate of beta diversity in the different health groups. This was done by using 
Hellinger transformation to compute the total sum of squares of the species 
composition from which the local contributions to beta diversity could be 
derived generating the total beta diversity. This generates values known as local 
contributions to beta diversity (LCBD) where a large LCBD value indicates 
samples that have different species composition. This was performed at OTU 
level producing a timeline of samples for each participant displaying the P values 
for the unhealthy samples.  
The abundance changes in community composition between the different health 
groups were tested by identifying the most significant OTUs present in regards to 
health status using the DESeq2 package (version 1.24.0) (Love et al., 2014) in R 
(version 3.1.2). This was determined from a negative binomial GLM to model the 
abundance data (OTU frequencies) and empirical Bayes to shrink OTU-wise 
dispersions to identify OTUs that have log-fold changes between different 
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conditions. The cut off value was P < 0.01 with P adjusted values being used for 
multiple comparisons (Chapter 2.11.2).  
Alpha diversity at OTU level was investigated to determine the possible 
associations between health status and oropharyngeal community structure. For 
alpha diversity analysis, samples were rarefied using rarefaction to the minimum 
number of reads (5118). The diversity indices calculated for healthy and 
unhealthy samples were species richness, Shannon H index and Simpson index 
(Chapter 2.11.2). Significant differences between the different health groups 
were measured using aov() from Vegan (version 2.4.0) taking into account 
repeated sampling from participants to calculate pair-wise ANOVA generating P 
values which were displayed on top of alpha diversity figures.   
4.3 Results 
4.3.1 Comparison of the healthy and unhealthy oropharynx 
microbiome from non-smokers 
4.3.1.1 Initial exploration of the unhealthy oropharynx microbiome 
The taxonomic profiling of unhealthy samples from the oropharynx of non-
smoking participants identified with RDP classifier revealed 5 to 9 phyla (median 
= 8), 20 to 70 genera (median = 38) and 100 to 300 assignments at OTU level 
(median = 182) (Table 4.1). This was broadly similar to the taxonomic profiling 
of healthy samples (5 to 10 phyla (median = 9), 20 to 70 genera (median = 45) 
and 140 to 340 OTUs (median = 218), but showing a reduction in OTUs in 
unhealthy samples as determined in a linear mixed model (t value = -5.693, P < 
0.001).   
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Table 4.1 – The total number of unhealthy samples from non-smokers and the 
range in taxa numbers received from each participant. Participants HB, HR and 
HT are excluded due to having no unhealthy samples. 
 
4.3.1.2 Community composition of the unhealthy oropharynx microbiome 
The five main phyla (in terms of abundance) found in the healthy samples 
(Actinobacteria, Bacteroidetes, Firmicutes, Fusobacteria and Proteobacteria) 
were also present in unhealthy samples (cold and viral samples) and antibiotic 
treated samples (Appendix 8) but the abundances between the different health 
conditions were different. There was a decrease in Firmicutes in 9 participants 
(n=12) and an increase in Proteobacteria in 9 participants (n=12) when going 
from a healthy to cold state (Figure 4.1A) whereas the viral group had a 
decrease in Firmicutes in 3 participants (n=4) and an increase in Proteobacteria 
in 2 participants (n=4) (Figure 4.1B). Antibiotic treated samples on the other 
hand showed similar abundances of Firmicutes in comparison to the healthy 
samples, but 2 participants (n=3) did show an increase in the phylum 
Actinobacteria (Figure 4.1C). Overall, when looking at the healthy and unhealthy 
group there was a significant increase in the abundance of the phylum 
Proteobacteria (P = 0.002) and a significant decrease in Bacteroidetes (P = 0.05) 
in unhealthy samples (Table 4.2). No differences between the healthy and 
unhealthy samples were found in the abundances of Firmicutes, Actinobacteria 
or Fusobacteria. 
Participant Total 
samples 
Phylum Genus OTU 
Min -
Max 
Median Min -
Max 
Median Min - 
Max 
Median 
HA 2 8-8 N/A 27-47 N/A 109-245 N/A 
HC 2 7-9 N/A 57-65 N/A 145-294 N/A 
HD 1 9 N/A 60 N/A 272 N/A 
HE 1 7 N/A 28 N/A 113 N/A 
HF 5 5-7 6 29-51 35 111-241 149 
HG 1 8 N/A 42 N/A 214 N/A 
HI 6 7 7-8 30-47 41 144-230 186 
HJ 4 6-8 7 29-44 37 125-198 173 
HL 1 6 N/A 40 N/A 163 N/A 
HM 3 6-8 7 35-44 43 158-206 180 
HN 1 8 N/A 44 N/A 198 N/A 
HO 1 8 N/A 35 N/A 130 N/A 
HQ 1 7 N/A 30 N/A 116 N/A 
HS 1 8 N/A 38 N/A 170 N/A 
HV 4 5-8 7 25-52 42 107-237 187 
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Figure 4.1A – Box plot showing the most abundant phyla (n=9) (the rest pooled 
in the category ‘Others’) and the median abundance in each participant in 
healthy and cold samples. 
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Figure 4.1B – Box plot showing the most abundant phyla (n=9) (the rest pooled 
in the category ‘Others’) and the median abundance in each participant in 
healthy and viral positive samples. 
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Figure 4.1C – Box plot showing the most abundant phyla (n=9) (the rest 
pooled in the category ‘Others’) and the median abundance in each 
participant in healthy and antibiotic treated samples. 
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Table 4.2 – Summary of the parameter estimates of the linear mixed model 
(LMM) investigating the abundances (response variable) of the five most 
abundant phyla in unhealthy samples compared to healthy samples (reference 
category). Significant P values are shown in bold. 
Unhealthy 
samples 
Estimate Std. Error df t value P value 
Firmicutes 0.028704 0.211088 313 0.136 0.891925 
Proteobacteria 0.9015 0.293 310.4 3.077 0.0023 
Bacteroidetes -0.552464 0.281813 307.71 -1.96 0.0509 
Actinobacteria -0.089296 0.274397 313 -0.325 0.745 
Fusobacteria -0.420947 0.292411 311 -1.44 0.151 
 
At genus level, the most abundant genera in both healthy and unhealthy samples 
(cold and viral) and antibiotic treated samples were Streptococcus, Prevotella 
and Veillonella, but there were marked increases in specific genera such as 
Pseudomonas in comparison to the healthy samples (Appendix 9). When 
comparing the healthy and cold samples (Figure 4.2A) there was a decrease in 
abundances of Streptococcus and Prevotella in 8 and 9 participants respectively 
(n=12). The viral group had 3 participants where the abundance of Streptococcus 
decreased (n=4) and an increase in Neisseria and Haemophilus was observed in 1 
and 3 participants respectively (n=4) (Figure 4.2B). For samples from subjects 
that had undergone antibiotic treatment (Figure 4.2C), 2 participants showed 
decreases in Streptococcus (n=3) and 2 participants had increases in the genus 
Actinomyces (n=2). When looking at the healthy and unhealthy samples overall, 
there was a significant decrease in the abundance of Prevotella in unhealthy 
samples (P = 0.012) with no significant difference in the abundance of 
Streptococcus and Veillonella (P = 0.808 & P = 0.385) (Table 4.3). Therefore, 
unhealthy communities had the same genera present, but the communities 
differed by having different abundances of genera. 
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Figure 4.2A – Box plot showing the most abundant genera (n=10) (the rest pooled 
in the category ‘Others’) and the median abundance in each participant in 
healthy and cold samples. 
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Figure 4.2B – Box plot showing the most abundant genera (n=10) (the rest pooled 
in the category ‘Others’) and the median abundance in each participant in 
healthy and viral positive samples. 
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Figure 4.2C – Box plot showing the most abundant genera (n=10) (the rest pooled 
in the category ‘Others’) and the median abundance in each participant in 
healthy and antibiotic treated samples. 
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Table 4.3 – Summary of the parameter estimates of the linear mixed model 
(LMM) investigating the abundances (response variable) of the five most 
abundant genera in unhealthy samples compared to healthy samples (reference 
category). Significant P values are shown in bold. 
Unhealthy 
samples 
Estimate Std. Error df t value P value 
Streptococcus -0.05 0.21 311.00 -0.24 0.81 
Prevotella -0.77 0.31 312.00 -2.53 0.012  
Veillonella -0.25 0.29 311.00 -0.87  0.39 
Serratia 0.23 0.38 313 0.59 0.55 
Pseudomonas 0.23 0.38 311 4.75 <0.001 
 
OTUs that were the most abundant in healthy samples were also present in the 
unhealthy samples (cold and viral - Figure 4.3A & B) and antibiotic treated 
samples (Figure 4.3C) but at differing abundances in participants. For example, 
participant HM showed an increase in Streptococcus salivarius in the cold 
samples, whereas participant HJ’s cold samples showed a decrease in 
Streptococcus salivarius. Therefore healthy and unhealthy samples had differing 
abundances of OTUs that varied in participants. 
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Figure 4.3A – Box plot showing the most abundant operational taxonomic units 
(OTUs) (n=10) with the rest pooled in the category ‘Others’ and the median 
abundance in each participant in healthy and cold samples. 
  101 
 
 
Figure 4.3B – Box plot showing the most abundant operational taxonomic units 
(OTUs) (n=10) with the rest pooled in the category ‘Others’ and the median 
abundance in each participant in healthy and viral positive samples. 
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Figure 4.3C – Box plot showing the most abundant operational taxonomic units 
(OTUs) (n=10) with the rest pooled in the category ‘Others’ and the median 
abundance in each participant in healthy and antibiotic treated samples. 
 
 
4.3.2 Local contributions to beta diversity 
The changes in community composition between the different health conditions 
in non-smoking participants were shown through time plots displaying the local 
contributions to beta diversity (LCBD) (Figure 4.4). Most unhealthy samples 
belonging to the cold group did have greater dysbiosis than other samples 
(shown by significant P values) suggesting that these samples were unique in 
community composition. Changes in community composition were shown in 
antibiotics (n=3, 38% of all antibiotics samples), cold (n=9, 47% of all cold 
samples) and viral samples (n=3, 43% of all viral samples) showing that 
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community composition was significantly changed in these samples. Some 
participants such as HC or HN also produced unhealthy samples (in this case 
categorised as cold) but these samples seemed to have a similar community 
composition to the healthy samples. To determine the specific changes in 
community composition of the unhealthy samples and antibiotic treatment, 
further investigation was done to show the most significant changes in the 
abundance of OTUs in their unhealthy group category (Table 4.4). Change from a 
healthy to a cold state was associated with an increase in the abundance of 
specific Staphylococcus OTUs and Serratia with a decrease in Streptococcus 
OTUs and Prevotella. Antibiotic treatment resulted in a decrease of many OTUs 
including Prevotella and Veillonella with an increase in Enhydrobacter and 
Actinomyces whereas viral infections were associated with an increase in the 
abundance of specific Moraxella OTUs with decreases in Acinetobacter and 
Veillonella OTUs. Viral infection was also associated with increases in 
Haemophilus and Neisseria OTUs.  
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Figure 4.4 - Participant time plots at operational taxonomic unit (OTU) level 
showing local contributions to beta diversity (LCBD) of samples in regards to 
health status. Significant P values are shown for unhealthy samples with the 
greatest changes in community structure. Time points refer to the week of when 
a sample was handed in. Participant HB is excluded due to not having enough 
samples. 
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Table 4.4 – The most significant operational taxonomic units (OTUs) (P adjusted 
values < 0.01) in terms of increasing abundance present in the different health 
groups. Only the 15 most significant OTUs were displayed for the healthy group 
due to the large numbers of significant OTUs, with the cold and viral samples 
only having 10 OTUs significantly increasing in abundance. 
Most significant OTUs (P adjusted value < 0.01) increased in different 
health states 
Healthy Cold Viral Antibiotics 
OTU_53  
Prevotella  
OTU_132 
unclassified_Prevotella  
OTU_433  
Streptococcus  
OTU_64  
Porphyromonas  
OTU_4  
Staphylococcus  
OTU_111  
Unclassified 
OTU_52  
Porphyromonas    
OTU_56  
Granulicatella   
OTU_75 
Fusobacterium  
OTU_104  
Veillonella   
OTU_53  
Prevotella   
OTU_81  
Prevotella  
OTU_130  
Unclassified 
OTU_113 Tannerella 
OTU_76 Acinetobacter 
OTU_751 
Staphylococcus  
OTU_1069 
Staphylococcus   
OTU_965 
Staphylococcus  
OTU_428  
Serratia 
OTU_19  
Neisseria 
OTU_86  
Sneathia 
OTU_1255 
Corynebacterium 
OTU_218 
Treponema 
OTU_14 
Serratia 
OTU_1202 
Unclassifed_ 
Clostridiales 
OTU_1877 
Unclassified_ 
Pasteurella 
OTU_926 
Unclassified_Neisseria 
OTU_1542 
TM7_genera_incertae
_sedis  
OTU_283 
Capnocytophaga  
OTU_1845  
Moraxella 
OTU_1936 
Acinetobacter 
OTU_29 
Moraxella 
OTU_621 
Unclassified_ 
Pasteurellaceae 
OTU_17  
Neisseria 
OTU_847 
Haemophilus 
OTU_69 
Enhydrobacter 
OTU_1871 
Actinomyces 
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4.3.3 Comparison of diversity in healthy and unhealthy 
communities 
A reduced diversity (in terms of both species richness and Shannon H index) at 
OTU level was shown in unhealthy samples (Figure 4.5) with greatest reductions 
in diversity occurring between the healthy and cold group (richness = P < 0.001, 
Shannon H diversity = P < 0.001, Simpson index = P < 0.001) and between healthy 
and antibiotics group (richness = P < 0.001, Shannon H diversity = P < 0.001, 
Simpson index = P = 0.007). Therefore, the healthy group were the most species 
rich and diverse followed by viral, cold and antibiotics, showing that the cold 
and antibiotics group are low diversity communities. The viral group had similar 
species richness and diversity compared to the healthy group. 
 
Figure 4.5 – Alpha diversity measures calculated for all samples at operational 
taxonomic unit (OTU) level. Samples are categorised according to health status 
and significant test results are done through pair-wise ANOVA with results 
shown as significant P values. 
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4.4 Discussion 
Samples from unhealthy subjects (suffering from a cold or viral infection) and 
from those receiving antibiotic treatment showed changes in community 
composition at the three taxonomic levels in comparison to the healthy samples; 
specifically in the abundances of taxa. A particularly prominent pattern was 
Firmicutes dominance in healthy and unhealthy samples, but unhealthy samples 
had increases in abundance in Proteobacteria. However, increases in abundance 
in the phylum Proteobacteria cannot be solely responsible for explaining disease 
or infection as there were also various healthy samples where Proteobacteria 
was the most dominant phylum. This could reflect the variation in taxa 
abundance present in participants as other studies have also shown the healthy 
oropharynx microbiome to be Proteobacteria dominant in abundance (Charlson 
et al., 2011). However, in a given participant, this ratio was more extreme in 
unhealthy samples where there was a higher representation of Proteobacteria in 
comparison to their healthy samples. At genus level there was a significant 
difference in the abundance of Prevotella in unhealthy samples, but there did 
not seem to be a significant difference in the abundance of Streptococcus in 
unhealthy samples, even though other studies have noted a decrease in 
abundance in Streptococcus during respiratory diseases such as chronic 
obstructive pulmonary disorder that directly affects the oropharyngeal 
community (Park et al., 2014). As Streptococcus was the most abundant genus in 
healthy and unhealthy samples, this may account for why no significant 
differences in abundance were observed in respect to health status. 
Streptococcus is a genus that contains various commensal and pathogenic 
species, so there may have been a decrease in the commensal OTUs and an 
increase in pathogenic Streptococcus OTUs. However, as only some of the 
Streptococcus OTUs could be identified to OTU level, it was difficult to 
distinguish between the commensal and pathogenic Streptococcus OTUs and how 
they varied in abundance in healthy and unhealthy samples. 
 
Specific health categories also showed changes in community composition 
showing that antibiotic treatment and colds affect the oropharynx microbiome in 
different ways. Healthy communities had greater abundances of OTUs belonging 
to the genera Streptococcus and Prevotella which were reduced in cold samples. 
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The cold samples had increases in abundance of specific genera and OTUs 
showing dysbiosis and changes in community composition in comparison to the 
healthy samples. Dysbiosis was also observed in the samples from subjects with 
viral infection, with increases in abundance of specific genera such as Neisseria 
and Haemophilus, but these communities were more similar to healthy 
communities. This suggests that viral infection may increase the abundance of 
specific OTUs. Antibiotic treatement resulted in a decrease in OTUs common in 
healthy samples, with exception to a few OTUs belonging to the genus 
Actinomyces that increased in abundance. Therefore, the specific changes in 
community composition in different health groups (and participants) needs to be 
further investigated to show exactly how a healthy community changes during a 
specific disease, infection or disturbance. 
 
In terms of diversity, healthy communities were the most diverse and antibiotics 
treated ones the least which was consistent with other studies as observed in the 
microbiome of the GI tract (Jakobsson et al., 2010). However, participants did 
show variation in healthy samples with changes in diversity and richness, 
sometimes on a weekly basis, but the dominant members of the community such 
as Streptococcus, Prevotella and Veillonella were always present. Even though 
highly diverse communities may be indicative of health, (as healthy communities 
overall had the highest diversity and species richness) there were some cases of 
healthy samples having low diversity communities, even though the overall 
diversity from the participant was not considered low compared to the rest of 
the participants. But from this sampling overall, significant differences in 
diversity were observed between the specific health categories. The diversity in 
different health states needs further investigation and should also take into 
account each individual participant to determine what OTUs still remain and 
what OTUs are removed in all healthy samples of high and low diversity 
communities. 
 
As in most microbiome studies, the causalities are challenging to determine. Do 
changes in the microbiome drive changes in health status or are they merely 
consequences of it? There were clear cases in participants reporting cold related 
symptoms and cold samples showing an increase in abundance in a specific genus 
or a decrease in abundance in Streptococcus. To conclude whether ill health or 
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disease in this case was caused by a specific genus still remains challenging due 
to lack of daily sampling and metadata collection.  However, this study does give 
insight into the changes that occur in the oropharynx microbiome during 
infections and disturbances, which is a starting point in determining if changes in 
the oropharynx are a cause or effect of a certain disease or condition. 
 
4.5 Conclusions 
Unhealthy samples had distinct community structures in comparison to healthy 
samples from non-smokers. These changes included increases in abundance of 
Proteobacteria at phylum level and decreases in abundance of Prevotella at 
genus level. Healthy communities were also the most diverse communities, with 
the cold and antibiotics samples having the least diversity. This shows that the 
oropharynx microbiome is affected by infections and antibiotics resulting in 
altered and low diversity communities. 
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5 Investigating the stability of the oropharynx 
microbiome in non-smoking participants 
5.1 Introduction 
Understanding the factors underlying the structure and composition of microbial 
communities in individuals is challenging due to interpersonal variation and 
fluctuations in composition, especially during disease and early development. 
The first step towards understanding the symbiotic relationships between 
microbes in the oropharynx with their hosts is to characterise the baseline 
healthy microbiome and the differences associated with disease as observed in 
Chapters 3 & 4. This improved understanding of the desired compositional states 
of the healthy microbiome will then determine which features, when disrupted, 
are associated with disease. However, the natural complexity of the 
microbiome, and the presence of intra- and inter-subject variability, further 
complicates the definition of what a “desired” state may look like for a 
population or an individual. But understanding these differences between 
individuals could potentially result in personalised restoration of the microbiome 
as a future clinical treatment. 
Variability in microbial community structure between individuals may arise from 
natural processes (colonisation history), but factors such as diet, lifestyle, 
environmental and host changes also play a role (David et al., 2014). A study by 
Bogaert et al., 2011 showed that variation in healthy individuals is increased at 
genus and species level  making it hard to define a core microbial population due 
to the diversity of OTUs present between individuals, but also due to the fact 
that variation occurred between the different seasons. The extent of variation of 
microbial communities within and between individuals over a period of time is 
still under investigation, but nevertheless very important as it determines the 
true microbial components of a community, as well as identifying the microbes 
that are not regular members of the community. From this, it is possible to 
explore how ones microbiome differs from another whilst examining the rich 
diversity of the community, and investigating whether these differences are 
natural changes or a result of a specific disturbance. It is especially important to 
understand natural variation over time to understand the stability of the 
microbiome and whether instability increases the risk of pathogen susceptibility. 
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Stability can be described as the ability of communities to withstand 
disturbances as well as the similarity of communities in terms of taxon presence 
and abundance. Stability can be measured by microbiome time series projects 
which have the advantage of recording specific metadata and linking microbial 
dynamics to host behavior. 
Understanding the variation in the healthy oropharynx has great importance. 
Further exploration of the community composition of the oropharynx 
microbiome improves the ecological understanding of these communities (Fierer 
et al., 2012). Understanding the relationships between microbes of the upper 
respiratory tract (URT) during perturbations is anticipated to provide insights 
into the pathogenesis of URT infections. It will also aid understanding of the 
effects of stability and resilience on these communities and the process of 
recovery in the oropharynx. Therefore, this chapter explores the extent of 
variation in microbial communities in non-smoking participants. This was 
investigated in different health states whilst observing the changes that occur to 
the oropharynx microbiome before, during and after disturbances to determine 
the stability and resilience in individual microbiomes. The objectives of this 
chapter can be broken down into the following questions: What is the variation 
in oropharyngeal communities? How does the community change before, during 
and after a disturbance? How stable is the microbiome in non-smokers and how 
quickly can the microbiome recover? The hypothesis is that non-smoking 
participants have a stable oropharynx microbiome that can recover quickly from 
disturbances. 
5.2 Methods 
5.2.1 Exploring variation in the oropharyngeal community 
All statistical analysis was performed in R (version 3.1.2). To assess the variation 
of the oropharynx microbiome between the different health groups, a NMDS plot 
using Bray-Curtis distance with variance ellipses (Chapter 2.11.2) was produced 
using Vegan package (version 2.4.0) (Oksanen, 2013). A NMDS plot at OTU level 
was produced showing similarity of community composition in samples with 
regards to health status. The variability in microbial community structure in 
regards to health status was investigated at OTU level using betadisper() in 
Vegan (version 3.1.2) and these distances were used to quantify the extent of 
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variation in each health group through a betadisper box plot (Bray-Curtis 
distance). This measured the distance of each individual sample to that group’s 
centroid (mean) allowing for comparison between the different health groups. 
Samples that had the greatest distance away from the group centroid were 
considered to have a different community structure as opposed to samples with 
a shorter distance to the centroid. ANOVA was performed on betadisper 
distances where the distance of each individual sample to the centroid (mean) of 
each different health group was assessed and the means compared to determine 
if variation changed according to health status. Tukey’s HSD test was used as a 
post-hoc test after ANOVA to determine which groups differed in variation. 
5.2.2 Exploring the stability of the oropharynx microbiome 
Using distances from betadisper, individual participant graphs were plotted to 
show the distance of each sample to that participant’s centroid (mean). These 
stability plots allowed comparison in distances of all samples within and 
between participants which could determine the degree of change in the 
microbial community during the sampling period. This would also determine 
whether fluctuations could be caused by disturbances such as changes in health 
status. Overall this would give an indication of the stability of a participant’s 
microbiome as peaks (greater distances) over the sampling period can be 
identified. A participant with higher peaks (corresponds to how different the 
microbiome is at different time points) is thought to show a more unstable 
microbiome compared to a participant with smaller consistent peaks. For each 
participant, the difference in distance of the individual sample to that 
participant’s centroid was plotted, making these plots comparable between 
participants. Community stability was quantified by calculating the coefficient 
of variation (ratio of standard deviation to the mean) for each individual 
participant using the distances from betadisper. 
The temporal stability in communities was statistically tested to observe if the 
community structure changed before, during and after a cold/viral disturbance 
through a linear mixed model (LMM) using distances from betadisper. This would 
determine if the community changed only during symptoms or if changes 
occurred before symptoms were present. Sampling week (to accommodate for 
potential temporal trends) was fitted as a fixed effect and participant ID as a 
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random effect using lme4 (version 1.1-9) and MASS (version 7.3-44) packages. 
This would also give an indication of how quickly the community would respond 
to the disturbance and if changes were still apparent to the microbiome after 
the disturbance had cleared and symptoms were no longer present.  
To determine a possible relationship between stability and diversity, the 
coefficient of variation was tested against diversity variables (species richness) 
using spearman correlation to determine any correlation between the overall 
stability of each participant and mean species richness of their communities. 
The resilience (resistance to disturbances) was also tested by using the number 
of cold/viral samples against species richness to characterise its resilience to 
perturbations (Chapter 2.11.3).  
5.3 Results 
5.3.1 Variation in the oropharynx microbiome in health and 
disease 
The variation in communities between the different health groups in non-
smokers was explored (Figure 5.1A). Healthy samples clustered together 
reasonably tightly although dispersion of some samples was observed, the 
differences of which could be due to natural variation from within and between 
participants. As there were uneven samples sizes between the different health 
categories, accurate investigation of the similarity in community structure in 
different health states was challenging. However from visual observation, the 
unhealthy samples were more disperse in that they were located further away 
from each other in comparison to the healthy samples that were clustered closer 
together; this shows that unhealthy groups overall were more variable in 
community structure compared to the healthy group. This was shown in the 
betadisper box plot, displaying which health group had the most variation 
(Figure 5.1B). From this box plot the cold samples showed to have the most 
variation between samples due to the dispersion of samples observed. The 
samples from the cold group were shown to be variable with a greater dispersion 
within samples compared to the healthy group. This would suggest samples from 
participants with the cold had greater changes in community structure compared 
to the healthy samples, as well as each cold sample having distinct communities. 
  114 
 
ANOVA testing showed that the extent of variation changed in different groups 
(P < 0.001) with significant differences between the healthy and cold groups (P < 
0.001) but not between the healthy and viral groups (P = 0.5), and healthy and 
antibiotics group (P = 0.6). Therefore this showed that variation of microbial 
community structure is affected by health status, with the cold group having the 
most variability and changes in community structure between samples. 
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Figure 5.1 - Variation in microbial community structure in healthy and 
unhealthy groups at operational taxonomic unit (OTU) level. The health status 
is indicated by different colours in the key. Figure 5.1A shows the variance 
ellipse and clustering from the non-metric multidimensional scaling (NMDS) plot 
in each health group and Figure 5.1B shows the median and distribution of 
distance (using betadisper) in samples from the centroid of each group. The P 
value (ANOVA) shows a significant difference in variability between groups. 
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5.3.2 Changes in the community structure before, during and 
after a disturbance 
5.3.2.1 Individual responses to disturbances 
The changes in community structure from disturbances for participant HI was 
observed through a NMDS plot (Figure 5.2A). This plot showed clusters of healthy 
samples that were considered stable with similar community composition and 
little changes in the communities on a weekly basis. However outliers were 
observed away from the cluster, some of which could be accounted for through 
changes in health status as participants recorded symptoms of illness for some of 
these samples. Participant HI had various cold symptoms over the duration of 
sampling with 2 samples of a viral infection (Rhinovirus). A taxa plot showing 
community composition in participant HI (Figure 5.2B) revealed a single cold 
sample showing an increase in abundance in the genus Haemophilus; there was 
also an increase in Neisseria during Rhinovirus infection. However viral samples 
looked similar to the healthy samples, indicating that in this case viral infections 
did not have a major impact on the microbiome. There seemed to be a distinct 
change in community structure during disturbances from the cold samples 
(negative for viral infections) with little changes in community structure pre-
disturbance. However, after a cold, the microbial community recovered quickly 
in that it returned back to a normal healthy state (within a week) where the 
post-disturbance sample returned back to a baseline representing health. 
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Figure 5.2 – Non-metric multidimensional scaling (NMDS) plot at operational 
taxonomic unit (OTU) level from participant HI (Fig. 5.2A) showing similarity of 
all samples in regards to health status. Figure 5.2B shows the taxa plot 
displaying the relative abundance of the top 20 most abundant genera. Week 
numbers are represented as sample numbers with cold (C) and viral (V) samples 
shown. Only the top 20 most abundant genera were chosen to give a clear 
visualisation of the most abundant taxa members in the community. 
B 
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5.3.2.2  Individual responses to antibiotic treatment 
The effects of antibiotic treatment on the oropharynx microbiome were also 
investigated through NMDS plots. Participant HF (Figure 5.3A) was on a month 
long prescription of tetracycline antibiotics for treatment of acne whereas 
participant HJ (Figure 5.3B) was on a 6 week prescription of erythromycin, also 
for treatment of acne. In addition, participant HF suffered from a viral infection 
(Respiratory Syncytial Virus) which showed a similar community composition to 
the healthy samples. For participant HF there was a divide in samples between 
the healthy and antibiotic samples, which also occurred for participant HJ. As 
participants were given different antibiotics, it is likely that specific members of 
the microbiome of each participant were affected differently by the antibiotic 
treatment. This is shown in the NMDS plots where participant HF had all 
antibiotic treated samples within the healthy centroid, whereas participant HJ 
had all antibiotic treated samples outside the centroid. This shows that 
antibiotic treatment affects participants very differently. These changes were 
easier to observe when looking at the individual participant’s taxa plots where 
increases in genera Pseudomonas and Actinomyces were found for participant HF 
(Figure 5.3C) and increases in Actinomyces and Acinetobacter for participant HJ 
(Figure 5.3D). However, some antibiotic treated samples were similar in 
composition to the healthy samples and this was seen in both participants. The 
first sample from participant HF on antibiotic treatment (HF20) was dramatically 
altered while the remainder of the antibiotics samples showed a similar 
community composition to the healthy samples. In participant HJ, the first 
antibiotics sample (HJ2) was more similar in community composition to the 
healthy samples, in comparison to the second sample received (sample HJ5) 
where a distorted community structure was observed. The next sample received 
(HJ7) showed an increase in the genus Streptococcus (which is a dominant 
member of the healthy oropharyngeal community) showing that this sample also 
resembled a healthy community. This sample was also similar in community 
composition to sample HJ8, which was a healthy sample received one week after 
antibiotics use. This data showed that antibiotic treatment did impact the 
microbiome, but the microbiome was able to restore itself whilst on treatment 
and recover quickly after treatment (usually within a week) where the 
community returned back to a state similar to samples obtained pre-treatment. 
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Figure 5.3 – Non-metric multidimensional scaling (NMDS) plots of participants HF 
(Fig. 5.3A) & HJ (Fig. 5.3B) at operational taxonomic unit (OTU) level 
demonstrating the degree of variability over the sampling period (variance 
ellipses are calculated from just the healthy samples). In both graphs, the 
starting and end point are marked and the arrows show the direction of sampling 
on a weekly basis. Health status for each plot is depicted through different 
colours in the legend. Taxa plots display the relative abundance of the top 20 
most abundant genera in Participants HF (Fig. 5.3C) and HJ (Fig. 5.3D).  
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5.3.3  Stability of the oropharynx microbiome 
Stability plots for each participant were produced to determine fluctuations 
throughout the sampling period (Figure 5.4). It was found that some participants 
such as participant HC were more consistent in their sampling as each sample 
had a similar distance which reflected that there was a similar change in 
community structure on a weekly basis. Other participants such as participant HS 
had far more deviations with greater peaks suggesting greater changes in 
community structure in comparison to other samples, which not all could be 
accounted for by changes in routine or health status. Therefore, in this case it 
was concluded that participant HC had a more stable microbiome than 
participant HS. The value of stability for each participant was obtained by 
calculating the coefficient of variation (also shown in Figure 5.4) which reflects 
the variation from the long-term mean and so is considered a suitable summary 
statistic as an indication of how stable participants’ oropharyngeal communities 
are. The coefficient of variation for participants were variable, with some 
participants having higher values indicating more changes in community 
structure on a weekly basis which could be regarded as a more unstable state. In 
regards to these values, participant HG had the highest coefficient of variation 
which could be regarded as having a more unstable microbiome (with greater 
changes in the microbial community structure between weeks and therefore 
greater variation overall). In contrast, participant HC was considered to show 
the most stable microbiome due to the lowest coefficient of variation and 
similar minimal changes in the microbial community on a weekly basis (there 
was not much change in microbial community structure over the sampling 
process). As the majority of participants had reasonably low coefficients of 
variations with similar distances, the healthy oropharynx microbiome for each 
participant was considered stable, as there did not seem to be major differences 
in community structure within participants on a weekly basis and most 
deviations in community structure (not all) could usually be linked to a change in 
health status. 
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Figure 5.4 - Individual stability plots for each participant showing the distance 
of each sample (from betadisper) to the participant’s group centroid as well as 
coefficient of variation (CV) values. Disturbances in health status are shown by 
either antibiotics, cold or viral labels (all other samples are considered healthy) 
with the time line of swabbing showing the weeks of when a sample was 
submitted. Participant HB was omitted due to not having enough samples. 
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5.3.3.1 Investigating the temporal stability before, during and after a 
disturbance 
To observe if the community structure changed before, during and after a 
cold/viral disturbance, a LMM was performed using the distances from 
betadisper. The results showed that there was a significant difference in 
community composition in communities one week before the disturbance 
(altered state due to the cold and positive viral samples) (P < 0.001) and during 
disturbance (P < 0.001), but no significant changes were observed in the 
community one week after the disturbance (P = 0.3266) (Table 5.1). This 
demonstrates that changes to the bacterial community were apparent one week 
before symptoms, with communities returning back to normal one week after 
symptoms were no longer present. This highlights the quick recovery from the 
disturbance. From the stability plots the communities showed strong resilience 
in returning rapidly towards the long-term mean composition i.e. shorter 
distance to the centroid showing the oropharynx microbiome to be resilient in 
that it responds and recovers quickly from a disturbance. 
 
Table 5.1 – Parameter estimates from a linear mixed model (LMM) where 
distance (from the betadisper stability plots at operational taxonomic unit (OTU) 
level) was tested against infection variables. Healthy samples are the reference 
category. Significant P values are shown in bold. 
Status of 
infection 
Estimate Std. Error df t value P value 
One week before 
symptoms 
0.05329 0.01428 298.6 3.733 0.000226 
During symptoms 
 
0.06548 0.0122 303 5.368 <0.0001 
One week after 
symptoms 
0.0207 0.02107 299.6 0.982 0.326694 
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5.3.3.2  Is diversity linked to stability? 
The diversity (as measured by species richness and Shannon H index) was shown 
to differ in each participant, especially at lower taxonomic levels. A change in 
diversity has been linked to a change in health status, but the link between 
diversity and stability remains uncertain. To determine a possible relationship, 
the coefficient of variation was tested against diversity variables (Table 5.2) 
using spearman correlation to determine any correlation between the overall 
stability of each participant and mean diversity (species richness) of their 
communities. The results from the spearman correlation and significance testing 
for stability (coefficient of variation) and each diversity variable are as follows: 
CVmeanphyla (-0.1672, P = 0.5211), CVmeangenera (-0.4064, P = 0.1054), CVmeanOTU,     
(-0.053, P = 0.8398), CVnumber of cold/viral disturbances (-0.0463, P = 0.8599). There was 
no obvious relationship between the diversity and stability of the microbiome of 
participants at the three taxa levels. Therefore, from this sampling, diversity is 
not a factor to drive stability as some participants that had high diversity values 
also had high coefficients of variation which could be seen as having more 
variable and unstable microbiomes.  
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Table 5.2 – Mean species richness for all participants and the numbers of 
disturbances identified as used in the diversity/stability test. Participant HB is 
excluded from this table due to not having enough samples. 
 
5.4 Discussion 
The results show that variation in the microbial community structure in the 
oropharynx microbiome occurred within and between participants over the 
timescale of sampling. In most participants, the changes in the microbiome over 
time were usually small fluctuations around a relatively stable microbial 
community. Each participant had a distinct oropharynx microbiome in that there 
was high beta diversity between participants, with abundances of taxa varying 
within and between participants (Fierer et al., 2012). This could also directly 
contribute to each participant having its own stability pattern; however 
variation did occur within participants over time. Variation in bacterial 
community structure is expected due to changes in host and environmental 
Participant 
 
Mean 
number of 
phyla 
Mean 
number 
of genera 
Mean 
number 
of OTUs 
Number of 
disturbances/antibiotics 
throughout sampling weeks 
(n= 45) 
Cold Viral Antibiotics 
HA 8 49 243 2 0 0 
HC 8 46 212 2 0 0 
HD 9 52 250 0 1 0 
HE 8 43 210 1 0 0 
HF 7 40 184 0 1 4 
HG 8 40 204 1 0 0 
HI 8 45 218 4 2 0 
HJ 8 41 184 0 0 3 
HL 8 47 211 0 0 1 
HM 7 39 190 3 0 0 
HN 8 43 216 2 0 0 
HO 8 43 206 1 0 0 
HQ 8 45 226 1 0 0 
HR 9 50 234 0 0 0 
HS 9 45 218 1 0 0 
HT 9 48 235 0 0 0 
HV 8 43 195 1 3 0 
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conditions as well as external factors. As each participant’s oropharyngeal 
community varies over time due to lifestyle, health, age, diet and culture, it is 
crucial to discriminate between the normal perturbations of the human 
microbiome and changes in response to a disturbance. It is this intra- and inter-
subject variability that makes it more difficult to determine a core microbiome, 
especially as not all healthy samples had similar abundances or presence of 
specific OTUs. Even though the majority of healthy samples had a dominant 
member of the community (Streptococcus or Prevotella at genus level), healthy 
samples were variable in terms of prevalence and abundance of taxa and 
community diversity on a weekly basis. This makes it challenging to give an 
accurate definition of what a healthy or desired state is for the oropharyngeal 
community.  
Viral infection (Rhinovirus and Respiratory Syncytial Virus) were not associated 
with changes to the microbiome. However, due to the small number of samples 
from subjects with viral infection, this needs to be further explored, especially 
due to conflicting results published from other studies where viruses do impact 
the oropharynx microbiome (Allen et al., 2014). There is the possibility that the 
cold group did contain viruses in some samples, but these viruses may not have 
been picked up from the respiratory screen because only a selection of viruses 
were tested as well some participants not handing in a viral swab when 
symptoms appeared. Therefore cold samples that were negative for viruses 
tested in the respiratory screen could either be other viruses not detected or 
could be samples that had symptoms occurring from the external environment 
such as irritants or pollen levels. Regardless, the cold samples did show changes 
to the microbiome, with the majority of changes occurring to the community 
structure before and during the symptoms. Even though sampling occurred 
weekly, changes to the microbiome were observed one week before the 
symptoms occurred. The reasons for this may include time required to overcome 
the existing microbial community; this includes the time required for the 
bacteria to multiply to the level required to produce disease and this 
multiplication stage may not result in any symptoms. This pattern was evident 
for most participants when suffering a cold, where the community seemed to be 
disrupted one week before symptoms were noted. One sample had increases in 
bacteria such as Neisseria whereas other samples had increases in Haemophilus 
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which were also present during the cold. However this will also depend on the 
type and severity of infection and how accurate participants were in recording 
symptoms as participants may only have recorded symptoms on sampling days 
and not have recorded any symptoms observed in between sampling days. 
 
Not surprisingly, antibiotic treatment altered the oropharynx microbiome and 
typically resulted in low diversity communities, even when the site of action for 
the antibiotics was not the oropharynx. This was also observed in other studies 
(Jakobsson et al., 2010) showing that antibiotic treatment does result in low 
diversity communities. Antibiotic treatment eliminates specific groups of 
bacteria (due to antimicrobials targeting a limited range of bacteria) and can 
therefore be expected to be changing the microbial populations. One study 
(Santiago et al., 2014) also reported the impact of antibiotic treatment on the 
gut microbiome resulting in increased microbial load specifically gram negative 
bacteria showing the effects of antibiotic treatment on the microbiome are more 
complex than previously thought. Post-antibiotic treatment, the oropharynx 
microbiome recovered quickly showing that it was resilient in that the diversity 
and abundances of taxa were restored again to a state similar to pre-treatment. 
Resilience is usually measured in terms of taxonomic composition; however, 
there should also be consideration in measuring function before, during and 
after a disturbance, as even though changes in taxa occur, this may be even 
more important to show that the community’s role has not changed after a 
disturbance (Jakobsson et al., 2010). Therefore despite disturbances affecting 
the microbiome, the microbiome in all participants was considered stable in that 
even though fluctuations in the community structure were apparent, these 
fluctuations were generally minor with the dominant taxa still present. 
Microbiomes of other body sites such as the skin in healthy participants have also 
shown to be stable (Oh et al., 2016) showing that stable microbiomes may be an 
indicator of health. During specific disturbances the community structure 
changed, but the microbiome was resilient in that it recovered from these 
disturbances quickly, usually within a week.  
 
The diversity-stability relationship was also assessed across participants and 
some participants’ communities were more stable than others. A more diverse 
community is expected to be more resistant to invasion by pathogens (Konopka, 
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2009) and therefore more stable. As some participants had high coefficients of 
variation, as well as high species richness values, no correlation in this case was 
found between diversity and stability. However, various studies in macroecology 
have reported that diverse communities tend to be the most stable ones  
(Loreau & de Mazancourt, 2013) (Lozupone et al., 2012), so this still remains 
unknown for microbiome studies, especially due to the small sample size of 
unhealthy communities in this study. Therefore, the role of diversity in different 
health states is complex and challenging, especially as it is still unknown if a low 
diverse state is the cause or consequence of the disease, and how this affects 
stability. Even though the oropharynx microbiome was found to be stable, 
determining the stability of the oropharynx microbiome over a longitudinal 
period of time was a challenge as samples were not present every week as 
participants did miss some weeks of swabbing. Participants may have also 
inaccurately reported symptoms due to forgetting, being rushed or reporting the 
wrong symptoms. This could explain why some samples had very distinct, 
different communities for which there were no obvious explanations. Overall 
though, it was found that each participant had a distinct oropharynx microbiome 
that was considered stable and resilient to disturbances at the genus and OTU 
level.  
 
5.5 Conclusions 
This chapter shows that healthy participants have stable and resilient 
oropharynx microbiomes. When faced with a disturbance the microbiome 
becomes altered with changes in abundances in taxa. However, the microbiome 
was quick to recover from these disturbances and return back to a normal and 
healthy state usually within a week. Healthy samples from participants were 
dominated by few taxa, with other taxa residing at lower abundances, but there 
was also variation in the abundances in the dominant taxa within and between 
participants. By understanding the extent of variation in healthy participants 
and bacterial abundances before, during and after infection, it may be possible 
in the future to identify respiratory diseases (from further investigations and 
controlled studies) and possibly restore health through investigating how to 
manipulate microbial populations. 
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6 Comparing the community structure and stability of 
the oropharynx microbiome of non-smoking to 
smoking participants 
6.1 Introduction 
Smoking has been associated with many risks; exposure to cigarette smoke 
results in changes in the host’s environmental conditions, disruption in the 
body’s natural defence mechanisms and impaired or reduced host immune 
responses against infections (Van Zyl-Smit et al., 2014). There is also an 
increased risk of respiratory tract infections (Bagaitkar et al., 2008) through 
disruption of commensal bacteria potentially providing an opportunity for 
colonisation and growth of pathogenic microorganisms.  
 
The effect of smoking on any microbiome is a still a topic under investigation; 
the introduction of next-generation sequencing (Petrosino et al., 2009) is 
changing this by enabling quick in-depth analysis of communities from various 
body sites. Studies using this technology have started exploring the effects of 
smoking on the oropharynx microbiome as the oropharynx is one of the first sites 
of contact for cigarette smoke. Results have already shown distinct communities 
between smokers and non-smokers (Charlson et al., 2010). The healthy 
oropharyngeal community consists of Firmicutes and Bacteroidetes as the 
dominant phyla, and Streptococcus, Prevotella and Veillonella the most 
abundant genera (Lemon et al., 2010). In contrast and comparison with non-
smokers, the dominant phyla in the oropharyngeal communities of smokers are 
Actinobacteria and Bacteroidetes with increases in the abundance of the genera 
Megasphaera and Fusobacterium as well as pathogenic Streptococcus species (S. 
pneumoniae). In addition, certain commensal Streptococcus, Prevotella and 
Peptostreptococcus species have a reduced abundance in smokers’ oropharynx 
microbiomes (Charlson et al., 2010). Various pathogens isolated from smokers 
communities have been associated with diseases such as periodontitis (Zeller et 
al., 2014), tonsillitis (Bagaitkar et al., 2008), chronic obstructive pulmonary 
disorder (Erb-Downward et al., 2011) and tuberculosis (Van Zyl-Smit et al., 
2014). 
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The changes in the oropharynx microbiome associated with smoking could also 
affect the stability properties of the community; longitudinal sampling would 
ideally show how the community changes over a defined period of time and in 
response to fluctuations. These changes in a healthy community structure may 
affect the overall stability of the microbiome, something that is relatively 
unexplored. These changes are important as they may determine the outcome or 
recovery from a disturbance or infection, as well as be responsible for making 
communities more susceptible to infections. There have been no studies 
exploring the longitudinal effects of smoking on the microbiome on a weekly 
basis and recovery from infections in comparison to non-smokers. This would 
determine if communities from smokers have specific bacteria responsible for 
increased susceptibility to infection, and also if smoking results in unstable 
communities. Therefore this chapter aims to determine the distinct differences 
in microbial community structure between healthy participants (non-smokers) 
and smokers. The objectives for this chapter are as follows: to compare the 
oropharynx microbiome of non-smoking healthy participants to smokers, to 
determine the changes that occur to the oropharyngeal community during a 
disturbance in smokers, to determine if healthy participants have more stable 
microbiomes compared to smokers and to determine if smokers have a longer 
recovery time from a disturbance (from the cold and viral samples only) 
compared to healthy participants. The hypothesis is that smokers will have a 
changed microbial community structure in comparison to non-smoking 
participants; the smoker’s microbiome will be unstable with increased 
differences in community structure in samples from the same participant and 
the community will take longer to recover from a disturbance. 
 
6.2 Methods 
6.2.1 Initial analysis 
In total, 490 oropharyngeal samples were obtained from 30 participants; 313 
samples from non-smoking participants (n=18) and 177 from smokers (n=12). 
Samples from the non-smokers and smokers were collected over two different 
years (2013 for non-smokers and 2014/2015 for smokers). From the non-smoking 
healthy participants’ samples, 34 samples were identified as unhealthy samples 
which were categorised into the following groups: cold (n=19 from 12 
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participants), antibiotics (n=8 from 3 participants) and viral (n=7 from 4 
participants). The cold group includes samples from participants self reporting 
symptoms of a cold but were negative for the respiratory screen at Gartnavel 
hospital as described in section Chapter 2.2.1. The antibiotics group included 
any participants undergoing antibiotic treatment and the viral group included 
only symptomatic samples with confirmed viruses from the respiratory screen. 
For the smokers, 32 samples were identified as unhealthy samples which were 
categorised into two groups, cold (n=14 from 6 participants) and antibiotics 
(n=18 from 2 participants). There were no positive viral samples from the 
smokers group. The rest of the smoker’s samples were considered as healthy 
samples – a healthy sample from a smoker is classified as one without any 
symptoms of disease or any changes in the normal routine of the participant.  
6.2.2  Microbial community composition 
Statistical analysis was performed in R software (version 3.1.2). Where 
appropriate, the abundance data were normalised (McMurdie & Holmes, 2014) 
before specific analyses. Linear mixed models (LMM) were constructed through 
lme4 package (version 1.1-9) using log transformed abundances on all samples 
from non-smoking participants and smoking participants (healthy and unhealthy) 
to determine differences in abundance of certain taxa between smokers and 
non-smokers. Week was used as a fixed effect as eventhough sampling for non-
smokers and smokers occurred in two different years, the weekly sampling 
procedure that occurred in non-smokers and smokers was the same. Participant 
ID was used as a random effect. 
Microbial compositional structure was assessed using non-metric 
multidimensional scaling plots (NMDS) to determine the differences in 
community composition in regards to smoker and health status. To determine 
the difference in community composition between non-smoking participants and 
smokers, an NMDS plot was produced from only the healthy samples of non-
smokers and smokers. The Bray-Curtis dissimilarity index was applied which 
considers bacterial taxon abundance. Unweighted UniFrac distance analysis from 
the Phyloseq package (version 1.17.2) was also used (McMurdie & Holmes, 2013) 
which takes into account the phylogenetic distances (relatedness) of taxa 
through presence or absence, but without accounting for their proportional 
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representation. A covariance ellipse using Ordiellipse() and veganCovEllipse() in 
Vegan (version 2.4.0) was added (95% confidence interval calculated from the 
standard errors of samples from the mean of each group) with the centroid of 
the ellipse representing the group mean. Covariance for each group was 
calculated using cov.wt() and the shape of the ellipse was defined by the 
covariance within each group - the bigger the ellipse, the more variability in 
community structure in samples within the group. Significant difference testing 
for different groups at OTU level was done using PERMANOVA through adonis() in 
Vegan (version 2.4.0). The significant difference testing for clustering was 
corrected using the command strata to take into account repeated sampling 
from participants. 
To find OTUs that are significantly different between non-smoking and smoking 
participants, DESeq2 package (version 1.24.0) in R (version 3.1.2) (Love et al., 
2014) was used as before. This determined the specific OTUs responsible for 
distinguishing between a non-smoker and smoker’s community by identifying the 
OTUs with the most significant differences in abundance between the two 
groups. This uses a negative binomial GLM fitting on the abundance data (OTU 
frequencies) and empirical Bayes to shrink OTU-wise dispersions to identify OTUs 
that have the log-fold changes between different conditions. Differential 
expressions are tested by performing a Wald test on shrunken log-fold changes 
and are adjusted for multiple comparisons. This results in adjusted P values for 
the most significantly different OTUs between non-smokers and smokers. 
6.2.3  Assessing community diversity 
Samples were rarefied to the minimum number of reads (5118) to test for alpha 
diversity. Alpha diversity at OTU level was investigated to determine the 
possible associations between non-smokers, smokers and health status in 
oropharyngeal community structure. The diversity indices calculated for healthy 
and unhealthy samples from non-smoking participants and smokers were species 
richness, Shannon H index and Simpson index. The aov() from Vegan (version 
2.4.0) was then used to calculate pair-wise ANOVA P values (taking into account 
repeated sampling from participants) which were displayed on top of alpha 
diversity figures.   
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6.2.4  Assessing community stability 
Stability plots were produced as described in Chapter 4.2.3 using betadisper() in 
Vegan (version 2.4.0) where the distance to the centroid (mean) from each 
sample was calculated for each participant showing temporal fluctuations for 
non-smokers and smokers. To determine if community structure changed before, 
during and after a disturbance for non-smokers and smokers, a linear mixed 
model (LMM) was constructed. The community composition of healthy samples 
from smokers was compared to healthy samples from non-smokers (as well as 
the unhealthy samples from non-smokers and smokers) in different infection 
states. The LMM used distances from betadisper to determine if there were 
differences in community structure between non-smokers and smokers. 
6.3 Results 
6.3.1 Comparison of healthy communities from non-smoking 
participants and smokers 
6.3.1.1 Initial analysis of smokers’ samples 
At the end of the sampling period, 177 smoker’s samples were received in total, 
with 145 designated as healthy. The number of samples (healthy and unhealthy) 
received from each smoking participant is shown in Table 6.1. 
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Table 6.1 – Metadata shown for smokers samples including the total number of 
samples (healthy and unhealthy) and the range in taxa numbers (with the 
median shown in brackets) received from each smoking participant. 
 
The taxonomic profiling of samples from the oropharynx of individual smoking 
participants identified with RDP classifier revealed 5 to 9 phyla, 11 to 59 genera 
and 97 to 347 assignments at OTU level which was similar to non-smokers (5 to 
10 phyla, 20 to 70 genera and 140 to 340 OTUs). The species richness at OTU level 
for non-smokers and smokers is shown in Figure 6.1. 
Participant Age Sex 
Total 
samples 
Number 
of years 
smoking 
Average 
number of 
cigarettes 
smoked 
per week 
Phylum Genus OTU 
SA 40 M 23 20 30 5-9 (9) 
11-59 
(46) 
97-347 
(221) 
SB 19 F 3 5 120 8-8 (8) 
42-46 
(42) 
183-199 
(184) 
SC 19 F 23 2 6 6-9 (8) 
32-53 
(44) 
136-254 
(208) 
SD 19 F 8 1 60 5-8 (6) 
28-46 
(37) 
127-225 
(156) 
SE 19 F 1 5 35 N/A N/A N/A 
SF 19 F 19 4 30 6-9 (7) 
30-51 
(41) 
120-260 
(179) 
SG 33 M 25 15 70 7-9 (8) 
29-58 
(53) 
158-295 
(201) 
SH 30 F 25 13 12 7-9 (9) 
31-58 
(44) 
101-313 
(223) 
SI 30 F 24 10 25 6-9 (8) 
29-59 
(46) 
126-279 
(222) 
SK 19 F 10 5 60 8-9 (9) 
40-52 
(47) 
172-279 
(235) 
SL 19 F 10 3 10 8-9 (8) 
41-54 
(46) 
209-286 
(234) 
SM 19 F 6 3 30 7-8 (8) 
45-52 
(50) 
208-236 
(228) 
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Figure 6.1 – Box plot showing species richness at operational taxonomic unit 
(OTU) level for healthy non-smokers (H_Healthy) and healthy smokers 
(S_Healthy) showing there is a significant difference in richness between the 2 
groups as observed by the significant P value. The significant difference testing 
for clustering was corrected due to having repeated sampling from participants. 
 
6.3.1.2 Community composition of healthy samples from non-smoking 
participants and smokers 
The most abundant taxa from healthy samples from smoking participants 
included Firmicutes (mean proportion of the whole sample ± SEM = 50% ± 2%), 
Bacteroidetes (18% ± 1%), Proteobacteria (13% ± 2%), Actinobacteria (13% ± 1%) 
and Fusobacteria (3% ± 1%) (Appendix 10 & Appendix 11). However, comparison 
of abundances from healthy (smoker) and healthy (non-smoker) samples showed 
smokers to have significant increases in abundance of all phyla apart from 
Fusobacteria (Table 6.2) showing that community differences in abundance 
between smokers and non-smokers were present at the phylum level. 
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Table 6.2 – Linear mixed model (LMM) parameters investigating the abundances 
(response variable) of certain phyla in healthy samples from smokers compared 
to healthy samples from non-smokers (reference category). Significant P values 
are shown in bold. 
Smokers 
samples 
Estimate Std. Error df t value P value 
Firmicutes 0.3350 0.1115 424 3.0060 0.002 
Proteobacteria 0.6834 0.2946 307 2.3200 0.02 
Bacteroidetes 0.7542 0.1949 25.9 3.8700 <0.001 
Actinobacteria 0.9916 0.1809 27 5.4830 <0.001 
Fusobacteria -0.0746 0.2845 22.3 -0.2620 0.796     
 
At genus level, healthy samples from smoking participants had the most 
dominant genera of Streptococcus (39% ± 2%), Prevotella (12% ± 1%) and 
Actinomyces (5% ± 1%) (Appendix 12 & Appendix 13). When comparing 
abundances of healthy samples (smokers) to healthy samples (non-smokers), 
smokers had significant increases in abundance in the genera Streptococcus (P = 
0.005) and Prevotella (P = 0.001) (Table 6.3).  
Table 6.3 – Linear mixed model (LMM) parameters investigating the abundances 
(response variable) of certain genera in healthy samples from smokers compared 
to healthy samples from non-smokers (reference category). Significant P values 
are shown in bold. 
Smokers 
samples 
Estimate Std. Error df t value P value 
Streptococcus 0.3130 0.1129 424 2.7720 0.005 
Prevotella 0.7884 0.2137 25.4 3.6890 0.001  
Veillonella 0.3341 0.1957 25.1 1.7080 0.1 
 
The most abundant OTUs belonged to Streptococcus species again reflecting the 
general abundance of their phylum, Firmicutes (Appendix 14). The most 
abundant OTUs identified included Streptococcus mitis, Streptococcus salivarius 
and Streptococcus parasanguinis which were also the most dominant OTUs in the 
healthy samples from non-smoking participants. 
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To determine the overall difference in community composition between non-
smoking participants and smokers, an NMDS plot was produced from only the 
healthy samples from non-smokers and smokers, where samples from each group 
clustered separately. This was characterised by differences in abundance of 
OTUs using Bray-Curtis distance (Figure 6.2A) and presence and absence of 
different types of OTUs using unweighted UniFrac distance (Figure 6.2B).  
Significant differences were observed for both distances (Bray-Curtis, P < 0.001; 
unweighted UniFrac, P < 0.001) showing that non-smoking participants and 
smokers differ in the abundances of OTUs and in the presence and absence of 
specific OTUs.  
These changes at OTU level were investigated to determine whether non-
smokers and smokers have a different composition of OTUs in their oropharynx 
microbiomes. Smokers have increased abundances of opportunistic and 
pathogenic microorganisms as shown in Table 6.4 which shows the 10 most 
significant OTUs in terms of differing abundance found between the healthy 
samples (from non-smoking participants and smokers). Smokers had increased 
abundances of specific OTUs that were potentially pathogenic, and decreased 
abundances of certain OTUs including commensals such as Neisseria oralis.  
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Figure 6.2 – Non-metric multidimensional scaling (NMDS) plots at 
operational taxonomic unit (OTU) level showing microbial community 
compositions of only the healthy samples in regards to smoker status. 
Variance ellipses were added by calculating the covariance for each group 
was calculated by cov.wt() and the shape of the ellipse was defined by the 
covariance within each group. Figure 6.2A uses Bray-Curtis distance whereas 
Figure 6.2B uses unweighted UniFrac phylogenetic distances. 
A 
B 
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Table 6.4 - The 10 most significant operational taxonomic units (OTUs) in terms 
of differing abundances found between the healthy samples from non-smoking 
participants and smokers. The abundance of the OTUs in smokers (whether 
increasing or decreasing) is shown through representation of arrows. 
OTU Abundance 
in smokers 
Adjusted 
P value 
Description 
OTU_216 
Porphyromonas 
gingavalis strain 
W83 
 <0.001 Major pathogen in 
periodontitis (Nelson et al., 
2003) - smoking increases 
risk of periodontal disease 
(Zeller et al., 2014) 
OTU_60 
Streptococcus 
agalactiae 
 <0.001 Commensal and pathogen 
involved in sepsis and 
pneumonia (Tettelin et al., 
2002) 
OTU_66 
Streptococcus 
pyogenes strain 
M1 
 <0.001 Pathogen that causes tonsillitis 
(Bagaitkar et al., 2008), 
pharyngitis and scarlet fever 
(Ferretti et al., 2001) 
OTU_82 
Enterococcus  
faecalis 
 
 <0.001 Some strains highly resistant to 
antibiotics known as 
vancomycin resistant 
Enterococci (Kristich & Rice, 
2009) 
Linked to oral cancer through 
increased release of hydrogen 
peroxide (Boonanantanasarn et 
al., 2012) 
Also found in periodontitis 
(Wang et al., 2012) 
OTU_192 
Bifidobacterium 
longum 
 <0.001 Commensal with some strains 
used as a probiotic in food and 
drinks (Sugahara et al., 2015) 
OTU_17 
Neisseria oralis 
 <0.001 Healthy commensal found in 
the oral tract 
OTU_8 
Chryseobacterium 
 <0.001 Common bacteria found in 
water and environmental 
sources 
OTU_857 
Fusobacterium 
necrophorum 
subsp. 
funduliforme 
 <0.001 Present in the oropharynx in 
healthy individuals but has 
been involved in tonsillitis 
(Jensen et al., 2007) 
OTU_13 
Corynebacterium  
propinguum 
 
 <0.001 Present in the oropharynx but 
has been involved in lower 
respiratory tract infections 
(Díez-Aguilar et al., 2013) 
OTU_29 
Moraxella 
nonliquefaciens 
 <0.001 Usually a commensal, can 
become pathogenic (Marrs, 
2016) 
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6.3.2 Comparison of unhealthy communities from non-smoking 
participants and smokers 
6.3.2.1 Community similarity in healthy and unhealthy samples from non-
smokers and smokers 
For both non-smoking participants and smokers, the communities changed when 
there was a disturbance in health status as observed through NMDS plots at Bray-
Curtis distance (Figure 6.3A) and unweighted UniFrac distance (Figure 6.3B). For 
non-smoking participants the community structure was altered when changing 
from a healthy to unhealthy state (Bray-Curtis, P = 0.005; unweighted UniFrac, P 
= 0.02). Colds were more associated with changes in abundances of OTUs 
whereas antibiotic treatment resulted in changes of the presence or absence of 
specific OTUs. For smokers, a change in health status also resulted in a change in 
community structure, but this was only significant for changes in abundance 
rather than presence or absence of OTUs when using a value of P < 0.1 for 
significance (Bray-Curtis, P = 0.07; unweighted UniFrac, P = 0.6). These changes 
were more apparent in the antibiotics group, as the cold samples from smokers 
showed similar community compositions to the healthy samples from smokers. 
Samples also clustered according to smoker and health status; healthy 
communities from non-smokers and smokers had tight clustering, whereas 
samples from the unhealthy groups (with the exception of cold samples from 
smokers) were more spread out from each other and had more variability in 
community structure compared to samples representing healthy states. However 
the antibiotic samples from both non-smoking participants and smokers seemed 
to have a similar community composition compared to the other samples 
showing that the effects of antibiotic treatment on non-smoking participants and 
smokers were similar. 
For the smoker’s samples only, a change in community structure was not 
observed in regards to how many cigarettes smokers smoked per week on 
average. This was apparent in both NMDS plots using Bray-Curtis and unweighted 
UniFrac distances (Bray-Curtis, P = 0.9; unweighted UniFrac, P = 0.8) where 
communities did not cluster according to the number of cigarettes smoked per 
week.  
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Figure 6.3 – Non-metric multidimensional scaling (NMDS) plot using Bray-Curtis 
dissimilarity index (Fig. 6.3A) showing differences in abundances of operational 
taxonomic units (OTUs) in regards to smoker and health status and the number of 
cigarettes smoked per week in relation to the size of circles – larger circles 
denote a greater number of cigarettes smoked weekly as opposed to smaller 
circles (smoker samples only). Figure 6.3B uses unweighted UniFrac phylogenetic 
distances showing presence and absence of OTUs in regards to smoker and health 
status and the number of cigarettes smoked per week (smoker samples only).  
A 
B 
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The specific differences in the unhealthy samples from non-smoking participants 
and smokers were investigated. The community composition in unhealthy samples 
from smokers showed a decrease in Firmicutes and Proteobacteria (compared to 
unhealthy samples from non-smokers) but these changes in abundance were not 
significant (Table 6.5). 
Table 6.5 – Linear mixed model (LMM) parameters investigating the abundances 
(response variable) of certain phyla in unhealthy samples from smokers 
compared to unhealthy samples from non-smokers (reference category). 
Unhealthy 
samples 
Estimate Std. Error df t value P value 
Firmicutes -0.1102 0.2882 66 -0.3820 0.7030 
Proteobacteria -0.5650 0.5634 17.71 -1.0030 0.3290 
Bacteroidetes 0.7738 0.4048 66 1.9110 0.0600 
Actinobacteria 0.4699 0.5600 14.71 0.8390 0.4149 
Fusobacteria -0.5936 0.4817 66 -1.2320 0.2220 
 
Unhealthy samples from smokers had Streptococcus (38% ± 4%), Prevotella (15% ± 
1%) and Serratia (8% ± 4%) as the most abundant genera (Appendix 15). However 
smokers showed no significant differences in the abundances in Streptococcus but 
a significant increase in Prevotella (P = 0.013) was observed in comparison to the 
unhealthy samples from non-smoking participants (Table 6.6). 
Table 6.6 – Linear mixed model (LMM) parameters investigating the abundances 
(response variable) of certain genera in unhealthy samples from smokers 
compared to unhealthy samples from non-smokers (reference category). 
Significant P values are shown in bold. 
Unhealthy 
samples 
Estimate Std. Error df t value P value 
Streptococcus -0.04024     0.31260   4.52 -0.129   0.903 
Prevotella 1.18553     0.46705 66 2.538    0.013 
Veillonella -0.17916     0.52267 12.29  -0.343    0.737 
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6.3.2.2  Comparison of diversity in healthy and unhealthy communities from 
non-smoking participants and smokers 
The diversity of samples in regards to smoker and health status was investigated 
using alpha diversity measures to observe changes in alpha diversity in regards to 
smoker and health status (Figure 6.4). In non-smoking participants at OTU level, 
significant differences were observed using pair wise ANOVA for richness and 
diversity measures. This was observed between the healthy and cold samples 
(species richness: P < 0.001, Shannon H index: P = 0.01, Simpson index: P 
<0.001) and healthy and antibiotics samples (species richness: P < 0.001, 
Shannon H index: P = 0.001, Simpson index: P = 0.007) showing that healthy 
samples (from non-smokers) had the greatest richness and diversity and 
unhealthy samples had the least richness and diversity. Looking at the smoker’s 
samples alone at OTU level, the healthy and cold samples from smokers had no 
significant differences in species richness, Shannon H diversity or Simpson index 
showing that these groups were similar in terms of richness and diversity. 
Significant differences were observed in species richness between the antibiotics 
and cold samples at OTU level (P = 0.003) with samples obtained during 
antibiotic treatment having reduced richness compared to the cold samples but 
there were no significant differences in Shannon H or Simpson diversity. A 
significant difference was also observed in Shannon H diversity between the 
antibiotics and healthy samples from smokers at OTU level (P = 0.003) with 
antibiotics having reduced diversity, but not species richness or Simpson 
diversity. Overall this shows at OTU level the healthy samples from non-smoking 
healthy participants were more diverse than the healthy samples from smokers 
(species richness: P = 0.01, Shannon H index: P <0.001, Simpson index: P < 
0.001), but the cold samples from smokers was shown to be the most rich and 
diverse. Diversity was impacted by health status where antibiotics use resulted 
in lower diversity in both non-smoking participants and smokers, whereas cold 
samples were associated with reduced richness and diversity in non-smokers but 
increased richness and diversity in smokers. 
 
 
  143 
 
Figure 6.4 – Alpha diversity measures at operational taxonomic unit (OTU) 
level. Samples are categorised by health and smoker status. Significance testing 
was performed using pair wise ANOVA with significant P values shown above. 
 
6.3.3 Comparing the stability of the oropharynx microbiome in 
non-smoking participants and smokers 
6.3.3.1 Stability of the oropharynx microbiome in non-smoking participants 
and smokers 
A combined stability plot for non-smoking participants and smokers showed the 
fluctuations of the oropharynx microbiome on a weekly basis and the changes in 
community structure during a disturbance (Figure 6.5). As determined before, 
non-smoking participants had disturbances that could be related to changes in 
health status, from which they would recover quickly, showing that the 
microbiome was resilient (Chapter 5). Smokers also had changes in health status 
which were determined by greater peaks – more so for samples collected during 
antibiotic treatment than for samples collected during colds. However, visually 
there seemed to be greater peaks present in smokers which were not related to 
reported changes in health status or routine. The coefficient of variation gave a 
numerical stability representation for each participant. The coefficient of 
variations determined for the non-smoking participants ranged from 12% to 26% 
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and 9% to 29% for smokers. The variability in community structure was apparent 
within and between participants from both groups (although visually there 
seemed to be greater variability between smoking participants). Instead, it was 
concluded that each participant had a stable microbiome regardless of smoker 
status, as even though smokers had an altered microbial community when 
compared to non-smoking healthy participants, the microbiome was still 
relatively stable over the weeks of sampling and the coefficient of variation 
values for participants from both groups were generally low. 
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Figure 6.5 - Stability plots for all participants using distances from betadisper – 
non-smoking healthy participants are identified as starting with H, whereas 
smokers start with S. Time points indicate the week of when a sample was 
handed in and peaks refer to altered communities as identified by having a 
greater distance away from the centroid. Participant’s HB and SE are omitted 
due to not having enough samples. 
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6.3.3.2  Is smoking associated with changes in community resilience after a 
disturbance? 
 
An LMM was constructed using the distances from betadisper showing that there 
were differences in community structure between non-smoking participants and 
smokers (Table 6.7). There were significant differences between the healthy 
communities from smokers and non-smoking participants (P = 0.05), one week 
before symptoms (P < 0.001) and during symptoms (P < 0.001) when compared to 
non-smoking participants. There were no significant differences when comparing 
the healthy smoker samples to any other smoker’s samples during the different 
health states. Therefore, for the smoker’s samples the time required for 
recovery from a cold could not be investigated. 
 
Table 6.7 – Linear mixed model (LMM) parameters comparing the healthy 
samples from smokers (reference category) to different health states in smokers 
and non-smoking participants. The response variable is the distances from 
betadisper which represents differences in community structures. Significant P 
values are shown in bold. 
Status of 
infection 
Estimate Std. Error df t value P value 
Smokers: One 
week before 
symptoms 
0.015 0.026 447.3 0.566 0.571 
Smokers: During 
symptoms 
-0.019 0.019 454.5 -1.047 0.296 
Smokers: One 
week after 
symptoms 
0.017 0.026 447 0.638 0.524 
Healthy 0.025 0.013 28.8 1.977 0.057 
Healthy: One week 
before symptoms 
0.078 0.019 124.6 4.126 <0.001 
Healthy: During 
symptoms 
0.09 0.017 89.9 5.167 <0.001 
Healthy: One week 
after symptoms 
0.043 0.025 266.1 1.692 0.092 
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6.4 Discussion 
The oropharynx microbiome of a smoker is distinct to the oropharynx 
microbiome of a non-smoking participant. Similar studies have also identified 
these differences with increased abundances of Fusobacteria and Actinobacteria 
at phylum level (Charlson et al., 2010). A higher percentage of  Firmicutes, 
Actinobacteria, Bacteroidetes and Proteobacteria was observed in smokers, with 
increased abundances of potentially pathogenic microorganisms such as 
Porphyromonas gingavilis, Streptococcus pyogenes and Fusobacterium 
necrophorum, all of which have been implicated in oral and respiratory tract 
diseases such as periodontitis and pharyngitis (Camelo-Castillo et al., 2015) 
(Zeller et al., 2014). Smoking seems to distort healthy microbial communities 
through changing abundances of bacteria; this can be through either a reduction 
in commensal bacteria or overgrowth of opportunistic pathogens (Wu et al., 
2016), which may affect the overall structure and functioning of the community. 
Increased abundances of potentially pathogenic OTUs were associated with 
certain oral and respiratory tract diseases like periodontitis (Nelson et al., 2003) 
and pharyngitis (Bagaitkar et al,. 2008).  
 
The smoker’s community was distorted during a disturbance, but more from 
antibiotics treatment rather than a cold. The community structure changed in 
both non-smoking participants and smokers on antibiotic treatment showing that 
antibiotics use results in a disruption of the microbiome which was also seen in 
other studies (Jakobsson et al., 2010). For samples collected when cold 
symptoms were present, non-smoking participants displayed a change in 
community structure when shifting from a healthy to cold status, but this was 
not observed for smokers. From this it can be assumed that smokers have a 
permanent altered state (which may even be more stable than non-smokers) 
with higher abundances of pathogenic microorganisms, and so their healthy 
samples are similar in community composition to the cold samples. 
 
The diversity of the oropharyngeal microbiome of non-smoking participants and 
smokers was also investigated and showed healthy samples from non-smokers to 
be significantly more diverse than the healthy samples from smokers in terms of 
species richness and Shannon H and Simpson diversity. The cold samples from 
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the smokers were also similar in diversity to the healthy samples from the 
smokers; this again confirms the similarity in community composition between 
these two groups. The cold samples from smokers were shown to be the most 
diverse overall at OTU level when compared to all other groups from smokers 
and non-smoking participants and this could be due to increased transient and 
unknown bacteria – other studies have also reported smokers’ communities to be 
more diverse than non-smokers (Charlson et al., 2010) with these studies 
suggesting that smokers may have greater resilience than non-smokers. However 
other studies have reported smokers to have less diverse communities when 
sampling in the oral tract (Camelo-Castillo et al., 2015) suggesting the role of 
diversity in smokers in the oropharynx and other body sites requires further 
investigation. Regardless, these results showed that smokers had differing 
diversity values (and OTU abundances) compared to non-smoking participants.  
 
Participants from both groups were found to have different microbial community 
compositions that were stable as communities’ had similar compositions on a 
weekly basis regardless of smoker status as confirmed through the stability plots. 
The coefficient of variation values in the non-smoking participants ranged from 
12% to 26% and 9% to 29% in smokers, showing that the values were relatively 
similar; therefore it could not be stated that smokers have a more unstable 
microbiome as previously hypothesised. Non-smoking participants had high 
resilience in that they recovered quickly from a disturbance (either antibiotic 
treatment) however this could not be investigated for the smokers as the 
participants that were undergoing antibiotic treatment were still continuing 
treatment at the end of the sampling period so it could not be determined how 
quickly communities recovered again. The community structure of non-smoking 
participants changed one week before a disturbance but did not for smokers; 
this suggests smokers have an altered but relatively stable state that is not 
changed during a disturbance. However, even if distinct changes did occur 
during infection, it would not be possible to determine whether the pathogen 
was present before the participants recorded symptoms, or if the microbiome 
was disturbed prior to the infection which facilitated the disease. As the 
majority of smoking participants had been smoking for a number of years (the 
average of years smoking prior to this study was 7) it could well be that initial 
smoking may make the microbiome less stable at first, but could eventually 
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settle to an altered stable state. The effects of initial smoking on the 
oropharynx microbiome were not investigated in this study. 
 
This sampling showed the distinct changes in the bacterial community structure 
of the oropharynx in non-smoking participants and smokers. Sampling for 
smokers was limited to a total period of 6 months (as compared to a total 
sampling period of 9 months for non-smoking participants). A smaller sample size 
for the smokers made it more difficult to perform longitudinal sampling and 
determine stability patterns as there were fewer samples to investigate for each 
participant. Interestingly though, a similar number of unhealthy samples was 
received from smokers (n=32) and non-smokers (n=34) in a shorter time frame 
suggesting that smokers are more vulnerable or susceptible to illness. However, 
no viral infections were confirmed for the smokers, even though it may be that 
that cold samples were positive for viruses that were not picked up in the 
respiratory screen. This could be due to weekly sampling missing the onset of 
the viral infection, but also due to participants, as the number of viral swabs 
received from smokers was low compared to the number of viral swabs received 
from non-smoking participants. This shows that the effect of viral infection on 
the smoker’s oropharynx microbiome still requires investigation.  
 
6.5 Conclusions 
These findings identify the characteristic patterns of microbial communities in 
smoking and non-smoking participants. Specific OTUs were found to have 
increased abundances in the smokers group and these were Porphyromonas 
gingavilis, Streptococcus pyogenes and Streptococcus agalactiae which are all 
pathogens involved in oral and respiratory tract infections. Smokers and non-
smoking participants also had different responses to deviations of the healthy 
state; non-smokers had high resilience with quick recovery, whereas smokers did 
not display changes to their microbiome during periods of a disturbance, 
suggesting a permanent altered state. Even though variability in community 
structure occurred within and between all participants, each participant’s 
microbiome was still stable regardless of smoker status. These results indicate 
that smokers do have stable but altered microbiomes compared to non-smoking 
participants. 
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7 Determining the function of the oropharynx 
microbiome 
7.1 Introduction 
As amplicon-based markers are widely used for microbiome studies, the 
prediction of the functional capabilities of these communities from 16S rRNA 
data sets would be extremely useful. For instance, by investigating the functions 
associated with microbial community structures it is possible to establish 
whether presence of certain taxa affects microbiome function, as well as 
explore functions associated with microbial communities of different health 
conditions (Shreiner et al., 2016). This not only provides information about the 
structure and general function of the community, but also investigates to what 
extent microbial variation between people might be associated with variation in 
its function. If this is observed, then this opens up the possibility for developing 
therapeutic tools where microorganisms can be used to restore or alter 
communities and thereby affect their functions in disease scenarios. Therefore 
investigating and understanding the functions associated with microbial 
communities are now becoming a very important area of research for 
microbiome studies. Improved methods for this have recently become available 
using the Tax4Fun package in R, (Aßhauer et al., 2015) which enables prediction 
of the functional community profile of 16S rRNA gene data by linking 16S rRNA 
gene sequences to already identified functions of sequences from genomes 
based on a minimum 16S rRNA sequence similarity.  
Several authors have explored the functions of the bacterial communities of the 
oropharynx by comparing it to some diseased state. Castro-nallar et al., (2015) 
explored the microbial and functional diversity between a control and 
schizophrenic group. There were significant differences between the abundance 
of specific taxa, with an increase in the abundance of lactic acid producing 
bacteria in the oropharynx of schizophrenics. The taxonomic changes in 
communities resulted in altered expression of pathways in the control and 
schizophrenic group. Control groups had significantly increased expression levels 
of pathways involved in energy metabolism such as ATP synthesis which was 
lowered in schizophrenic patients. The schizophrenic group had significantly 
increased expression levels of pathways involved in environmental information 
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processing such as glutamate transport, which had reduced expression levels in 
the control group. Schizophrenia has been linked to disturbances in the 
neurotransmitters glutamate and dopamine (Moghaddam & Javitt, 2012), 
suggesting that bacterial communities may also influence or exacerbate 
symptoms of this condition by having increased expression levels of these 
pathways in their communities.  
However, the functional roles of the oropharynx microbiome are still not well 
defined highlighting the need for more studies focusing on both taxonomic 
composition and functional diversity of the oropharynx in healthy participants. 
This information can then be used in disease scenarios, comparing how 
functional profiles of the oropharynx differ during upper respiratory infections, 
disturbances such as antibiotic treatment as well as lifestyle factors like 
smoking. Smoking has been shown to result in altered community structures in 
the oropharynx when compared to non-smoking participants (Chapter 6), yet 
there is still very little information on whether smoking affects the functional 
roles of the oropharynx microbiome. 
This chapter will explore the predicted functions associated with the 16S rRNA 
gene from the oropharynx of healthy and unhealthy samples from non-smokers, 
as well as a comparison of just the healthy samples from non-smokers and 
smokers. The objectives of this chapter are to address the following questions: 
what predicted oropharyngeal functions are associated in non-smoking 
participants, and do smokers have changed oropharyngeal functions compared to 
non-smokers. 
7.2 Methods 
All samples were processed as described in the methods chapter (Chapter 2). To 
predict functions associated with oropharynx samples, functional profiles of 16S 
rRNA gene sequences were identified using the Tax4Fun package (version 0.3.1) 
(Aßhauer et al., 2015) in R (version 3.1.2) which links 16S rRNA gene sequences 
with the functional annotation of sequenced prokaryotic genomes using a 
nearest neighbour identification based on a minimum sequence similarity. This 
involves (i) annotating the representative sequences of the OTUs against the 
SILVA database, (ii) transforming the annotated 16S rRNA profile to its 
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equivalent KEGG (Kyoto Encyclopedia of Genes and Genomes) taxonomic profile 
using a precomputed association matrix, (iii)  normalising the abundance of 
KEGG organisms by 16S rRNA copy number, and (iv) combining the normalised 
KEGG abundance profile with precomputed functional profiles of KEGG 
organisms (obtained with UProC; Meinicke, 2015) to predict the functional 
profile of the microbial community under study. This generates a relative 
abundance of KEGG orthology (KO) identifiers associated with each sample 
depending on matches of the representative sequence from each OTU to KEGG 
organisms. All prokaryotic KEGG organisms are available in Tax4Fun for SILVA 
SSU Ref NR database release 115 and KEGG database release 64.0. The 200 most 
abundant predicted KO identifiers were selected for the comparisons of the 
conditions of interest. Statistically significant differences in relative abundances 
of predicted functions between conditions were estimated using Kruskal-Wallis 
tests with Benjamini- Hochberg correction for false discovery rate, with a 
significance level of P < 0.05. For this study, 16S rRNA gene sequences were used 
to predict functional community profiles between healthy and unhealthy 
samples from firstly non-smoking participants and then between the healthy 
samples from non-smoking participants and smokers. Figures show the top 20 
most significant results as displayed on a log transformed scale for visualisation.  
7.3 Results 
7.3.1 Predicted functions associated with the healthy 
oropharynx microbiome 
From previous chapters it has been determined that different community 
compositions exist in the different health groups of non-smoking participants 
(Chapters 3 & 4). These changes in community composition could potentially 
affect the functions associated with the communities. The predicted functional 
properties of oropharyngeal communities from the different health groups (as 
shown as the abundances of KO pathways/enzymes) were explored. The 
significant differences in abundances of KO’s between the health groups showed 
which predicted functions were associated when going from a healthy to 
unhealthy state (as described by cold and viral samples) and a disturbed state 
(antibiotics samples). When observing the 20 most significantly different 
predicted functions between the healthy and cold samples, higher abundances in 
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KO’s were seen in the enzymes/pathways associated with the healthy samples 
(Figure 7.1), showing that these enzymes are present and required in healthy 
and unhealthy samples. Specific pathways that were significantly different 
between the healthy and cold samples include the pathway K06610 MFS 
transporter which is involved in sugar transport across membranes (Pao et al., 
1998) and K06969 23S rRNA (cytosine1962-C5)-methyltransferase which is an 
enzyme involved in ribosome production (Purta et al., 2008) (Table 7.1). The 
lower abundance of KO’s associated with enzymes/pathways in the cold samples 
may be an effect of this kind of disturbance/infection with cold samples having 
lower abundances of OTUs as opposed to baseline abundances of OTUs in the 
healthy samples. 
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Figure 7.1 – Predicted functional profiles showing the top 20 most significantly 
different relative abundances of KO’s (kyoto encyclopedia of genes and genomes 
orthology) shown by P values between healthy (blue) and cold (red) samples 
from non-smokers. Box plots are plotted showing the median (and the 25th and 
75th percentiles) abundance of KO for each health group. 
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Table 7.1 – The kyoto encyclopedia of genes and genomes orthology (KO) 
numbers and description of the enzymes/pathways identified in healthy and cold 
samples as shown in Figure 7.1. 
KO 
numbers  
Pathways 
K06610  MFS transporter, SP family, inositol transporter 
K09704  uncharacterized protein 
K12373  hexosaminidase 
K01364  streptopain 
K07238  zinc transporter, ZIP family 
K00634  phosphate butyryltransferase 
K00657  diamine N-acetyltransferase 
K00847  fructokinase 
K03768  peptidyl-prolyl cis-trans isomerase B (cyclophilin B) 
K03816  xanthine phosphoribosyltransferase 
K04041  fructose-1,6-bisphosphatase III 
K06969  23S rRNA (cytosine1962-C5)-methyltransferase 
K09686  antibiotic transport system permease protein 
K10536  agmatine deiminase 
K16211  maltose/moltooligosaccharide transporter 
K07025  putative hydrolase of the HAD superfamily 
K00980  glycerol-3-phosphate cytidylyltransferase 
K03734  FAD:protein FMN transferase 
K00282  glycine dehydrogenase subunit 1 
K00941  hydroxymethylpyrimidine/phosphomethylpyrimidine kinase1 
 
There were also significant differences in abundance of KO enzymes/pathways 
between the healthy and viral samples (Figure 7.2). There were various KO’s 
that had higher abundance in the viral samples than the healthy samples such as 
the enzyme K00007 D-arabinitol 4-dehydrogenase (Table 7.2) which is involved in 
fructose metabolism. From the enzymes identified in Figure 7.2 & Table 7.2, 
only K00002 alcohol dehydrogenase (involved in degradation of aromatic 
compounds) and K00075 UDP-N-acetylmuramate dehydrogenase (carbohydrate 
metabolism) had increased abundance in the healthy samples.  However, viral 
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samples also had significant increases in abundance in other KO enzymes not 
shown in Figure 7.2 or Table 7.2. This included the magnesium and cobalt 
transport protein CorA which has been implicated in virulence during infection 
(Kersey et al., 2012) and therefore had a reduced abundance in healthy samples. 
In comparison to the microbiome from the cold samples, the microbiome from 
viral samples had an increase in abundance in KO enzymes and pathways 
required for everyday processes but also in enzymes/pathways involved in 
virulence. 
Figure 7.2 - Predicted functional profiles showing the top 20 most significantly 
different relative abundances of KO’s (kyoto encyclopedia of genes and genomes  
orthology) shown by P values between healthy (red) and viral (blue) samples 
from non-smokers. Box plots are plotted showing the median (and the 25th and 
75th percentiles) abundance of KO for each health group. 
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Table 7.2 - The kyoto encyclopedia of genes and genomes orthology (KO) 
numbers of the enzymes/pathways identified in healthy and viral samples as 
shown in Figure 7.2. Asterisks represent KO enzymes/pathways that had the 
highest abundance in viral samples. 
KO 
Numbers 
Pathways 
K00002 alcohol dehydrogenase 
K00004* butanediol dehydrogenase / meso-butanediol dehydrogenase / 
diacetyl reductase 
K00007* D-arabinitol 4-dehydrogenase 
K00023* acetoacetyl-CoA reductase 
K00035* D-galactose 1-dehydrogenase 
K00039* ribitol 2-dehydrogenase 
K00059* 3-oxoacyl-[acyl-carrier protein] reductase 
K00075 UDP-N-acetylmuramate dehydrogenase 
K00104* glycolate oxidase 
K00109* 2-hydroxyglutarate dehydrogenase 
K00114* alcohol dehydrogenase (cytochrome c) 
K00115* glucose dehydrogenase (acceptor) 
K00121* S-(hydroxymethyl)glutathione dehydrogenase / alcohol 
dehydrogenase 
K00124* formate dehydrogenase iron-sulfur subunit 
K00126* formate dehydrogenase subunit delta 
K00127* formate dehydrogenase subunit gamma 
K00146* phenylacetaldehyde dehydrogenase 
K00151* 5-carboxymethyl-2-hydroxymuconic-semialdehyde 
dehydrogenase 
K00154* coniferyl-aldehyde dehydrogenase 
K00155* NAD-dependent aldehyde dehydrogenases 
 
Antibiotic treatment on the other hand was associated with a reduced 
abundance in KO enzymes/pathways that had higher abundances in the healthy 
samples (Figure 7.3). The enzymes/pathways identified in both groups of 
samples (Table 7.3) are involved in everyday processes such as membrane 
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transport (K11077 mannopine transport system permease protein). But the 
reduction in all pathways in the antibiotic treated samples, an example being 
the production of flagella for bacteria (K02383 flagellar protein FlbB) is perhaps 
due to the antibiotic treatment eliminating groups of bacteria. This showed that 
in comparison to the predicted baseline abundance of these KO 
enzymes/pathways in the healthy samples, antibiotic treatment resulted in 
reduced abundance of pathways, most likely a result of antibiotic treatment 
killing bacterial populations. 
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Figure 7.3 - Predicted functional profiles showing the top 20 most significantly 
different relative abundances of KO’s (kyoto encyclopedia of genes and genomes 
orthology) shown by P values between healthy (blue) and antibiotic treated 
samples (red) from non-smokers. Box plots are plotted showing the median (and 
the 25th and 75th percentiles) abundance of KO for each health group. 
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Table 7.3 - The kyoto encyclopedia of genes and genomes orthology (KO) 
numbers of the enzymes/pathways identified in healthy and antibiotic treated 
samples as shown in Figure 7.3.  
KO 
numbers  
Pathways 
K00254  dihydroorotate dehydrogenase 
K04747  nitric oxide reductase NorF protein 
K06963  tRNA acetyltransferase TAN1 
K11077  mannopine transport system substrate-binding protein 
K11078  mannopine transport system permease protein 
K11131  H/ACA ribonucleoprotein complex subunit 4 
K11889  type VI secretion system protein ImpN 
K15234  citryl-CoA lyase 
K07055  tRNA wybutosine-synthesizing protein 2 
K13967  N-acetylmannosamine-6-phosphate 2-epimerase / N-
acetylmannosamine kinase 
K03626  nascent polypeptide-associated complex subunit alpha 
K09006  uncharacterized protein 
K13829  shikimate kinase / 3-dehydroquinate synthase 
K00844  hexokinase 
K10670  glycine reductase 
K02383  flagellar protein FlbB 
K03047  DNA-directed RNA polymerase subunit D 
K07049  TatD-related deoxyribonuclease 
K07268  opacity associated protein 
K10115  maltooligosaccharide transport system permease protein 
 
Overall these results show that various KO enzymes and pathways predicted from 
the 16S rRNA gene are shared between healthy, unhealthy and antibiotic treated 
samples from non-smoking participants. Disturbances affected the functions of 
the oropharynx microbiome in different ways, by having reduced abundances of 
KO enzymes/pathways in cold samples, increased abundances in viral samples 
(as well as having increased functions involved in virulence) and reduced 
abundances in antibiotic treated samples. 
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7.3.2 Do smokers have changed functions in the oropharynx? 
Analysis of the top 20 most significantly different KO’s between the healthy 
samples from non-smoking participants and smokers are shown in Figure 7.4. 
This showed that non-smoking participants and smokers had the same pathways 
identified such as roles in amino acid or carbohydrate metabolism, but smokers 
had increased abundances of KO’s. However, smokers were found to have 
reduced abundances of certain functions (Table 7.4) compared to those of non-
smoking participants. This included pathways for production of single-stranded 
DNA specific exonucleases (K07462) and the DNA mismatch repair protein MutL 
(K03572) which is not shown in the 20 most significant results. Both of these 
enzymes play a role in correcting errors after DNA replication and are vital for 
DNA repair (Skaar et al., 2002). Therefore, smokers had reduced abundances in 
KO pathways that were involved in DNA repair. 
Although smoking resulted in increased abundances in pathogenic bacteria 
(Chapter 6), it also affected the functions involved in bacterial pathogenesis and 
survival by having reduced abundances of KO enzymes/pathways involved in 
virulence and resistance. An example being the K06158 ATP binding cassette 
which is involved in virulence such as transportation of toxic molecules 
(Davidson et al., 2008) where there was reduced abundances in smokers. This 
was also seen in the copper resistance phosphate response regulator CusR which 
provides natural resistance to copper which is toxic to bacteria (not shown in the 
20 most significant results), with reduced abundance levels being observed in 
smokers (Munson et al., 2000). Therefore these results suggest smoking can 
actually influence the replication and survival of bacteria during colonisation by 
reducing abundances of some virulence factors which may affect the outcome of 
infection and pathogenesis.  
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Figure 7.4 - Predicted functional profiles showing the top 20 most significantly 
different relative abundances of KO’s (kyoto encyclopedia of genes and 
genomes orthology) shown by P values between healthy samples from non-
smokers (red) and smokers (blue). Box plots are plotted showing the median 
(and the 25th and 75th percentiles) abundance of KO for both groups. 
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Table 7.4 - The kyoto encyclopedia of genes and genomes orthology (KO) 
numbers of the enzymes/pathways identified in only the healthy samples from 
non-smoking participants and smokers as shown in Figure 7.4. Asterisks 
represent KO enzymes/pathways that had increased abundances in the healthy 
samples from smokers in comparison to the healthy samples from non-smoking 
participants. 
KO 
numbers  
Pathways 
K01964  acetyl-CoA/propionyl-CoA carboxylase 
K03679  exosome complex component RRP4 
K03684* ribonuclease D 
K05838*  putative thioredoxin 
K07462  single-stranded-DNA-specific exonuclease 
K10805* acyl-CoA thioesterase II 
K09136*  ribosomal protein S12 methylthiotransferase accessory factor 
K00982*  glutamate-ammonia-ligase adenylyltransferase 
K01792*  glucose-6-phosphate 1-epimerase 
K10113*  maltooligosaccharide transport system substrate-binding protein 
K13288* oligoribonuclease 
K08300*  ribonuclease E 
K02438*  glycogen operon protein 
K06158  ATP-binding cassette, subfamily F, member 3 
K01494*  dCTP deaminase 
K01011*  thiosulfate/3-mercaptopyruvate sulfurtransferase 
K01632*  fructose-6-phosphate phosphoketolase 
K07339  mRNA interferase HicA 
K14153*  hydroxymethylpyrimidine kinase 
K05831  LysW-gamma-L-lysine/LysW-L-ornithine carboxypeptidase 
 
7.4 Discussion 
This study has shown the oropharynx microbiome to have various predicted 
functions involved in metabolism, protein synthesis and DNA repair. 
Metagenomic analysis has shown a wealth of data reporting how functions from 
bacterial communities in the GI tract promote a healthy state in the host 
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(Gerritsen et al., 2011). This includes bacteria in the GI tract having metabolic 
activities that lead to the production of important nutrients such as short-chain 
fatty acids, vitamins and amino acids, which humans are unable to produce 
themselves (Wong et al., 2006). Therefore the bacterial communities in the 
oropharynx may also interact with the human host not just in defence but also in 
metabolic or immune response activities. 
 
Healthy and unhealthy samples from non-smoking participants showed largely 
the same predicted functions, however, there were functions associated with 
virulence and pathogenesis in the unhealthy samples which may be a result of 
higher abundances of pathogenic bacteria. Smokers also had significant 
differences in KO’s or predicted functions compared to non-smoking 
participants. As cigarette smoke contains carcinogens, toxins and oxidants, it is 
expected that this would disrupt microbial communities through inducing 
cellular damage and host changes such as inflammation which could change 
functions (Bagaitkar et al., 2008). This study showed reduced abundances in the 
predicted functions of DNA synthesis and repair mechanisms in bacteria from 
smokers (compared to non-smoking participants) showing that smoking does 
affect the oropharynx microbiome in terms of pathogenic microorganisms and 
the functions associated. Cigarette smoke has been linked to increased DNA 
mutations and DNA abnormalities in buccal cells (Tan et al., 2008) suggesting 
that the oropharyngeal microbial populations in smokers may also have reduced 
functions of DNA repair (which may arise due to increased DNA mutations) 
especially as enzymes such as MutL are extremely important in preventing 
mutations from becoming permanent in dividing cells (Li, 2008). However there 
were numerous predicted functions present in both groups that are necessary for 
everyday processes but in general there was an increased abundance in smokers.  
 
The purpose of predicting functions of the oropharynx microbiome is to 
determine if differences in functional diversity of the microbiome can contribute 
to specific diseases. Associations have already been reported in schizophrenia 
where schizophrenic patients’ pathways were significantly involved in 
environmental information processing whereas controls had higher proportions of 
pathways involved in energy metabolism (Castro-Nallar et al., 2015). However to 
truly understand the functional differences between health and disease, there 
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must first be an investigation and understanding in whether the changed state of 
the microbiome is the cause or effect of the disease. This can only be 
determined through longitudinal sampling over a range of healthy and diseased 
subjects to explore community composition and transcriptomics to measure 
function. Once this has been established, functional differences may then be 
used for the development of biomarkers in health or disease. 
 
The advantages of using the Tax4Fun package is that 16S rRNA sequencing is 
more cost-efficient than whole-genome shotgun sequencing, especially for initial 
exploration into the functions of the community. The disadvantage is that it only 
predicts the functional profile related to what is available in the reference 
database, therefore prediction is limited. Other disadvantages also incluce strain 
differences within OTUs and no actual measurement of expression. As this is 
based on predicting functional profiles, the validity of the functional profiling 
has not been investigated; therefore the coverage of taxonomic assignments 
needs to be investigated to check the reliability of the predictions. In order to 
gain a better representation of the functions associated with any microbiome, 
metagenomics and transcriptomics would need to be performed which would 
identify functions associated with genes from bacteria as well as the other 
microorganisms recovered from the oropharynx. It would also be interesting to 
look at participants who had recently started smoking (as all smokers 
participants had been smoking for at least over a year) and to determine when 
exactly the functions began to change. This would involve doing longitudinal 
sampling again for non-smoking participants and smokers and doing functional 
profiles for each sample on a weekly basis to determine how long it takes for 
changes to occur and if all participants’ functional profiles change in the same 
way. Longitudinal sample would also give an estimate to how long recovery 
would take for a changed microbiome to return back to normal after stopping 
smoking. However, initial exploration of the predicted functions associated with 
the healthy oropharynx microbiome show these communities to be involved in 
various pathways. Disruption of these communities (either through illness or 
smoking) do show changes in these functions, suggesting respiratory infection or 
smoking results in changed functions. 
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7.5 Conclusions 
Non-smoking participants had increased abundances of KO’s (predicted 
functions) that were reduced in the unhealthy samples or in antibiotic treated 
samples. Smokers also had different functional profiles including reduced 
abundances of KO pathways involved in DNA repair, suggesting that bacterial 
communities in smokers were prone to DNA mutations. Therefore the 
microbiome of non-smoking communities has various predicted functions that 
are changed during disturbances including smoking and antibiotic treatment. 
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8 Conclusions and future work 
The purpose of this PhD project was to develop the ecological knowledge and 
understanding of bacterial communities isolated from the oropharynx of non-
smoking participants and smokers. Understanding these dynamics will provide 
opportunities to improve knowledge and information regarding the community 
structure of the healthy oropharynx microbiome and the changes that occur 
during respiratory infections and disturbances. More specifically, this thesis 
addressed the following questions: 
What is the community composition of the healthy oropharynx microbiome in 
non-smokers? 
How does the community change during a disturbance and antibiotic treatment? 
How stable is the community and how does this change over a defined period of 
time? 
How does the oropharynx microbiome of a non-smoker compare to a smoker’s 
microbiome? 
What functions are predicted to be associated with the oropharynx microbiome 
in non-smokers and smokers? 
Overall, this PhD project has shown that the healthy oropharynx microbiome of a 
non-smoker consists of a diverse community of taxa that is similar at phylum and 
genus level between participants. The changes that occur during a disturbance 
are distinct and require further investigation in how the microbiome affects the 
host and health status. 
8.1 Conclusions 
8.1.1 Characterisation of the healthy and unhealthy oropharynx 
microbiome in non-smokers 
Investigation into the microbiome of the oropharynx showed the healthy 
oropharynx microbiome to be Firmicutes and Streptococcus dominated at 
phylum and genus level, respectively. Participants had broadly similar bacterial 
community structures at phylum level with increasing differences at genus and 
OTU level. Healthy communities overall were the most diverse, with samples 
taken when participants had a cold or were undergoing antimicrobial treatment 
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having less diversity, which was consistent in other studies where diseases 
seemed to have the least diversity in microbiome compositions in comparison to 
their healthy counterparts (Lozupone et al., 2012). The microbiomes from 
healthy samples consisted of various bacteria existing together which were 
investigated through co-occurrence networks. These showed interactions of 
bacteria in healthy states; some competing, whilst others were mutual. In 
microbiomes from healthy samples all genera were involved in positive 
interactions, in that as one genus increased in abundance then so did another 
genus. These interactions may be a factor to why taxa are assembled in these 
proportions to maintain a homeostatic status. A disorder in these proportions 
may be a result of disturbed interactions between genera, either through 
presence or increased abundance of other genera altering the community as a 
whole. This may be the case in unhealthy samples, but the abundances in 
communites may also fluctuate in healthy and unhealthy settings so 
overrepresented taxa in unhealthy situations may also be a result of bacteria 
adapting. But, investigation of these networks in healthy samples did allow 
identification of the important drivers or key genera present in the community. 
And so, rather than focusing on determining a core microbiome in the healthy 
oropharynx, the project focused on identifying the most abundant phyla and 
genera in healthy and unhealthy communities; for the healthy communities 
these were Streptococcus, Prevotella and Veillonella at genus level. Taxa were 
more variable at OTU level, but there was still identification of certain OTUs 
such as S. mitis that were always present in participants. This species has 
previously been described as a dominant community member of the healthy 
oropharynx (Mitchell, 2011).  Variation in OTUs within and between participants 
could be a result of host and lifestyle factors (David et al., 2014), but lifestyle 
factors such as diet, alcohol consumption or activities performed were not 
recorded and so this study cannot determine how much of the external 
environment affects and influences characterisation and variation in the 
oropharynx microbiome. 
Characterisation of the unhealthy samples showed different community 
structures – the microbiome of samples that tested positive for viruses had 
increases in bacteria such as Haemophilus and Neisseria which was also observed 
in other studies (Hofstra et al., 2015). The microbiome of virus-negative samples 
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collected during colds had increases in Haemophilus, Neisseria and Serratia 
whereas the microbiome of samples collected during antibiotic treatment had 
increases in Pseudomonas and Actinomyces. Overall viral infection was not 
associated with major changes to the oropharynx microbiome, perhaps due to 
the fact that there was a small sample size of viruses (n=8) received. However, 
whether or not a pathogen can cause infection depends on the balance of 
microbiome homeostasis and abundances of pathogens. This homeostasis of 
commensal bacteria such S. mitis or S. salivarius (determined as the most 
abundant OTUs in healthy participants) may keep pathogenic species such S. 
pneumoniae or H. influenzae residing at low levels (Santagati et al., 2012) – H. 
influenzae was shown to be present in the majority of healthy samples but 
increased abundances were noticeable during colds and viral infections. 
Therefore opportunistic or pathogenic species may already be well established in 
the resident microbiome at levels that will not cause an infection or disease, but 
do increase in abundance either before the onset of infection or during disease 
or infection. The loss of protective species may be the cause of this and 
detrimental to the microbiome resulting in an altered community. Therefore the 
result of studies exploring healthy and diseased scenarios identifies the presence 
or absence of specific bacteria that are predictive of, or the cause of disease. 
8.1.2 Stability and recovery of the healthy oropharynx 
microbiome 
Investigating the individual stability patterns of the microbiomes of non-smoking 
participants showed participants to have stable oropharynx microbiomes in that 
each participant had a community structure that was relatively similar on a 
weekly basis and the fluctuations (as observed from the stability plots) that did 
occur between weeks were usually small. This was how stability was defined in 
this study; an unstable microbiome would be one that had different community 
structures weekly and greater fluctuations between samples from the same 
participants. Even though there was variation in community structure present in 
samples within and between participants, the oropharynx microbiome was still 
resilient to disturbances in that it returned towards their long-term average 
state within a week of recovering after disturbances; this has also been observed 
in other studies where oropharynx samples have been taken from the same 
participant after a noted period of time showing similar community structures in 
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the two samples (Charlson et al., 2011). However there is a need to understand 
the immigration and emigration patterns of microbes in healthy and unhealthy 
states to understand the variation present in the healthy oropharynx 
microbiome. For example, is post-infection recovery driven by ecological forces 
such as migration rates and competitive exclusion or does the host play an active 
role in rebuilding a stable ecosystem? The microbiome is involved in resilience 
against pathogens, but is also involved in immune regulation and barrier 
defence. Therefore the host may impact the microbiome of various body sites 
and host-microbiome interactions are being explored most notably in the 
microbiome of the GI tract using mouse models (Kostic et al., 2013). However, 
how it impacts the assembly, stability and resilience of microbial communities in 
the oropharynx needs investigating. The oropharynx is constantly exposed to the 
external environment and is influenced by respiratory and gastrointestinal 
processes of which bacteria are adapted to. Therefore the crosstalk between the 
host and the oropharynx microbiome could be involved in influencing the 
outcome of a disease or infection. 
 
Stable communities may contain keystone taxa (Streptococcus, Prevotella and 
Veillonella in the healthy samples), and if these keystone taxa are lost, this may 
result in abrupt changes to the community (Fierer et al., 2012). In unhealthy 
samples, there were increased abundances in Haemophilus or Serratia and a low 
diversity community. Streptococcus was still present but did not show any 
significant difference in abundance between the healthy and unhealthy samples, 
whereas a significant reduction in Prevotella was observed in the unhealthy 
samples. Therefore a combination of taxa may be responsible for promoting a 
healthy stable community. High biodiversity has shown to promote stable 
communities  in various ecosystems ranging from plants to fish (McCann, 2000), 
but no relationship between bacterial diversity and stability was observed in this 
study. All microbiomes are subject to perturbations over the course of normal 
development, ageing and disease, so all this needs to be considered when 
determining what makes a community stable whilst taking into account the 
natural variation present. 
Even though there were similarities in microbial composition between healthy 
participants, participants still had differences in abundances and 
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presence/absence of taxa which makes it more challenging to use individual 
variation in finding therapeutic options and treating disease. It may be that 
each individual needs to be studied in health and response to a disease to 
determine which bacteria respond and how the microbiome recovers overall. A 
standardised bacterial community to restore a healthy state may not be useful 
if healthy individuals vary in their bacterial communities and so personalised 
treatments may be required.  
 
8.1.3 Comparison of the oropharynx microbiome in non-smokers 
and smokers 
When comparing the healthy non-smoking microbiome to a smoker’s 
microbiome, smokers were found to have high diversity communities (similar to 
healthy participants) that were distinct in community structure from non-
smoking healthy participants. Charlson et al., (2010) observed smokers’ 
communities to be significantly more diverse than non-smokers in that there was 
greater species richness and samples had high Shannon H indexes. This could be 
due to smokers having more potentially pathogenic species (Bagaitkar et al., 
2008) or an increase in transient species, especially as smokers were shown to 
have an increased abundance in Chryseobacteria which is a common 
environmental bacterium (Salter et al., 2014). Specific OTUs were found to have 
increased abundances in the smokers group and these were Porphyromonas 
gingavilis, Streptococcus pyogenes and Streptococcus agalactiae which are all 
pathogens involved in oral and respiratory tract infections (Abusleme et al., 
2013) (Santagati et al., 2012). Other studies have also reported different 
community structures in smokers with increased abundances in specific genera 
such as Megasphaera, Streptococcus, Veillonella and Actinomyces (Charlson et 
al., 2010) whereas this study showed increases in Streptococcus, Prevotella and 
Porphyromonas. This shows that smoking results in altered oropharyngeal 
communities, and also affected individuals in different ways by altering 
abundances. However this may depend on the participant’s individual 
community structure prior to smoking.  
 
Smokers and non-smoking participants also had different responses to 
disturbances; non-smokers had high resilience with quick recovery whereas 
smokers did not display changes to their oropharynx microbiome during periods 
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of a disturbance which suggests a permanently altered state. As a result, this 
permanently altered state may suggest that the smoker’s microbiome is more 
stable during disturbances which may make them more resilient. Smokers may 
also have more “invaders” which colonise the oropharyngeal community 
increasing susceptibility to infection (Bagaitkar et al., 2008).  Regardless of the 
different community structure compared to non-smokers, the smokers’ 
oropharynx was still seen as stable as samples did not drastically change in 
community composition over a weekly basis (which was also observed in healthy 
non-smoking participants). However smokers may be more at risk of respiratory 
disease due to having higher abundances of potentially pathogenic bacteria in 
their oropharynx microbiome. 
 
8.1.4 Predicted functions of the non-smoking and smoking 
oropharynx microbiome 
The predicted functions of bacteria from the oropharyngeal communities were 
investigated in the different health groups in non-smoking participants and 
between smokers and non-smokers. Various functions were predicted from the 
healthy oropharynx microbiome deemed as necessary in bacteria (that are vital 
functions) such as protein synthesis to carbohydrate metabolism. In terms of the 
different health groups, healthy participants had increased abundances of KO’s 
that resulted in higher levels of most enzymes/pathways in comparison to 
participants with a cold. This could be due to the healthy group having increased 
diversity of OTUs as well as increased abundances of Streptococcus, Prevotella 
and Veillonella OTUs. Microbiomes from virus-positive samples had increased 
abundances of certain KO enzymes/pathways that were needed for everyday 
processes but also involved in virulence. Antibiotics usage on the other hand 
resulted in reduced abundance of the majority of pathways/enzymes in 
comparison to the healthy groups, which may be indicative of antibiotics 
eliminating certain groups of bacteria as there were many OTUs that had 
reduced abundances in comparison to the healthy groups (Langdon et al., 2016).  
 
The bacterial communities in smokers was associated with different predicted 
functional profiles including reduced abundances of KO pathways/enzymes 
involved in DNA repair, suggesting that bacteria from smoker’s samples were 
prone to DNA mutations. Smoker’s communities had higher abundances of 
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pathogenic bacteria than non-smokers which may contribute to the different 
functional profiles observed in the smoker’s communities. Further investigation 
is required in understanding if reduced abundances of the DNA repair pathways 
in smokers (and other pathways) affect health and the bacteria that influence 
this. Determining the predicted functions of bacteria in healthy samples from 
non-smokers can show what predicted functions are associated with healthy 
communities and which can become changed during a disturbance or smoking. 
Microbiome studies need to address the similarities and differences among 
participants in both microbial taxa and functional pathways; changes in gene 
expression and functions can be investigated by transcriptomics which could lead 
to the use of biomarkers to identify disease. 
8.2 Limitations and drawbacks of this study 
The strengths of this study included longitudinal analyses, a reasonable number 
of non-smoking participants and use of high-throughput technology; however the 
limitations included the modest sample size especially in unhealthy samples and 
sequencing depth. In this study, a cut off of 5000 reads for each sample was 
used which still resulted in adequate community coverage. This is important in 
drawing conclusions regarding species richness, diversity or relative abundance 
of community members detected. A larger read size would have been ideal, but 
regardless of this, these results still show that valid conclusions were drawn at a 
cut off of 5000 reads. A larger sample size would also have resulted in more 
samples in the healthy as well as unhealthy groups, especially as some 
participants only had 1 unhealthy sample. As a result the differences observed in 
the unhealthy microbiome may have been due to natural variation, hence the 
importance of collecting metadata for each sample. The ratio of males to 
females in smokers and non-smokers were also different, with more females 
participating and more samples collected from females than males. This resulted 
in uneven sample sizes in categories which may influence the data as the 
changes in the microbiome may have been observed in females rather than 
males due to having more samples.  Having more samples would also address the 
differences of the normal microbiome between males and females. Microbiome 
studies should consider power tests and sample size to ensure there are enough 
samples present in categories ensuring greater statistical power to show a 
biological difference. 
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Another limitation was that it was not possible to identify all OTUs to species 
level through only sequencing the V1-V2 region, even though some Streptococcus 
OTUs could be named. By sequencing a larger region such as the V1-V3 region, 
more OTUs could be further identified, especially as there are various 
commensal and pathogenic bacteria present within the same genus. An example 
is Streptococcus in the oropharynx; various commensal and pathogenic 
Streptococcus species exist in the oropharynx and characterisation studies need 
to address which species are the most abundant in health and disease. However, 
sequencing larger regions also depend on the technologies capable of doing so, 
and the literature available supporting this. The V1-V2 region in this study was 
deemed acceptable due to the literature supporting use of this primer set in 
oropharynx studies in classifying Streptococcus to species level (Chakravorty et 
al., 2008). 
 
External contamination may have been introduced into the samples either 
through the participant or from sample/sequencing processing, hence the need 
for strict metadata collection and negative controls for DNA extraction kits and 
PCR processes. Previous studies have shown that contamination can be 
introduced through extraction processes either through kits or water (Salter et 
al., 2014) amplifying taxa that are ubiquitous in the environment. This is 
particularly a problem from low biomass sites, where low template DNA 
concentration is competing for amplification with contaminating DNA (Biesbroek 
et al., 2012). In order to reduce this issue, specific steps were taken such as 
ensuring initial DNA template concentrations of 15ng/µl per sample pre PCR 
amplification, sequencing of negative controls and removal of taxa that were 
present in the negative controls from all other samples. The negative control in 
this study had a low number of sequenced reads (<1000) and necessary steps 
were followed to distinguish contaminating bacteria from actual bacteria 
representative of the oropharynx microbiome. Contaminating bacteria were 
assessed on whether they were found in the extraction controls, mock 
community, in high or low abundance and matched against studies listing 
common contaminating bacteria in microbiome studies (Salter et al., 2014). 
Additionally, background contaminating bacteria may also have been accounted 
for by qPCR but this was not done in this study. However, this only applies to 
contaminating bacteria from extraction kits and so there is a possibility that the 
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participant may have introduced contaminating bacteria into the sample either 
through dropping the swab, hitting other surfaces in the mouth or through 
inefficient swabbing technique or handling of swab which may have not been 
reported.  
 
An epidemiological limitation is that non-smokers and smokers were sampled in 
different years. Therefore some of the differences observed in the non-smokers 
and smoker’s microbiome may be due to differences between years and 
sampling months. These differences could be attributed to outbreaks of 
influenza, temperature changes and seasonal changes such as fluctuating pollen 
levels. However, as other research studies reported similar findings when 
comparing the non-smokers and smokers microbiome, this shows that there must 
also be other factors other than the different sampling years responsible for 
these differences in microbiome composition. 
 
In regards to stability, even though the microbiome was found to be stable in all 
participants, determining the stability of the microbiome over a longitudinal 
period was a challenge as samples were not present every week as participants 
did miss some weeks of swabbing. Participants were given strict swabbing 
instructions to reflect the oropharynx microbiome. However, they may have also 
inaccurately reported symptoms due to forgetting, being rushed or reporting the 
wrong symptoms. This could explain why some samples that had no associated 
symptoms of disease or illness had very distinct, different communities for which 
there were no obvious explanations.  
 
Lastly, as microbiome based studies are based on observations, there is still the 
question of linking these observations in changes in community structure to the 
cause or effect of the disease. This is a limitation in most microbiome studies 
where there is limited information or data to determine whether the changes in 
the microbiome are caused by the disease or an effect of the disease. As this 
sampling was done on a weekly basis, it was not possible to determine the exact 
changes that occurred during the health disturbance (to do this, daily sampling 
would be required) and therefore this is a limitation of the current study. 
However, it should be noted that it was not possible to know the frequency of 
the fluctuations of the oropharynx microbiome beforehand, and a balance 
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between what was reasonable to ask from the participants and the aim of 
covering a relatively long time period had to be found. Another way to approach 
the question of cause or effect in microbiome studies would be to use an animal 
model where the effects of a certain disease through inoculation and the 
changes in community structure can be observed. This could be a possibility 
especially in determining if certain taxa can cause respiratory disease and if 
certain key taxa can restore the oropharynx microbiome. 
 
Therefore to improve the study there would need to be a larger sample size with 
more participants to ensure greater statistical power and reliability of results. 
There would need to be strict swabbing procedures and metadata collection to 
be able to link diseased samples to their symptoms. To also try and address the 
cause and effect of diseases on the microbiome, animal models can be used to 
determine how the microbiome responds to specific disturbances. Sampling 
should also be continued longitudinally, daily rather than weekly to try and 
capture the changes that occurred to the microbiome that may have been 
missed when sampling on a weekly basis. 
 
8.3 Significance and wider implications of the current 
study 
One of the key challenges in any microbiome study is to determine whether and 
how a given microbiome affects human health (Cho & Blaser, 2012). Microbiome 
studies commonly focus on characterising microbial communities in specific 
disease states or trying to determine the changes that occur during the course of 
a disease. However, demonstrating causality between the microbial variation 
and pathology instead of mere association is often extremely difficult as 
controlled experiments are not yet practical in most cases. However controlled 
studies showing a cause and effect response has been demonstrated through the 
use of faecal studies to restore the microbiome of the GI tract (Aroniadis & 
Brandt, 2014). In this study, the healthy oropharynx microbiome was 
characterised using longitudinal sampling and respiratory disturbances such as 
the common cold were investigated by linking back to metadata which allows 
establishing the timeline of events. This design allowed not only determining 
what would constitute a healthy oropharyngeal microbial community, but also 
investigating how the community changed during a disturbance and on antibiotic 
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treatment. Therefore the cause and effect relationship was not investigated, but 
this is the only study (to date) that has looked at the oropharynx microbiome 
over a defined period of time on a weekly basis. This is also the only study to 
determine how the community changes before, during and after a disturbance, 
again providing novel information on how the microbiome changes during a 
disturbance, and its recovery time and resilience. 
Another significant finding of this thesis was determining the changes that 
occurred to the microbiome of smokers in comparison to non-smokers and 
investigating the stability and recovery from a health disturbance of the two 
groups. The changes observed were present in abundances and 
presence/absence in taxa and function showing distinct changes in the 
oropharynx microbiome between smokers and non-smokers. Smokers also 
responded differently during a disturbance in that significant differences were 
not observed before, during or after a disturbance suggesting that smokers may 
possibly have a permanent altered microbiome. This is the only study 
investigating the stability of the smokers’ microbiome over a defined period of 
time and the weekly changes that occur during a disturbance. 
Therefore, the significance of this project overall is that it has provided new 
knowledge about the oropharynx microbiome in non-smoking participants and 
smokers. This knowledge provides a solid starting point for further 
investigations; for instance, to first develop deeper understanding on the 
ecological interactions between bacteria now known to be present and 
fluctuating in abundance, and perhaps in future, once the fluctuations of the 
microbiome members are understood better, this knowledge could be used to 
manipulate or restore a person’s microbiome during or after a respiratory 
disease. A smoker’s microbiome could also be manipulated to mimic the 
microbiome of a non-smoker. 
This thesis may be used as increased knowledge of the oropharynx microbiome 
to improve diagnosis of disease states. This could result in treatments such as 
probiotic supplementation (with the necessary taxa) to restore microbiome 
balance that may be a useful and necessary treatment against respiratory 
disease and infections. The future work required for this project is as follows: 
longitudinal sampling and characterisation of the oropharynx microbiome over a 
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long period of time (daily and weekly sampling over months to years) in healthy 
participants (non-smokers with no underlying disease) to understand natural 
variation of taxa in healthy people, daily sampling to catch progress of recovery 
from confirmed infections while ensuring large sample sizes of healthy and 
unhealthy samples and production of metagenomic profiles of the oropharynx in 
healthy participants and specific diseased scenarios (and altered communities 
such as smoking) through sequencing of all genes in the community rather than 
just focussing on one gene – this will also detail the viruses, archaea and 
eukaryotic microorganisms that also inhabit the oropharynx.  
8.4 Future for microbiome studies 
As microbiome studies are on the increase, there are now various new issues 
that need to be considered and addressed. Determining what microbes are there 
is no longer enough, there needs to be an understanding of the ecology of these 
communities (Costello et al., 2012). For example it is still uncertain whether the 
microbiome can help protect the host from infection or whether it can aid in 
developing infection. How are these communities built, what defines the 
structure and how do these communities change in time? Microbial ecology is 
important as it provides an understanding of how microbes interact with each 
other, if diversity affects the stability of communities and whether patterns of 
co-existence are observed among microbiomes and if this is indicative of health 
and disease. Microbial ecological theory also impacts pharmaceuticals, food 
production, diagnosis/treatment and industrial applications (Ursell et al., 2012). 
The future of investigating the healthy microbiome involves understanding 
natural variation in taxa and function in healthy participants (Lloyd-Price et al., 
2016), how various factors such as age, sex and diet affects variation, whether 
observed differences are the cause or effects of a certain disease, and the 
potential restoration of microbial ecology - either through restoring certain taxa 
in healthy hosts or increasing biodiversity. Microbiome studies also need to 
address how to manipulate the microbiome through intervention trials. This 
could be through a probiotic drug which would require long-term follow up to 
determine how the microbiome responds to the intervention. This would 
determine the differences in microbiome structure before, during and after the 
intervention, with the necessary controls in place. Therefore there will always 
be a need to identify the taxonomic compositions of the microbiome, but it may 
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also be useful and necessary to start focussing on functions and finding target 
pathways in healthy scenarios as well as those that have altered expression 
levels in diseased states. 
 
8.5 Concluding remarks 
The work presented in this thesis provides a better understanding of the 
oropharynx microbiome in healthy non-smokers, and how this community is 
affected by respiratory infections and disturbances. It showed the oropharynx 
microbiome to be a stable community over time, with distinct differences 
apparent between the oropharynx of non-smokers and smokers, in both 
community composition and predicted function. Using the information gathered 
in this thesis, alongside future research, it may be possible in future to diagnose 
and treat respiratory disease through analysing and manipulating the oropharynx 
microbiome. 
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Appendix 1  
 
QIA-AMP DNA extraction protocol 
 
1. Store swabs in transport medium during transport to the laboratory.  
If swabs are not processed immediately they should be stored at 2-8°C for up to 
24 hours. Any period longer than this will be require storage at -20°C. 
 
2. All swabs should be vortexed to ensure dispersal of microorganisms from swab 
to fluid.  
 
3. Remove swab and place in a 2ml microcentrifuge tube. Centrifuge swab tip at 
5,000 x g or 8,000rpm to remove any remaining fluid in the tube.  
After centrifugation remove swab tip and transfer 1ml of suspension fluid into 
the same 2ml microcentrifuge tube and centrifuge for 10 minutes at full speed 
(20,000 x g; 14,000rpm). 
 
4. Suspend pellet in 180µl of enzymatic lysis buffer (20mg/ml lysozyme or 
200μg/ml lysostaphin; 20mM TrisHCl, pH 8.0; 2mM EDTA; 1.2% Triton). 
If there is no pellet formed or pellet formation is very small, remove as much 
supernatant as possible without touching the bottom of the tube and add 180μl 
of enzymatic lysis buffer to the same microcentrifuge tube. 
 
5. Incubate for at least 30 minutes at 37°C. 
 
6. Add 20μl Proteinase K and 200μl Buffer AL. Mix by vortexing for 10 seconds. 
 
7. Incubate at 56°C for 1 hour. If using a heat block, vortex the tube for 10 
seconds every 10 minutes. 
 
8. Centrifuge for a few seconds to remove drops from inside the lid. 
 
9. Incubate the 2ml microcentrifuge at 70°C for 10 minutes. If using a heat block 
vortex the tube for 10 seconds every 3 minutes to improve lysis. 
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10. Centrifuge for a few seconds to remove drops from inside the lid. 
 
11. Add 200µl ethanol (96-100%) to the sample and mix by vortexing for 10 
seconds. 
 
12. Centrifuge for a few seconds to remove drops from inside the lid. 
 
13. Carefully transfer the lysate from the 2ml microcentrifuge tube into a 
QIAamp Mini spin column (2ml collection tube).  
Close the cap and centrifuge at 8000 x g (6000rpm) for 1 minute (if the lysate 
has not completely passed through the 2ml column after centrifugation, 
centrifuge at a higher speed until the QIAamp Mini spin column is empty). 
Place the QIAamp Mini spin column in a clean 2ml collection tube and discard 
the tube containing the filtrate. Transfer any remaining lysate from the 2ml 
microcentrifuge tube and repeat as above. 
 
14. Add 500µl of Buffer AW1 to the QIAamp Mini spin column. Close the cap and 
centrifuge at 8000 x g (6000rpm) for 1 minute. Place the QIAamp Mini spin 
column in a clean 2ml collection tube and discard the tube containing the 
filtrate. 
 
15. Add 500µl of Buffer AW2 to the QIAamp Mini spin column. Close the cap and 
centrifuge at 8000 x g (6000rpm) for 1 minute. Place the QIAamp Mini spin 
column in a clean 2ml collection tube and discard the tube containing the 
filtrate. 
 
16. Centrifuge at full speed (20,000 x g; 14,000rpm) for 3 minutes to dry the 
membrane. 
 
17. Place the QIAamp Mini spin column in a clean 1.5ml microcentrifuge tube 
and discard the collection tube containing the flow-through. Carefully open the 
lid of the QIAamp Mini spin column and apply 50μl Buffer AE (having 2 
centrifugation steps of 25μl Buffer AE and a final re-elution step increases DNA 
yield). 
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18. Close the lid and incubate at room temperature for 5 minutes. Centrifuge at 
full speed (20,000 x g or 14,000rpm) for 1 minute. 
 
19. Qubit. 
 
20. Run 10µl of DNA extract with 2µl loading buffer on a gel to check purity 
(best to run extractions on a 1% gel -1g agarose to 100ml TAE or TBE.) 
If using Bioline mix reagents loading gel does not need to be used on the gel. 
 
21.  Run at 100v for 50 minutes. 
 
22. Store DNA at -20°C until required. 
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Appendix 2  
Production of an rDNA clone library  
 
Production of PCR products: 
 
1. Set up the following 50µl PCR reaction:  
 
25µl Bioline PCR mix 
1µl primer (forward and reverse) at 12.5pmol each 
2µl DNA template 
21µl water 
Total Volume 50µl 
 
2. The PCR reaction should run under the following conditions:  
 
Initial denaturation - 95°C for 5 minutes 
35 cycles of denaturation - 94°C for 1 minute 
Annealing - 62°C for 1 minute 
Extension - 72°C for 1 minute 
Final Extension - 72°C for 10 minutes 
 
3. Check the PCR product by agarose gel electrophoresis to ensure production of 
a single discrete band. 
 
QIA gel extraction kit protocol – extraction and purification of DNA from 
agarose gels: 
 
1. Cut DNA fragment from the agarose gel with a scalpel. 
 
2. Weigh the gel slice in a colourless tube.  
Add 3 volumes of buffer QG to 1 volume of gel (100mg - 100µl).  
For >2% agarose gels, add 6 volumes of Buffer QG. The maximum amount of gel 
slice per QIAquick column is 400mg; for gel slices >400mg use more than one 
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QIAquick column.  
 
3. Incubate at 50°C for 10 minutes. 
Vortex every 2-3 minutes to dissolve the gel. 
 
4. After the gel slice has dissolved completely, check that the colour of the               
mixture is yellow (similar to Buffer QG without dissolved agarose). If the colour 
of the mixture is orange or violet, add 10μl of 3M sodium acetate, pH 5.0, and 
mix. The colour of the mixture will turn yellow. 
 
5. Add 1 gel volume of isopropanol to the sample and mix (if the agarose gel 
slice is 100mg, add 100μl isopropanol).  
 
6. Place a QIAquick spin column in a provided 2ml collection tube. 
 
7. To bind DNA, apply the sample to the QIAquick column and centrifuge (1   
minute). Discard flow-through and place QIAquick column back in the same 
collection tube. 
 
8. Add 300ml of buffer QG to QIAquick column and centrifuge for 1 minute to 
remove all traces of agarose. 
 
9. To wash, add 300ml of Buffer PE to QIAquick column (stand for 2-5 minutes) 
and centrifuge for 1 minute. 
 
10. Discard the flow-through and centrifuge the QIAquick column for an 
additional 1 minute at > 10,000 x g (13,000rpm). 
 
11. Place QIAquick column into a clean 1.5ml microcentrifuge tube. 
 
12. To elute DNA, add 30μl of Buffer EB (10mM TrisCl, pH 8.5) to the centre of 
the QIAquick membrane and centrifuge the column for 1 minute at maximum 
speed. For an increased DNA concentration, let the column stand for 5 minutes, 
and then centrifuge for 1 minute. 
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Production of lunia bertani broth and agar plates: 
 
For 500ml broth: 
5g – Tryptone 
2.5g – Yeast agar 
5g – NaCl 
Add water to make a total volume of 500ml and autoclave. 
When broth has cooled add 5ml of Kanamycin. 
 
For 200ml agar plates: 
Add 3g of agar in 200ml of water and autoclave. 
When agar has cooled add 2ml of Kanamycin. 
Flame the bottle top using a Bunsen burner. 
Pour into plates. 
Flame agar plates to get rid of any bubbles. 
Let plates harden and store in fridge. 
 
Performing TOPO cloning reaction: 
 
1. Set up the following reaction:  
Fresh PCR product – 0.5 - 4µl 
Salt solution - 1µl 
Water – add to a total volume of 5µl 
TOPO vector - 1µl 
Total volume - 6µl 
The cloning reaction can be stored overnight at -20°C. 
2. Mix the reaction gently and incubate for 30 minutes at room temperature 
(22°C - 23°C). 
 
3. Place the reaction on ice ready for the next step. 
 
Transforming cells: 
 
1.  Warm selective plates to 37°C prior to spreading. 
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2.  Add 2µl of the TOPO cloning reaction into a vial of OneShot®Chemically 
competent E. coli and mix gently. 
 
3.  Incubate on ice for 30 minutes. 
 
4.  Heat shock the cells for 30 seconds at 42°C without shaking. 
 
5.  Immediately transfer the tubes to ice. 
 
6.  Add 250µl of S.O.C medium.  
 
7. Cap the tube tightly and shake the tube horizontally (200rpm) at 37°C for 1 
hour. 
 
8. Spread 10-50µl from each transformation on a pre-warmed selective plate. To 
ensure even spreading of small volumes, add 20µl of S.O.C medium (plate two 
different volumes to ensure that at least one plate will have well-spaced 
colonies). Spread at least 5 plates in total. 
 
9. Incubate plates at 37°C (ampicillin plate should produce colonies within 8 
hours whereas kanomycin plates should be incubated overnight). 
 
10. An efficient TOPO cleaning reaction should produce several hundred 
colonies. Pick 100-200 colonies for analysis. 
 
Analysing transformants: 
 
1. Pick 100-150 colonies for analysis. 
 
2. Aliquot 500µl of LB kanamycin into a 96 deep well plate. 
 
3. By the flame of a Bunsen burner, using a pipette and clean tip, pick up a 
single colony and inoculate a well in the deep well plate. Incubate overnight 
with shaking at 37°C at 200rpm. 
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4. Screen the colonies the next day for the correct insert. 
 
5. Remove 200µl of each sample in the deep well plate (96 samples altogether) 
to be amplified using the M13F and M13R primers. 
 
6. Set up the following PCR reaction to ensure the samples take up the vector:  
Biomix – 10µl 
M13F primer – 0.5µl 
M13R primer – 0.5µl 
Water - 7µl 
DNA - 2µl 
Total volume = 20µl 
 
The reaction should run for 25-30 cycles at the following conditions:  
95°C – 5 minutes 
94°C – 1 minute 
55°C – 1 minute 
72°C – 1 minute 
72°C – 10 minutes 
 
Run a gel at 100v for 60 minutes to ensure that each sample has taken up the 
plasmid.  
 
Restriction digest: 
 
1. Do a restriction digestion on all 96 samples. 
 
2. Set up the following reaction:  
PCR reaction - 5µl 
Hae 111 restriction digest – 0.1µl 
Water – 8.4µl 
Buffer – 1.5µl 
Total volume = 15µl 
 
3. Centrifuge tubes and incubate at 37°C for 4 hours. 
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4. Prepare a 2% gel for all 96 isolates (add 3µl of loading dye to the 15µl   
reaction). Run the gel at 100v for 90 minutes. 
 
5. From the gel group isolates into OTUs depending on the same banding 
patterns. Each type of OTU will be sent for Sanger Sequencing.  
 
6. Grow each OTU selected for Sanger Sequencing overnight in 5ml of LB and 
kanamycin (37°C, 200rpm for 20-24 hours). 
 
Plasmid extractions: 
 
1. Extract the DNA from the plasmid using the Invitrogen Purelink Quick Plasmid 
MiniPrep Kit. 
 
2. Centrifuge 1–5ml of the overnight LB-culture (5 minutes at 5000rpm). 
 
3. Add 250μl Resuspension Buffer (R3) with RNase A to the cell pellet and 
resuspend the pellet until it is homogeneous. 
 
4. Add 250μl Lysis Buffer (L7). Mix gently by inverting the capped tube until the 
mixture is homogeneous. Do not vortex. Incubate the tube at room temperature 
for 5 minutes. 
 
5. Add 350μl Precipitation Buffer (N4). Mix immediately by inverting the tube or 
for large pellets by vigorously shaking the tube, until the mixture is 
homogeneous. Do not vortex. Centrifuge the lysate at >12,000 × g for 10 
minutes. 
 
6. Load the supernatant from step 4 onto a spin column in a 2ml wash tube. 
Centrifuge the column at 12,000 × g for 1 minute. Discard the flow-through and 
place the column back into the wash tube. 
 
7. Add 500μl Wash Buffer (W10) with ethanol to the column. Incubate the 
column for 1 minute at room temperature. Centrifuge the column at 12,000 × g 
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for 1 minute. Discard the flow-through and place column back into the wash 
tube. 
 
8. Add 700μl Wash Buffer (W9) with ethanol to the column. Centrifuge the 
column at 12,000 × g for 1 minute. Discard the flow-through and place the 
column into the wash tube. Centrifuge the column at 12,000 × g for 1 minute. 
Discard the wash tube with the flow-through. 
 
9. Place the spin column in a clean 1.5ml recovery tube. Add 75μl of preheated 
TE Buffer (TE) to the centre of the column. Incubate the column for 1 minute at 
room temperature. 
 
10. Centrifuge the column at 12,000 × g for 2 minutes. The recovery tube 
contains the purified plasmid DNA. Discard the column. Store plasmid DNA at 
4°C (short-term) or store the DNA in aliquots at −20°C (long-term). 
 
Long term storage: 
 
1.  Streak out the original colony on LB plates. 
 
2.  Isolate a single colony and inoculate into 1-2ml of LB. 
 
3.  Grow overnight until culture is saturated. 
 
4.  Mix 0.85ml of culture with 0.15ml of sterile glycerol and transfer to a 
cryovial. 
 
5.  Store at -80°C. 
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Appendix 3  
QIAGEN QIA gel extraction kit protocol  
 
1. Cut the DNA fragment from the agarose gel with a scalpel. 
 
2. Weigh the gel slice in a colourless tube. Add 3 volumes of buffer QG to 1 
volume of gel (100ml - 100µl). For example, add 300μl of Buffer QG to each 100 
mg of gel. For >2% agarose gels, add 6 volumes of Buffer QG. The maximum 
amount of gel slice per QIAquick column is 400mg; for gel slices >400mg use 
more than one QIAquick column. 
 
3. Incubate at 50°C for 10 minutes. 
 
4. After the gel slice has dissolved completely, check that the colour of the 
mixture is yellow (similar to Buffer QG without dissolved agarose). If the colour 
of the mixture is orange or violet, add 10μl of 3M sodium acetate, pH 5.0, and 
mix. The colour of the mixture will turn to yellow. 
 
5. Add 1 gel volume of isopropanol to the sample and mix (if the agarose gel 
slice is 100mg, add 100μl isopropanol).  
 
6. Place a QIAquick spin column in a provided 2ml collection tube. 
 
7. To bind DNA, apply the sample to the QIAquick column and centrifuge for 1 
minute. 
 
8. Discard flow-through and place QIAquick column back in the same collection 
tube. 
 
9. Add 0.5ml of Buffer QG to QIAquick column and centrifuge for 1 minute to 
remove all traces of agarose. 
 
10. To wash, add 0.75ml of Buffer PE to the QIAquick column and centrifuge for 
an additional 1 minute. 
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11. Discard the flow-through and centrifuge the QIAquick column for an 
additional 1 minute at > 10,000 x g (13,000rpm). 
 
12. Place QIAquick column into a clean 1.5ml microcentrifuge tube. 
 
13. To elute DNA, add 50μl of Buffer EB (10mM TrisCl, pH 8.5) to the centre of 
the QIAquick membrane and centrifuge the column for 1 minute at maximum 
speed. For an increased DNA concentration, add 30μl elution buffer to the 
centre of the QIAquick membrane, let the column stand for 1 minute, and then 
centrifuge for 1 minute. 
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Appendix 4 
Supplementary Table 3.1  
Supplementary Table 3.1 – Descriptive statistics of the most abundant phyla 
from normalised communities in healthy samples. 
 
 
 
 
 
 
 
 
 
 
 Firmicutes Bacteroidetes Proteobacteria Actinobacteria Fusobacteria 
samples 279 279 279 279 279 
min 0.147 0.008 0.003 0.004 0.001 
max 0.946 0.558 0.614 0.219 0.230 
range 0.799 0.549 0.611 0.214 0.229 
sum 169.21 43.57 29.99 19.85 12.575 
median 0.612 0.142 0.063 0.063 0.032 
mean 0.606 0.156 0.107 0.071 0.045 
SE.mean 0.009 0.005 0.007 0.002 0.002 
CI.mean 
(0.95) 
0.019 0.011 0.014 0.005 0.004 
var 0.027 0.010 0.014 0.001 0.001 
std.dev 0.164 0.100 0.121 0.044 0.041 
coef.var 0.271 0.640 1.130 0.619 0.919 
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Appendix 5 
Supplementary Table 3.2  
Supplementary Table 3.2 – Descriptive statistics of the top 5 most abundant 
genera from normalised communities in healthy samples. 
 
 
 
 
 
 
 
 
 
 Streptococcus Prevotella Veillonella Neisseria Actinomyces 
samples 279 279 279 279 279 
min 0.061 0.002 0.004 0 0.002 
max 0.899 0.498 0.312 0.548 0.163 
range 0.838 0.495 0.307 0.548 0.161 
sum 131.2 26.42 16.27 14.92 11.26 
median 0.469 0.077 0.049 0.022 0.031 
mean 0.470 0.094 0.058 0.053 0.040 
SE.mean 0.011 0.004 0.002 0.005 0.001 
CI.mean (0.95) 0.022 0.008 0.004 0.009 0.003 
var 0.035 0.005 0.001 0.007 0.001 
std.dev 0.187 0.075 0.041 0.084 0.033 
coef.var 0.399 0.796 0.708 1.581 0.825 
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Appendix 6 
Supplementary Figure 3.1 
 
 
Supplementary Figure 3.1 – Plot showing the differences in microbiome 
composition regarding sex in healthy samples (n=279). Negative binomial GLMs 
were performed using DESeq2 package to show the 30 most significant OTUs and 
the log relative abundance of each OTU in males (M) and females (F).  
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Appendix 7  
Supplementary Figure 3.2 
 
 
Supplementary Figure 3.2 - Plot showing the differences in microbiome 
composition due to age in healthy samples (n=279). Negative binomial GLMs were 
performed using DESeq2 package to show the 30 most significant OTUs and the 
log relative abundance of each OTU in three different age categories – teens, 
twenties and thirties. 
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Appendix 8 
Supplementary Table 4.1  
Supplementary Table 4.1 – Descriptive statistics of the top 5 most abundant 
phlya from normalised communities in unhealthy samples. 
 
 
 
 
 
 
 
 
 
 
 
 Firmicutes Bacteroidetes Proteobacteria Actinobacteria Fusobacteria 
samples 34 34 34 34 34 
min 0.138 0.003 0.002 0.002 0.001 
max 0.966 0.467 0.825 0.184 0.285 
range 0.828 0.462 0.823 0.182 0.284 
sum 17.44 3.305 9.351 2.308 1.419 
median 0.512 0.087 0.121 0.059 0.014 
mean 0.513 0.097 0.275 0.067 0.041 
SE.mean 0.043 0.017 0.052 0.009 0.011 
CI.mean 
(0.95) 
0.089 0.034 0.106 0.019 0.021 
var 0.065 0.009 0.093 0.003 0.003 
std.dev 0.256 0.099 0.306 0.056 0.061 
coef.var 0.498 1.021 1.114 0.827 1.471 
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Appendix 9 
Supplementary Table 4.2 
Supplementary Table 4.2 – Descriptive statistics of the top 5 most abundant 
genera from normalised communities in unhealthy samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Streptococcus Pseudomonas Prevotella Serratia Veillonella 
samples 34 34 34 34 34 
min 0.043 0 0.001 0 0.001 
max 0.932 0.699 0.165 0.776 0.191 
range 0.889 0.699 0.164 0.776 0.189 
sum 13.06 1.947 1.815 1.680 1.645 
median 0.322 0.0001 0.042 0.001 0.033 
mean 0.384 0.057 0.053 0.049 0.048 
SE.mean 0.041 0.028 0.008 0.030 0.008 
CI.mean 
(0.95) 
0.083 0.057 0.017 0.062 0.016 
var 0.057 0.027 0.002 0.032 0.002 
std.dev 0.240 0.165 0.051 0.179 0.048 
coef.var 0.625 2.880 0.964 3.635 0.999 
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Appendix 10 
Supplementary Figure 6.1  
 
 
Supplementary Figure 6.1 – Box plot showing the most abundant phyla (n=10) 
and the mean relative abundance in healthy (red) and unhealthy (blue) 
samples from smoking participants.   
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Appendix 11 
Supplementary Table 6.1 
Supplementary Table 6.1 – Descriptive statistics of the most abundant phyla 
from normalised communities of smokers. Healthy communities are denoted by 
SH and unhealthy communities by SUH. 
 
 
 
 
 
 
 
 
 
 Firmicutes Bacteroidetes Actinobacteria Proteobacteria Fusobacteria 
Health SH SUH SH SUH SH SUH SH SUH SH SUH 
samples 145 32 145 32 145 32 145 32 145 32 
min 0.012 0.126 0.011 0.002 0.003 0.008 0.001 0.001 0.001 0.001 
max 0.949 0.904 0.975 0.382 0.811 0.351 0.943 0.832 0.661 0.120 
range 0.937 0.778 0.964 0.379 0.808 0.343 0.943 0.831 0.661 0.120 
sum 73.12 16.19 26.80 5.789 19.37 3.236 19.33 5.677 4.677 0.766 
median 0.523 0.511 0.157 0.166 0.085 0.071 0.041 0.054 0.014 0.014 
mean 0.504 0.506 0.184 0.180 0.133 0.101 0.133 0.177 0.032 0.023 
SE.mean 0.016 0.034 0.012 0.020 0.012 0.015 0.016 0.045 0.005 0.004 
CI.mean 
(0.95) 
0.033 0.070 0.025 0.042 0.024 0.030 0.031 0.092 0.011 0.010 
var 0.041 0.038 0.023 0.013 0.022 0.007 0.037 0.066 0.004 0.001 
std.dev 0.203 0.196 0.154 0.116 0.151 0.085 0.194 0.257 0.071 0.028 
coef.var 0.402 0.387 0.836 0.644 1.131 0.846 1.458 1.451 2.188 1.176 
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Appendix 12 
Supplementary Figure 6.2 
Supplementary Figure 6.2 – Box plot showing the most abundant genera (n=9) 
(with the rest pooled in the ‘Others’ category) and the median abundance in 
healthy (red) and unhealthy samples (blue) from smoking participants. 
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Appendix 13 
Supplementary Table 6.2 
Supplementary Table 6.2 – Descriptive statistics of the top 5 most abundant 
genera from normalised communities in healthy samples from smokers (SH). 
 
  
 
 
 
 
 
 
 
 
 
 Streptococcus Prevotella Actinomyces Veillonella Neisseria 
Health SH SH SH SH SH 
samples 145 145 145 145 145 
min 0.007 0.002 0.001 0.001 0.001 
max 0.801 0.452 0.281 0.244 0.428 
range 0.793 0.449 0.279 0.243 0.428 
sum 56.18 17.22 8.102 7.759 4.596 
median 0.387 0.108 0.035 0.041 0.007 
mean 0.387 0.118 0.055 0.053 0.031 
SE.mean 0.016 0.007 0.004 0.004 0.005 
CI.mean (0.95) 0.031 0.015 0.008 0.008 0.011 
var 0.037 0.008 0.002 0.002 0.004 
std.dev 0.193 0.092 0.054 0.050 0.063 
coef.var 0.498 0.778 0.976 0.938 2.012 
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Appendix 14  
Supplementary Figure 6.3 
 
Supplementary Figure 6.3 – Box plot showing the most abundant OTUs (n=10) 
(with the rest pooled in the ‘Others’ category) and the median abundance in 
healthy (red) and unhealthy samples (blue) from smoking participants.  
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Appendix 15 
Supplementary Table 6.3 
Supplementary Table 6.3 – Descriptive statistics of the top 5 most abundant 
genera from normalised communities in unhealthy samples from smokers (SUH). 
 
 
 
 
 
 
 
 
 
 Streptococcus Prevotella Serratia Actinomyces Veillonella 
Health SUH SUH SUH SUH SUH 
samples 32 32 32 32 32 
min 0.086 0.001 0 0.003 0.001 
max 0.878 0.372 0.795 0.176 0.168 
range 0.791 0.370 0.795 0.173 0.167 
sum 12.28 4.903 2.839 1.522 1.377 
median 0.346 0.142 0.001 0.035 0.028 
mean 0.383 0.153 0.088 0.047 0.043 
SE.mean 0.036 0.019 0.041 0.007 0.006 
CI.mean (0.95) 0.074 0.040 0.083 0.015 0.013 
var 0.042 0.012 0.053 0.001 0.001 
std.dev 0.206 0.111 0.231 0.044 0.038 
coef.var 0.537 0.726 2.612 0.931 0.896 
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